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Abstract  
Patient engagement in research includes a range of activities in which researchers 
involve patients in ways other than as subjects of research.  Research funders and 
researchers are increasingly recognizing patient engagement as a strategy that can lead to 
beneficial effects including the production of research that is more relevant to patients or 
of higher quality.  The Patient-Centered Outcomes Research Institute (PCORI), a large 
research funding organization Congressionally authorized under the Patient Protection 
and Affordable Care Act, requires engagement of patients and other stakeholders in its 
funded comparative effectiveness research.  Despite growing support for engagement, 
there is little empirical research and little conceptual scholarship examining patient 
engagement.  
 This dissertation seeks to advance current understanding of patient engagement 
through three aims. Aim one seeks to characterize researchers’ experiences with patient 
engagement in research funded by PCORI, and aim two seeks to characterize patients’ 
experiences being engaged in PCORI-funded research. To address these empirical aims, 
interviews were conducted with both researchers and with the patients they were 
engaging in their PCORI-funded research.  
The results of these aims are reported in two papers. The first describes patient 
engagement in PCORI-funded projects including how, when, and why patients were 
engaged, and the extent to which patient input was reported to impact the relevance, 
feasibility, acceptability, and quality of the research.  Findings suggest that the particular 
approach researchers use to engage patients may be less relevant to achieving desired 
outcomes than the manner in which engagement strategies are implemented.  
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The second empirical paper focuses on challenges to and successful strategies for 
patient engagement as reported in interviews.  This paper also provides suggested actions 
to address challenges and bolster infrastructure for engagement including modifications 
to institutional policies, development of programs and researcher networks, and provision 
of resources and training. 
 Aim three explores the value of patient engagement from a normative perspective 
and ascertains the circumstances in which patient engagement is morally important. 
Drawing on interview findings, this conceptual paper analyzes the moral importance of 
the instrumental effects of engagement—namely, enhanced relevance, accountability, and 
respect—and whether engagement can be said to have intrinsic moral value.  
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MANUSCRIPT 1: Characterizing Patient Engagement in PCORI-
Funded Research to Enhance Understanding of Its Ethical and 




Background: There is growing interest in patient engagement in research from both 
ethical and practical standpoints, yet there are few empirical investigations of the nature 
of patient engagement and its effects.  This information is needed to advance discussions 
on the ethical and practical value of patient engagement and when it ought to be 
conducted.  Methods: The aim of this study was to characterize patient engagement in 
research funded by the Patient-Centered Outcomes Research Institute (PCORI) as a step 
toward enhancing current understanding of how patient engagement is operationalized 
and its effects.  Qualitative interviews were conducted with 19 PCORI-funded principal 
investigators and with 33 patients engaged in 18 of the same 19 projects.  Results: 
Reasons cited for engaging patients included to enhance relevance and feasibility and to 
improve dissemination.  While engagement occurred at different points during the 
research, patients were most commonly engaged in reviewing study materials and less 
commonly engaged at earlier points.  Engagement varied by approach, frequency of 
interaction, and the extent to which patient input changed the research and was reported 
to impact the relevance, feasibility, acceptability, and quality of the research.  
Conclusion: These findings suggest that researchers and funders should focus less on 
particular engagement approaches and more on how patients can best influence decision-
making, as this tracks with achievement of impacts of engagement on the research 
process.  While more research is needed to evaluate the effects of engagement, these 
findings offer insights into the kinds of influence that engagement can have on the 
research process and thus the ethical and practical arguments that may motivate 




Patient engagement in research refers to researchers involving patients in research 
in ways other than as subjects of research (Hanley et al., 2003) and includes activities 
falling anywhere on a spectrum from low levels of engagement such as single 
consultations with patients to patient-researcher collaborations or even patient-led 
research (Staley, 2009).  
There is growing interest in patient engagement.  The Institute of Medicine (2009) 
identified engagement of patients and stakeholders as a priority for comparative 
effectiveness research (CER).  This priority is exemplified in the Patient-Centered 
Outcomes Research Institute (PCORI), a private, nonprofit research organization that was 
Congressionally authorized under the Patient Protection and Affordable Care Act (2010) 
to fund CER that engages patients and other stakeholders (PCORI, 2014).  With over 
$730 million awarded to a total of 365 research projects to date (PCORI, 2015) and plans 
to fund over $3 billion in research on a wide range of topics by the end of this decade 
(Washington & Lipstein, 2011), PCORI’s research portfolio has resulted in an 
unprecedented commitment to patient engagement in the United States.  
Increased support for patient engagement is fueled by the belief that it may have 
practical benefits on the research process including enhanced relevance of research to 
patients, higher quality research, and improved uptake of research findings (Caron-
Flinterman, Broerse, & Bunders, 2005; Roehr, 2010; Selby, Beal, & Frank, 2012; Sox & 
Greenfield, 2009).  These practical benefits are also significant from a normative 
perspective.  For example, higher quality research may be more useful to patients, more 
socially valuable, and a better use of limited resources.  Further, patient engagement may 
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be ethically important for other reasons such as a mechanism to hold researchers and 
funders accountable or as a way to show respect to patients (Boote, Telford, & Cooper, 
2002; Gradinger et al., 2013; Tritter & McCallum, 2006).  To the extent to which any of 
these practical and ethical reasons for engaging patients in research are compelling, it 
becomes important to understand how patients are being engaged in research and the 
effect of their engagement on the research process. 
A number of recent literature reviews provide emerging evidence in support of 
some of the hypothesized effects of engagement (Brett et al., 2014; Concannon et al., 
2014; Domecq et al., 2014; Forsythe et al., 2014; Shippee et al., 2013); however, these 
literature reviews are limited by several factors including the absence of indexing terms 
for literature searches on engagement, the lack of uniform reporting on engagement, and 
insufficient details reported or underreporting about engagement approaches and their 
effects.  Further, there have been no empirical investigations specifically on PCORI-
funded studies, which are bringing a new magnitude to engagement.  Empirical studies 
examining the nature of engagement approaches, the effects of engagement, and which 
approaches appear most impactful remains an area of need (Brett et al., 2014; Concannon 
et al., 2014; Snape et al., 2014; Staniszewska et al., 2011; Workman, Maurer, & Carman, 
2013).  This qualitative study was undertaken as a step toward enhancing current 
understanding of patient engagement, including the practice of patient engagement and 
the nature and degree of the effects of engagement, all of which are relevant to arguments 
on the ethical and practical value of patient engagement in research.  The research 
question of this qualitative study was: “how was patient engagement operationalized in 




The objective of this study was to characterize experiences with patient 
engagement in PCORI-funded research.  The approach to data collection and analysis 
followed a qualitative descriptive approach which aims to generate a comprehensive 
description of the event under investigation (Sandelowski, 2000).  This study was 
approved by the Johns Hopkins Bloomberg School of Public Health Institutional Review 
Board (JHSPH IRB).   
Sampling 
Purposeful sampling from PCORI’s first two rounds of funding awards—the Pilot 
Projects Grant Program (50 two-year projects awarded in June 2012) (PCORI, 2012a)  
and the Cycle I Awards (25 three-year projects awarded in December 2012) (PCORI, 
2012b)—was conducted as these projects were closest to completion at the time this 
study was initiated.  Funding applications were reviewed to aid the sampling process.  
Only studies with funding applications describing plans for patient engagement—defined 
as the involvement of patients, patient representatives, community members, and/or 
caregivers of patients in a way other than as subjects of research—were eligible for 
inclusion.  
The goal of purposeful sampling was to include typical engagement approaches 
described in the funding applications while also capturing variation with respect to other 
project attributes relevant to engagement that were also described in the funding 
applications, including: the population engaged (e.g., healthy patients, sick patients, 
patients from advocacy organizations, lay patients, minority patients, elderly patients), 
whether researchers had a previous relationship with the patients they were engaging, 
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whether projects were also engaging non-patient stakeholders (e.g., clinicians, 
policymakers, purchasers, payers), and the study topic (e.g., behavioral health, chronic 
disease, rare disease).  Eligible projects were grouped by the kinds of engagement 
approaches described in the applications, including: advisory groups, focus 
groups/interviews, surveys, patient co-investigators, patient research team members, pilot 
testing, and novel methods.  The sample was built to ensure each approach was included 
and that there was variation with respect to the other characteristics described above.  
When principal investigators (PIs) were recruited, they were asked their 
willingness to (i) participate in an interview themselves and (ii) refer up to two patients 
who were actively engaged in their projects and had somewhat different backgrounds or 
experiences (e.g., affiliation with advocacy organizations, health status, experience with 
study topic, experience with engaged research, age, gender) for possible interviews.  PIs 
were asked to first seek patients’ permission to share contact information with 
investigators of this study, and then, if patients were willing, contact information was 
forwarded to investigators.  
Interviews and Questionnaires 
 Oral consent was obtained before each interview.  During both the recruitment 
and informed consent processes, interview participants were informed that the 
interviewer (LE) worked at PCORI and that PCORI was aware of but had no involvement 
in the project.  Participants were also told that the project comprised the research for the 
student’s doctoral dissertation, and that PCORI would have no access to any information 
about which studies or individuals were recruited or interviewed, nor would PCORI have 
access to any data collected as part of the research.   
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All interviews were audio-recorded.  Interviews adhered to a guide covering four 
domains: background information about the project and nature of engagement activities, 
the purpose and goals of patient engagement, experiences being involved in the 
engagement activities, and general beliefs about patient engagement.  However, 
respondents were free to discuss topics within these domains that were of greatest 
relevance to them.  Participants also completed a short questionnaire with demographic 
and background questions. 
To assess the appropriateness and understandability of interview questions, two 
cognitive interviews following the approach outlined by Beatty and Willis (2007) were 
conducted.  One was with a Johns Hopkins Hospital researcher with experience engaging 
patients and the other was with a patient involved in a community advisory board through 
Johns Hopkins Hospital.  Interview and questionnaire items were also reviewed by a 
community research advisory council, and changes were made in response to community 
feedback. 
Analysis 
Data collection and analysis occurred in an iterative fashion, with interviews 
conducted until informational redundancy was reached.  The thematic analysis relied on a 
combined deductive and inductive approach.  Audio-recordings were transcribed and 
reviewed for accuracy.  Questions from the interview guide informed development of an 
initial coding scheme, with inductive codes added as transcripts were reviewed.  Codes 
were organized into thematic families, applied to a subset of transcripts, and further 
refined before a finalized coding scheme was applied to all transcripts.  
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A second coder was trained and coded six transcripts.  The double-coded 
transcripts were reviewed and percent agreement of the codes was calculated to assess the 
reliability of the scheme.  A high level of concordance (80% agreement) was achieved.  
Questionnaire data were analyzed to consider participant demographics, and the software 




This section reports study findings.  The findings from the questionnaire include 
background and demographic information about study participants.  The findings from 
the interviews consist of details about patient engagement in the projects including the 
reasons why researchers engaged patients in projects and reasons why patients decided to 
become engaged in the projects, the types of engagement approaches used in the projects, 
how relationships between researchers and patients were established, when in the 
research process engagement took place, and the key contributions of engagement.  
Throughout this section, interview quotations are labeled by funding cycle (“PP” for Pilot 
Project; “C” for Cycle I), study number (PP1-PP9; C1-C10), and respondent type (“PI” 
for investigator; “Pt A” or “Pt B” for the first or second patient interviewed from a given 
study). 
Participants 
Qualitative interviews were conducted with 19 PIs from 19 different PCORI 
projects and 33 patients from 18 of the same 19 projects.  Interviews were conducted 
between December 2013 and May 2014.   
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Pilot Projects that engaged patients (42 of 50) were eligible for this study.1 
Nineteen Pilot Project PIs were contacted to see if they were willing to participate and to 
refer patients for interviews (Figure 1.1).  Nine of the 19 Pilot Project PIs enrolled in the 
study, and 10 declined participation: one did not respond after four attempts and the 
others cited reasons including lack of time (n=3), IRB concerns (n=1), not yet engaging 
patients (n=1), not willing to have patients interviewed (n=2), and no longer able to 
contact patients whom they had already engaged (n=2).  All 25 Cycle I Awards engaged 
patients and thus were eligible.  Fourteen PIs from Cycle I Awards were recruited (Figure 
1.2).  Ten of the 14 enrolled in the study, and four declined participation: one did not 
respond after four attempts and the others declined because of lack of time (n=1) and not 
willing to have patients interviewed (n=2).  A total of 19 interviews were conducted with 
PIs, 11 in-person and 8 by phone.  The mean length of PI interviews was 45 minutes 
(range: 27 to 67 minutes).  Eighteen Pilot Project patients were recruited; 16 participated 
and two declined because of lack of interest.  Nineteen Cycle I Award patients were 
recruited; 17 participated and two declined: one cited lack of time and there was no 
response from the other.  A total of 33 patients were interviewed, 14 in person and 19 by 
phone.  The mean length of patient interviews was 42 minutes (range: 16 to 62 minutes). 
Of PIs interviewed, half were female; the majority were white, and ages ranged 
from under 30 to over 61 years (Table 1.1).  Nearly all Pilot Project PIs had engaged 
patients in prior studies, but few Cycle I PIs had.  Most PIs had been on faculty for at 
least six years and had served as PI on at least four grants, including their PCORI project. 
1 As early, methods-focused studies, the Pilot Projects did not all engage patients and were also 
not required to be comparative, unlike the Cycle I Awards which were comparative studies. 
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Over two-thirds of patients interviewed were female; the majority were white, 
with a wide age range represented (Table 1.2).  Over two-thirds were employed and held 
a college or graduate degree, and about half reported having a chronic condition.  While 
over a third had previously engaged in research, more patients from the Pilot Projects had 
previous experience compared to Cycle I Awards.  
Reasons for Patient Engagement 
 PIs and patients both reported getting patient input as a general goal of patient 
engagement; however, PIs tended to further specify that such input was valuable for 
multiple specific reasons.  The main reasons reported by PIs were to enhance the 
relevance of research, enhance feasibility, improve dissemination, and fulfill PCORI’s 
requirement.  Patients also described increased relevance as a main reason for patient 
engagement.    
 Relevance: About two-thirds of investigators (n=13) and nearly half of patients 
(n=15) described engaging patients to enhance relevance, making it the most commonly 
cited reason.  PIs viewed engagement as a way to understand patients’ needs so that 
research could address them: “I think the main reason is just to find out what matters to 
them” (PI, C10).  Patients expressed the same idea: “If you leave the user out of the 
process, then you deliver a product that isn’t going to meet their needs as well (Pt A, 
PP7).  
 Feasibility: Just over half of investigators (n=10) described engaging patients to 
enhance feasibility.  This included engaging patients to identify the most practical 
research processes and to anticipate challenges.  Investigators often described relevance 
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and feasibility together: “It has helped us to design a process, both process and content, 
that is much, much more usable and meaningful to patients, which is the goal” (PI, C2). 
 Dissemination: About half of investigators (n=9) described engaging patients to 
improve dissemination, such as to ensure results were understandable and would reach 
the intended audience: “One of the goals of the [advisory group] is to be able to 
understand the results, interpret the results, and then be able to explain the results to other 
people” (PI, C3).  
Requirement: Lastly, about half of investigators (n=9) cited PCORI’s 
requirement as a reason, though not necessarily the main reason, they engaged 
patients in their PCORI project.  
Why Patients Became Engaged 
Patients articulated a diverse set of motivations for becoming engaged in research 
including to reciprocate benefits they had received from the investigator’s institution, to 
improve the patient community’s health, to improve one’s own health, and to learn more.  
Patients often discussed multiple reasons for joining projects: “Not only did I think that 
maybe I had something I could contribute, but that also I would be learning as well” (Pt 
A, PP9).  Patients with preexisting relationships with PIs cited that as a reason for 
becoming engaged: “I did it because [researcher] asked me to do it and that was it… It 
was a personal relationship” (Pt A, PP8). 
Types of Engagement 
A range of approaches to engagement was included in the sample, and PIs and 
patients described these various approaches: advisory groups, patient co-investigators, 
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patient research team members, pilot testing, focus groups, interviews, surveys, and novel 
methods (Table 1.3).  About three-quarters of projects (n=14) used more than one 
approach.  
Advisory Groups: Used by almost all of the projects (n=16), advisory groups 
were the most commonly used approach that informants in the sample described.  This 
included community advisory boards (CABs), patient and family advisory councils, and 
multi-stakeholder steering committees.  PIs and patients described the frequency with 
which these groups met for their projects; meetings ranged from monthly to annual, with 
quarterly meetings the most common.  Advisory group meetings typically included 
activities such as researchers providing progress updates, presentations and discussions 
on study-related topics, and requests for feedback on specific areas of the research.  
Investigators described advisory groups as people “who we can go to and say, ‘Hey, what 
do you think about this approach?  What do you think about this method?  How should 
we say this?’” (PI, PP1). 
 Patient Research Team Members: About half of projects (n=9) involved 
patients as members of the research team, including as co-investigators, making it the 
second most common approach described by interview participants.  Patient research 
team members reported that they met regularly with scientific investigators, provided 
input throughout the research, and often connected PIs to other patients or led advisory 
group meetings.  A typical PI statement about a patient in this role describes the patient 
as  “critical, not only to provide the patient perspective when we were developing and 
writing the proposal, but also to connect us with other stakeholder groups” (PI, C5).  
Similarly, a patient co-investigator described her leadership role: “[It] was stated in the 
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grant proposal that I would be leading the patients/family advisory board, and so one of 
my tasks is to be the chair of that board” (Pt A, PP3). 
 Pilot Testing: Patients and researchers from about half of projects (n=9) 
describing engaging patients in pilot or usability testing of study interventions or 
materials to see how user-friendly, feasible, or understandable they were.  As a patient 
explained: “Once the iPad application was ready to be used with the patients, we were 
given it for a couple of weeks to play with and practice, and then go through all the uses 
that a patient would use it for.  So we gave some feedback on that” (Pt B, PP9).  
 Focus Groups, Interviews, and Surveys: While less common than the use of 
other methods, focus groups/interviews were used by about a third of projects (n=7), and 
surveys were used by just a few projects (n=3).  These methods to engaging patients 
usually involved single interactions to get input in targeted ways such as discussing 
domains for inclusion in study instruments, ranking outcomes of greatest priority, or 
designing the study intervention. 
 Novel Methods: A few projects (n=3) used novel methods to engage patients.  
These methods included an interactive web-based discussion forum to get patient input 
on study materials, a multi-stakeholder engagement workshop to help design the study 
intervention, and a PI-created in-person presentation and discussion forum to get patient 
input throughout the research process. 
How Relationships were Established 
 PIs and patients from over half of the projects (n=11), mostly Pilot Projects, 
described having preexisting relationships, often from prior engagement or professional 
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interactions including working at the same institution or shared membership in an 
organization.  Investigators sought new relationships with patients through referrals from 
healthcare providers, clinics, national patient associations, local disease group leaders, 
clinician co-investigators, or other patients.  About a quarter of PIs (n=5) reported 
recruiting participants from their PCORI project to serve as some of their engagement 
partners, while about a third of PIs (n=6) described recruiting engagement partners from 
existing groups, such as the hospital’s patient advisory council. 
Engagement by Stage of Research  
 Patients were engaged at different points during the research.  The majority of 
both PIs (n=16) and patients (n=22) referred to patients being involved in reviewing or 
developing study instruments, consent documents, recruitment materials, or intervention-
related materials.  Patients and PIs also commonly mentioned engagement in study 
design and methods.   
 Beyond this, patients and researchers from each project described patients being 
engaged in usually just one or two of the following several areas: proposal development, 
study interventions, study outcomes, recruitment, and data analysis/interpretation.  For 
each area, about half of studies reported engagement.  Projects varied regarding in which 
of these areas they engaged patients.   
 Engagement was uncommon at the earliest stages of research.  Only a few 
researchers (n=3), all from Pilot Projects, described engaging patients in research 
question development.  No patients commented specifically on being engaged in research 
question development, although patients from one study described participating in early 
meetings to “frame the whole issue” (Pt A, PP5).  
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 Both researchers and patients provided many specific examples of engaging 
patients throughout the research process and the effects of such engagement. Quotations 
from researchers and patients illustrating various effects of patient engagement at 
different points in the research process are depicted in Table 1.4. 
Key Contributions of Engagement  
Patients and PIs described their views on how patient engagement contributed to 
the research.  What PIs perceived as the main contributions of engagement matched some 
of the reasons they cited for engaging patients including to enhance relevance and to 
improve feasibility.  Researchers and patients also described improved appropriateness 
and acceptability of the research and increased research quality as effects of patient 
engagement.  Patient responses were generally not as detailed as PI responses, but their 
responses were consistent with the substance mentioned by researchers. 
Enhanced relevance  
 Enhanced relevance was the most common reason for engaging patients and was 
also described most frequently as the main outcome of engagement.  Nearly all 
researchers (n=16) and about half of patients (n=16) described ways in which patient 
input impacted the relevance of the research including the relevance of study materials, 
interventions, and outcomes.  About a third of PIs (n= 7) and a fourth of patients (n=9) 
noted that patient input enhanced the relevance of interventions.  PIs described modifying 
interventions to better address patients’ interests based on what they learned through 
engagement.  One investigator reported that engaging patients and providers in designing 
the intervention “kept the patient needs front and center” (PI, C6).  In an unusual 
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example, early discussions with patients led a Cycle I investigator to realize that patients 
were using a resource offered through local community centers in lieu of clinical 
treatment options, so the investigator added this community-based intervention as a third 
study arm. 
Nearly a fifth of patients (n=6) specifically described being asked to give opinions 
on the relevance of outcome measures, and a third of PIs (n=7) described how 
conversations with patients confirmed the relevance of outcomes or prompted the 
addition of secondary outcomes that patients felt were important.  For example, one PI 
stated, “[We] clearly needed to have very active engagement with patients to find out 
what they thought were important outcomes” (PI, PP3).  A patient from that study 
confirmed this: “I think the consumer voice adds a lot to this, and we saw that especially 
with our outcomes” (Pt A, PP3).  
Enhanced feasibility 
 About a third of patients (n=12) reported that their feedback enhanced study 
feasibility.  A patient engaged in pilot testing of a novel intervention, for example, 
expressed this common belief: “The people that actually need the treatment, I think, can 
provide some pretty significant feedback in what works, what doesn’t work” for the 
intervention (Pt B, PP7).  About a third of investigators (n=7) echoed this sentiment, 
describing how patient input helped them anticipate and solve challenges to 
transportation, compensation, and other study logistics.   
Similarly, just less than half of PIs (n=8) attributed successful enrollment to 
patient input on recruitment materials and strategies: “I think probably the enrollment 
process has gone more smoothly because we had folks involved… I think that’s really 
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related to having a lot of patient input in terms of how to design the form and present the 
study to potential participants” (PI, C2).  
Improved appropriateness and acceptability  
With almost all of PIs reporting engaging patients in reviewing study materials 
(n=16), examples of changes to study materials prompted by patient input were described 
by over half of PIs (n=11) and just less than half of patients (n=14).  Patients enhanced 
the appropriateness of study materials by providing input on the length of instruments, 
their comfort level answering certain questions, and the understandability of the 
language.  A PI described patient feedback as prompting him to consider appropriateness 
for all kinds of patients: “What about patients who are lower in terms of socioeconomic 
status and lower health literacy?  How is this going to apply to people who have 
significant disabilities?  You know?  She kept reminding us” (PI, PP2).  Patient feedback 
of this nature was reported to spur changes to the wording and content of materials.  
About a third of PIs (n=7) also reported that patient feedback confirmed the 
acceptability of study methods or prompted changes.  For example, patients’ concerns 
about asking participants to share personal information in focus groups prompted an 
investigator to switch to individual interviews.  Another investigator shortened the 
follow-up period and made arrangements for post-trial access to the experimental 
intervention after patient advisors expressed wanting all study participants to have an 





Improved quality  
 Often contrasting their PCORI projects with earlier research, about a third of PIs 
(n=7), mostly from Pilot Projects, suggested that their projects were better because of 
engagement.  As one investigator expressed: 
You are going to come up with a better design for that survey if you’re engaging 
patients in the process. And maybe because I’m old enough to have seen the old 
method of doing this, which is where the professors come up with the survey, and 
then watch people either not fill it out or give you invalid data because it’s—from 
their perspectives—stupid questions or questions that are not really relevant or 
understandable to them. (PI, PP6) 
A few PIs (n=3) linked other effects of engagement—namely, enhanced relevance and 
appropriateness of study materials—with subsequent effects on research quality, noting 
that results are less accurate when patients do not understand questions asked of them.  A 
few patients (n=5) also made this link: “It’s going to make the information gained from 




 This study of PCORI projects describes researchers’ and patients’ experiences and 
opinions regarding patient engagement in research.  The findings provide insights into 
two areas identified previously as lacking sufficient evidence: the nature of patient 
engagement and its effects (Brett et al., 2014; Concannon et al., 2014; Snape et al., 2014; 
Staniszewska et al., 2011; Workman et al., 2013).  As such, this study informs 
discussions on the importance of patient engagement from both practical and ethical 
perspectives.  
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This study found that patient engagement occurred at different points, both within 
given projects and across different projects.  Further, in this sample, patient engagement 
also varied by approach, frequency of interaction, and researchers’ responses to 
engagement across the various projects.  Patients were most commonly engaged in 
reviewing study materials, while engagement early in the research was uncommon.  PIs 
most commonly engaged patients in advisory boards, followed by as research team 
members, and lastly in other ways including focus groups, surveys, and pilot testing, all 
of which are documented methods (Concannon et al., 2014; Domecq et al., 2014; Staley, 
2009).  Frequency of interactions was remarkably varied but most commonly included at 
least quarterly meetings.  Researchers’ responses to engagement—that is, how 
engagement fit within the context of their project—ranged from using patient opinions to 
inform their decision-making to having patients play a greater role in decisions. 
Investigators and patients in this study described how engaging patients in 
reviewing study materials and methods improved their appropriateness and enhanced the 
feasibility and relevance of the research.  This suggests that patient engagement can 
achieve both ethical and practical goals and is consistent with other studies reporting 
similar influence (Brett et al., 2014; Concannon et al., 2014).  Perhaps one reason why 
patients were most commonly engaged in reviewing study materials is because it is easier 
for patients who are unfamiliar with research to provide feedback on this generally less 
technical aspect of research.  Alternatively, it may be that the stages at which patients are 
engaged inform the nature of the effects of patient engagement on the research process.  
Researchers and patients reported enhanced relevance of the research as both a 
main reason for engaging patients and as a key contribution.  The relevance of the 
 18 
research to patients likely factors into patients’ views of the social value of research, 
which is widely accepted as an ethical requirement of research (Emanuel, Wendler, & 
Grady, 2000); thus, these findings suggest that patient engagement may be a morally 
important strategy to increase the social value of research, at least from the patients’ 
perspective.  Despite the fact that relevance was commonly cited as a reason for 
engagement, researchers mostly did not engage patients early in the research process, 
where key contributions to the relevance of the overall research project could be made 
(Brett et al., 2014).  Engagement throughout all phases of research including early in the 
process is a principle of community-based participatory research (Israel et al., 2003).  
Researchers may not have realized that engaging patients early in the process could 
enhance relevance, or they may have lacked time, support, and experience to engage 
patients at earlier points, especially prior to receiving funding (e.g., in formulating the 
research question and developing the grant proposal).  Investigators accustomed to 
writing grants on their own, for example, may find it difficult to involve patients in that 
process, especially without dedicated resources for doing so.  Given that relevance is both 
ethically and practically important and that early engagement may be key for enhancing 
relevance, funders should consider providing support for early engagement, perhaps even 
during proposal writing.  Efforts to align funding mechanisms with the current grant 
writing process may facilitate early engagement as a means to produce research that is 
more relevant to patients. 
In this study, researchers’ responses to engaging patients varied independent of 
engagement approach and frequency of interaction.  Some PIs involved patients in ways 
where patients could provide reactions and advice, while others described situations 
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where patients were more equal decision makers.  This is comparable to what some in the 
field have classified as “consultative” versus “collaborative” levels of engagement 
(Hanley et al., 2003).  Consultation refers to researchers asking for patients’ opinions but 
not being committed to follow them.  By contrast, collaboration refers to an ongoing 
partnership, which involves sharing some control of the project with patients.   
Arguably the purpose of engaging patients is for patients to influence the 
research, whether through advancing practical goals, ethical goals, or a combination of 
the two.  Investigators and patients in this study gave multiple reasons for engagement, 
including to enhance the relevance and feasibility of research, which suggest the 
expectation for patient engagement to have some effect.  A key question, therefore, is 
whether differences in engagement approach are relevant to the nature of, or degree to 
which, such influence occurred.   
In this study, researchers’ responses to engagement—that is, their receptivity to 
patient feedback and the extent to which patients were involved in a leadership or 
decision-making role—as well as the frequency of interaction between researchers and 
patients seemed most related to the achievement of key practical and ethical 
contributions.  While there is a need for research into whether certain effects of 
engagement are associated with different approaches, these findings suggest that the 
particular approach to engagement may be less relevant to achieving desired outcomes 
than the manner in which any number of engagement strategies are implemented.  This 
suggests that researchers and funders ought to focus less on types of engagement and 
more on other characteristics, such as whether there is opportunity for patients to 
influence decision-making at certain points in the research, as this tracks with 
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achievement of goals of engagement.  The particular reason for engaging patients in a 
given study is predictive of the kinds of influence that patients can have on the research.   
There were several limitations to this study.  First, it included only PCORI 
projects, which differ not only in their requirement for engagement but also in the support 
they receive for engagement. While this may limit the transferability of findings, the 
results may be relevant to other funders who may similarly introduce engagement as a 
requirement.  Because half the investigators were new to engagement, the findings likely 
differ from more experienced investigators; however, the majority of investigators do not 
engage patients routinely, and thus findings may be relevant more broadly.  Second, 
participating investigators may have had different experiences compared to those who 
declined participation, which may bias the results.  There were a higher proportion of 
female investigators and double the proportion of investigators with senior academic 
rankings among refusing investigators compared to participating investigators; however, 
they were similar with regard to geographic region, academic degrees, and institution 
type (e.g., university, foundation, or other organization).  Third, because projects were in 
progress, this study was unable to explore the effects of engagement on dissemination, 




This study provides a rich description of patient engagement in PCORI projects, 
enhancing current understanding of how patient engagement is operationalized and what 
researchers and patients perceive as its main effects.  Further, this study characterizes 
how, when, and why patients can be engaged in research, contributing to a limited 
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evidence base.  Because reasons for engaging patients in research may be motivated by 
the anticipated effects of such engagement, knowing how patients can influence the 
research process is key to advancing arguments on the ethical and practical importance of 
patient engagement in research.  Patient engagement may enhance the relevance, 
feasibility, acceptability, and quality of the research, all of which are important from 
practical and ethical perspectives.  While future research is needed to develop objective 
measures to evaluate these effects of patient engagement and explore other possible 
ethically important outcomes of engagement (e.g., respect, accountability), this research 
offers insights into the kinds of influence that patient engagement can have on the 
research process and thus the ethical arguments that may motivate researchers to engage 
patients in their research.   
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TABLES AND FIGURES 
 
Table 1.1: Background Characteristics of PIs  
(n = 19) 
Age 
Under 30 years 1 
31-40 years 4 
41-50 years 5 
51-60 years 6 
61+ years 3 
Race/Ethnicity 
African American (non-Hispanic) 1 
Asian/Pacific Islander (non-Hispanic) 1 





Prior Experience  
Engaged patients in research prior to this 10 
Participated as a human subject in research 16 
Grants on Which Served as PI (Inclusive) 
1-3 grants 5 
4-6 grants 5 
7-9 grants 3 
10+ grants 6 
Years Serving on Academic Faculty 
<1 year 0 
1-5 years 4 
6-10 years 4 
11-20 years 5 
20+ years 6 
 
The source of these data is a short questionnaire 




Table 1.2: Background Characteristics of 
Patients (n= 33) 
Age 
Under 30 years 3 
31-40 years 1 
41-50 years 4 
51-60 years 12 
61+ years 13 
Race/Ethnicity 
African American (non-Hispanic) 4 
Asian/Pacific Islander (non-Hispanic) 1 





Prior Experience  
Engaged in research prior to this 13 
Participated as a human subject in research 19 
Highest Educational Attainment 
Some high school, no diploma 0 
High school graduate 2 
Trade/technical/vocational training 1 
Some college, no degree 5 
College degree 11 
Graduate degree 14 
Employment Status 
Employed full-time 16 
Employed part-time 8 
Not employed, seeking employment 1 
Not employed, not seeking employment 8 
Health Status 
Chronic disease/condition 17 
The source of these data is a short questionnaire 




Table 1.3: Characteristics of Engagement in Projects in 
Study Sample (n =19) 
Type of Engagement 
Advisory group 16 
Patient research team member or co-investigator 9 
Pilot Testing 9 
Focus groups/interviews 7 
Surveys 3 
Novel Methods 3 
Used more than one engagement approach 14 
Populations Engaged 
Patients or community members 18 
Patient representatives from organizations 6 
Caregivers  7 
Also engaged non-patient stakeholders  12 




Northeast  5 
Southeast and South 6 
 Midwest and West 8 
 
These data were derived from PI interviews. Novel methods 
included unique activities developed by the researcher: an 
interactive web-based discussion forum, an in-person multi-
stakeholder workshop, and an in-person presentation and 
discussion forum. Pilot testing included patients testing 
study instruments or interventions to provide feedback on 













Table 1.4: Patient & Investigator Quotations on the Effects of Engagement at 
Various Points During the Research Process 
Quotations from Investigators Quotations from Patients 
Research Topics/Question Development 
Our goal was to utilize [measures] which 
were able to cover many of these other 
domains of health and see whether they 
were able to reflect these areas that patients 
had told us were important… There was 
the patient engagement in terms of 
formulation of the question. (PI, PP2)  
There are times in which the people in the 
community are the experts. So they are the 
experts on how we address the needs of 
[patient population]. They shape that 
conversation with us, we framed it out of 
conversations with the community advisory 
board. (Pt B, PP5) 
Proposal Development 
There was a period of time when we were 
writing the grant and crafting the idea 
where the idea morphed because of the 
input of the team… Because we had an 
opportunity to engage a number of but not 
all parents in the process of crafting of the 
application, they already had ownership 
over it. (PI, PP1) 
I wasn’t there when [PI] formulated the 
idea in his head, but I was there just 
beyond…[PI] would do the main writing of 
the grant proposal…And then we would all 
have the document to make comments, 
suggested corrections or additions, 
deletions, etcetera, etcetera. (Pt A, PP3) 
Study Design/Methods 
Our stakeholders really sort of actually 
came up with that design, corroborated 
with us that “Yes, that is a good design”… 
It allowed us to get at data in different 
ways, and to actually test –well, it’s not 
really testing, but asking the stakeholder up 
front, “Would you have something to say 
about this? Could you spend an hour or two 
talking about your situation?” (PI, PP9) 
We are also going to be interviewing, 
doing online methods… Even that involves 
a patient and a family voice, so that 
involves, actually, my son... meeting with 
[researchers] and saying, “Well, this is how 
I would feel comfortable communicating 
online. This is how I wouldn’t be.” And 
then going to our families and saying, 
“How would you feel comfortable 
communicating online?” (Pt A, PP1) 
Study Materials 
It was going to be like an interview… The 
way it ended up happening is we now have 
all the participants do a written, self-
directed portion, where they work through 
things on their own, and then there’s a 
debriefing interview in the second half of 
it. That was a pretty substantial reworking 
of it, that went really well, but that was 
based on stakeholder feedback. (PI, C5) 
So I think what I brought to the study were 
making our questions that we ask to a third 
grade reading level and also incorporating 
an aspect of the study where the questions 
could be read to the person through the 
computer, that there would be an audio, 
instead of just assuming people read… 
that's one of the components that I felt like 
I was able to bring. (Pt A, C2) 
Study Intervention 
We started with, very broadly, “This is 
what the intervention will feel like as a 
patient or a family member; how does that 
sound?” And then we’ve been getting 
Basically we’ve been involved from the 
beginning of discussions about what the 
procedures are and then we’ve looked at 
proposed documents for all of the various 
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really into the details where every month 
we’ll have a representative…talk about the 
intervention in detail and get their feedback 
on the intervention. (PI, C3) 
steps in the process… timing of the 
communication beforehand, involvement 
of the pharmacist as well as the nurses and 
social workers in that process. (Pt B, C3) 
Study Outcomes 
This choice of secondary outcome measure 
being a measure of physical performance… 
That was informed by these community 
discussions. I would not have included that 
originally. That was not my intent. But 
after speaking to so many people that told 
me they wanted to be more active, I 
realized, I need to measure that. (PI, C9) 
I think the biggest way that we’ve impacted 
the research is by giving our perspective. 
What might be an outcome that’s desirable 
in the medical community could be 
completely different to a patient. And so 
we’ve been able to say where we were 
coming from, and I think that’s really 
helpful. (Pt B, PP3) 
Recruitment 
They’ve helped us out with everything 
from website design to the best ways to 
approach folks in the hospital. (P1, C8) 
We also shared with him some other 
community resources… There’s a small, 
local publication… They weren’t aware of 
that, so I sent them the publication and the 
contact information. (Pt B, C9) 
Analysis/Interpretation 
In terms of where we are now, analyzing 
and interpreting the data, I think they bring 
a lot into just kind of giving us a different 
perspective of how we’re thinking about 
that. So when things don’t come out 
exactly how we thought, they are like, “Oh 
yeah, but that may be because of A, B, or 
C.” (PI, PP5) 
Once the preliminary interviews were 
done… we were called in to just hear the 
assessment of the interviews and give them 
feedback on their summaries of the patient 
interviews. (Pt B, PP9) 
Dissemination 
Just based on the diversity of the people in 
our board, I think there’s going to be a lot 
of potential opportunities on both a very 
local level and then a more statewide level 
to disseminate our results. (PI, C1) 
Even things of how we’re going to publish 
and where we’re going to publish things. I 
think that that really can be very helpful to 
have somebody who… knows those places 
where patients will read information and 
know that they’ll understand. (Pt A, C5) 
This table depicts select quotations from interviews with investigators (on the left) and 
patients (on the right) about patient engagement at various points during the research 
process. With the exception of Study Intervention, the investigator and patient in each 
row are not from the same study. 
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MANUSCRIPT 2: Challenges to and Successful Strategies for Patient 




Despite increasing support for patient engagement in research, guidance on how to 
engage patients is limited.  The aim of this study was to describe challenges to and 
successful strategies for patient engagement.  Interviews were conducted with 19 
investigators of projects funded by the Patient-Centered Outcomes Research Institute 
(PCORI) and with 33 patients engaged in 18 of the same 19 projects.  Informants 
reported experiencing logistical and substantive challenges.  Logistical challenges 
referred to challenges in planning engagement, including extra time and effort, difficulty 
working with investigators’ institutions, and difficulty holding meetings.  Substantive 
challenges included challenges to selecting, orienting, and interacting with patients and to 
incorporating patient feedback.  Successful techniques included using existing resources, 
communicating goals, providing patient education, and treating patients respectfully.  
These findings suggest actions for consideration that are relevant to funders, institutions, 
and researchers.  Modifications to policies, the development of programs and researcher 
networks, and the provision of resources and training are suggested.  As opportunities for 







Patient engagement—when researchers involve patients in research in ways other 
than as subjects of research—is gaining support.  Strategies include having patients on 
advisory boards or as research team members, serving as advisors or partners (Hanley et 
al., 2003; Staley, 2009).  A growing evidence base shows that patient engagement may 
enhance relevance to end users, improve recruitment, and produce higher quality research 
(Brett et al., 2014; Concannon et al., 2014; Domecq et al., 2014; Shippee et al., 2013).  
Because of these benefits, some funding organizations support engagement, while others 
require it.  Most notably, the Patient-Centered Outcomes Research Institute (PCORI), a 
non-profit research funding organization Congressionally authorized under the Patient 
Protection and Affordable Care Act (2010), requires engagement in its funded 
comparative effectiveness research (CER)  (PCORI, 2014a).   
While a robust literature on community-based participatory research (CBPR) 
exists, including on successful strategies like developing reciprocal relationships 
(Viswanathan et al., 2004) and identifying common goals (Israel, Schulz, Parker, & 
Becker, 1998), and on challenges from power imbalances to time demands (Israel et al., 
1998), guidance specifically on patient engagement is limited.  Some literature exists on 
challenges to patient engagement including on lack of time and resources (Brett et al., 
2014; Cargo & Mercer, 2008; Concannon et al., 2014; Domecq et al., 2014; Minkler, 
Blackwell, Thompson, & Tamir, 2003; Saunders & Girgis, 2010; Trivedi & Wykes, 
2002) and on difficulty finding representative patients (Concannon et al., 2014; Snape et 
al., 2014; Stewart & Liabo, 2012), and some literature exists on successful strategies 
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(Hewlett et al., 2006; Hoffman, Montgomery, Aubry, & Tunis, 2010).  However, most 
report on the experiences of individual investigators or are reviews of individual studies. 
 As funders increasingly support engagement, there will be more opportunities for 
researchers to engage patients.  Such opportunities may attract investigators with little 
experience engaging patients as well as those more experienced.  Having a better 
understanding of successful engagement strategies, challenges, and ways to address 
challenges is a priority.  
Investigators funded under PCORI’s early initiatives have navigated patient 
engagement in an environment of limited guidance and may be considered trailblazers 
from which we can learn, informing engagement strategies and recommendations for 
funders, institutions, and researchers going forward.  The research questions of this 
qualitative study were: (i) “What were the challenges faced by researchers and patients 
when participating in patient engagement work in the first set of PCORI-funded 
projects?” and (ii) “What strategies did researchers and patients identify as helpful or 




This study’s aim was to understand challenges to and successful strategies for 
patient engagement through qualitative interviews with PCORI-funded principal 
investigators (PIs) and patients engaged in their projects.  Approval by the Johns Hopkins 
Bloomberg School of Public Health Institutional Review Board (JHSPH IRB) was 




Purposeful sampling was used to select projects from PCORI’s earliest funding 
awards: the 50 Pilot Projects (two-year projects awarded in June 2012) (PCORI, 2012a) 
and the 25 Cycle I Awards (three-year projects awarded in December 2012) (PCORI, 
2012b).  These were chosen because they were furthest underway when interviews were 
conducted (December 2013 through May 2014).   
The goal of sampling was to capture projects using different engagement 
approaches (e.g., advisory groups, focus groups/interviews, surveys, patient research 
team members) while also ensuring diversity with respect to other attributes: the patient 
population engaged (e.g., healthy patients, sick patients, patients from advocacy groups, 
patients from minority populations), whether non-patient stakeholders were also engaged 
(e.g., policymakers, providers, purchasers), the research topic (e.g., chronic or rare 
diseases, behavioral health), and whether patients and researchers had prior relationships.  
Funding applications were reviewed to identify studies with patient engagement—
defined as having patients, patient representatives, community members, and/or 
caregivers involved in ways other than as research subjects—as only these studies were 
eligible.  Eligible projects were grouped by engagement approach, and projects were 
selected to ensure each approach was included and that variation was achieved regarding 
the aspects described above.  The principal investigators of the selected eligible projects 
were contacted by email and/or phone about their interest in participating in an interview 
for this study and their willingness to refer patients engaged in their projects for potential 
interviews.  Interested investigators were enrolled in the study.  
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Participating investigators identified one to two patients engaged in their projects 
who were somewhat different from each other (e.g., age, gender, health, relationship with 
advocacy groups, experience with engagement) to approach for participation in an 
interview.  Investigators obtained patients’ permission before sharing their contact 
information.  
Interviews and Questionnaires 
Interviews were audio-recorded and oral consent was obtained.  During 
recruitment and informed consent, participants were told that the interviewer (LE) 
worked at PCORI and that PCORI was aware of but had no involvement in the project.  
Participants were informed that the project comprised the research for the student’s 
doctoral dissertation, and that PCORI would have no access to information about which 
studies/individuals were recruited or interviewed, nor would PCORI have access to any 
data collected.   
Participants completed a questionnaire on demographic and background 
information.  Prior to conducting study interviews, two cognitive interviews were 
conducted to test the understandability of interview questions.  One was with a researcher 
with experience engaging patients and the other was with a patient on a research advisory 
board.  The interview guide and questionnaire were also reviewed by a community 
research advisory council, and modifications were made in response to feedback. 
Analysis 
Data collection and analysis occurred iteratively with interviews conducted until 
informational redundancy was reached.  Audio-recordings were transcribed and reviewed 
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for accuracy.  The coding scheme was developed deductively from interview questions 
and inductively from open coding.  Codes were applied to all transcripts.  A second coder 
coded six transcripts to assess reliability; a high concordance between coders (80% 




This section reports study findings, including demographic and background 
information about participants obtained from the questionnaire, a brief description of 
engagement approaches used by projects, and then key findings related to (i) logistical 
challenges to patient engagement, (ii) substantive challenges to patient engagement, and 
(iii) successful strategies for patient engagement.  Interview quotations used in this 
section are labeled by random study identification and by respondent (“R” for researcher; 
“Pt1” or “Pt2” for the first or second patient interviewed from a study).   
Participants 
There were 67 studies with engagement and thus eligible.  A total of 33 PIs were 
recruited from eligible projects based on the sampling criteria described above; 19 PIs 
participated and 14 declined.  Of those that declined, two did not respond after four 
attempts and the others cited lack of time (n=4), IRB concerns (n=1), not yet engaging 
patients (n=1), not being comfortable having patients interviewed (n=4), and no longer 
being able to contact patients whom they engaged (n=2).  The proportion of declining 
investigators was higher among Pilot Projects.  Interviews were conducted with a total of 
19 PIs from 19 projects, 11 in person and 8 by phone.  The average interview was 45 
minutes (range: 27 to 67 minutes).  Most PIs were white, and about half were female, had 
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served as PI on seven or more grants including their PCORI study, and had experience 
engaging patients. 
A total of 37 patients were approached for interviews; 33 participated and four 
declined.  One declining patient did not respond after four attempts, one cited lack of 
time, and two cited lack of interest.  A total of 33 patients (from 18 of the same 19 
projects) were interviewed, 14 in person and 19 by phone.  The average interview was 42 
minutes (range: 16 to 62 minutes).  Most patients were white, and over two-thirds were 
female, employed, and at least college educated.  About half reported having a chronic 
condition, and more than a third had previously engaged in research.  Recruitment 
numbers and participant characteristics are summarized in Table 2.1 and Table 2.2, 
respectively.  
Engagement Approaches 
Most projects used multiple engagement approaches (n=14), including involving 
patients in advisory groups (n=16), as co-investigators or research team members (n=9), 
and in focus groups/interviews (n=7) or surveys (n=3).  Advisory groups usually met at 
least quarterly to discuss study progress and provide input.  The nine studies engaging 
patients as co-investigators or team members involved patients in regular meetings to get 
their input, and over half of these studies (n=5) had patients leading other engagement 
activities (e.g., patient advisory groups).  Focus groups, interviews, and surveys usually 
involved single meetings to get feedback on particular areas (e.g., outcomes, 
instruments).  Nearly half of studies (n=9) engaged patients in pilot testing study 
materials, and over half (n=11) had preexisting researcher-patient relationships. 
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Challenges 
When asked what hindered engagement in the project, participants reported 
logistical and substantive challenges.  Logistical challenges referred to challenges in 
planning engagement, including extra time and effort, working with investigators’ 
institutions, and holding meetings.  Substantive challenges included challenges to 
selecting, orienting, and interacting with patients and to incorporating patient feedback.  
While researchers and patients articulated the same challenges, researchers discussed 
logistical challenges and resolutions more than patients.  Challenges are described below, 
and select quotations are provided in Table 2.3.  
Patterns between funding cycles and among engagement approaches were 
explored and no differences regarding the nature or frequency of challenges were found.  
Because patterns were not noted, data are not disaggregated by funding cycle or 
engagement approach in the presentation of findings on challenges and successful 
strategies..  
Logistical Challenges 
Extra Time and Work 
Over half of investigators (n=11) noted the extra time or work needed to build 
capacity and organize engagement.  This preparation was necessary as failing to do so 
could slow the research process.  About a quarter of investigators (n=5) failed to 
anticipate the extent of work: “It really takes time to set up this process and to do it 
well… it can delay you” (108R).  One investigator described the work required to 
incorporate patient feedback after engagement: “You’re on a fixed timeline and a fixed 
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budget... that’s been challenging” (107R).  A few investigators (n=3) noted that “lessons 
learned would be to anticipate [the time required] and work it into the timeline” (109R). 
Institutional Processes 
About half of investigators (n=9) faced institutional barriers to actively engaging 
patients.  Arranging patient partners’ compensation could be administratively onerous: 
“Just invoicing everybody for their time and doing all the paperwork to pay them for each 
of the calls takes time, and I would say we underestimated that” (113R).  One 
investigator expressed frustration that her institution capped compensation to patients, 
who sometimes missed work or needed childcare to participate.  
About a third of researchers (n=6) reported difficulty with institutional review 
boards (IRBs).  IRBs did not understand that patient partners were not research subjects 
needing to sign consent forms.  Communication with the IRB helped address this.  There 
were also challenges with completing IRB-required human subjects protections training.  
An investigator said it required “a huge amount of resource,” and patients from that study 
agreed, one calling it “one of the toughest hurdles” (115R, 115Pt1).  
Scheduling and Having Meetings 
Difficulty having meetings was reported by about a quarter of investigators (n=5).  
To address this, one investigator scheduled meetings when stakeholders were already at 
the institution; another held three meetings throughout the week when no time worked for 
everyone. 
A few patients (n=5) reported difficulty meeting in-person because of physical 
impediments or transportation issues.  Two investigators responded by communicating 
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electronically and meeting virtually.  While high technology strategies were generally 
successful for projects employing them, they had drawbacks.  Some patients had trouble 
accessing or using the Internet.  One researcher mailed materials to an elderly patient 
with no Internet access; two investigators switched from virtual to in-person meetings in 
response to patients’ preferences.  
Substantive Challenges 
Selecting Patients 
Investigators and patients described challenges to the process of selecting patients 
for engagement.  About half of investigators (n=9) expressed concern that interested 
patients did not fully represent the patient population to which the study applied.  One 
investigator addressed this by recruiting from several segments of the population to 
include healthy, ill, at-risk, low-income, and higher income patients.  Alternatively, two 
investigators prioritized patients with experience and investment in the topic over 
representative patients. 
Investigators generally spoke highly of patient partners; however, about a fifth 
(n=4) wished they had done more screening: “I would probably figure out a way to 
recruit patients more like a job interview… I would invest a lot more time in recruiting 
and selecting patients that would fit with the team” (115R).  
A third of patients (n=11) articulated the importance of screening: “If you are 
getting a patient that has not been… screened or any due diligence done, you don’t know 
what you’re getting, and if you’re going to get somebody who is just coming in to 
complain about their lot in life, it is not going to help a study” (116Pt2).  While 
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researchers who discussed screening emphasized selecting patients that fit with the team, 
patients emphasized selecting patients who could focus on the patient population’s needs 
rather than personal issues.  
Over a third of patients (n=13) described the ideal type of patient to engage.  Of 
this group, about half (n=6) felt that trained advocates provided contextualized input that 
regular patients could not while the other half (n=7) felt that regular patients with no 
medical background provided a needed outside perspective.  A few patients (n=4) saw 
equal but different value in both, suggesting regular patients were ideal sounding boards 
while advocates were ideal for setting agendas. 
Orienting Patients 
It could be difficult and time consuming for researchers to explain research 
concepts and orient patients.  About half of investigators (n=9) and about a third of 
patients (n=12) noted that if time were not devoted to teaching patients about research 
methods and study topics, patients’ lack of familiarity could delay meetings, impede their 
contributions, and make them uncomfortable.  Patients needed courage to ask questions: 
“I have got to have the guts to ask: ‘Can I just ask a question?... Can you just explain to 
me what you just said in terms that I can understand?’” (102Pt1). 
Few resolutions were reported.  One investigator, as described by a patient, told 
patients: “Why don't we have a pre-meeting before the meeting?... Come with all of your 




The Engagement Interaction Itself 
Investigators described feeling unprepared for engaging patients, and patients 
described challenges they faced during engagement.  About a third of investigators (n=6), 
mostly without engagement experience, reported not fully grasping what engagement 
entailed or how to do it well and struggled to find appropriate activities, formats, or 
questions to ask patients.  One investigator found that asking targeted questions yielded 
better feedback than did asking for general comments.  About a quarter of researchers 
(n=5), both with and without prior experience, expressed wanting training, with two 
specifically noting disparities between researcher and patient training: the institution 
“spends a half day conditioning [the patient] or teaching [the patient] how to interact with 
the researchers, but there's no effort to condition the researchers” (102R).  
About a fourth of patients (n=8) reported feeling frustrated when researchers used 
jargon because it impeded their participation: meetings were “all research stuff; it was all 
these acronyms… that really didn’t have a lot of meaning” (117Pt1).  A quarter of 
investigators (n=5) addressed this by pausing to explain jargon. 
Incorporating Patient Feedback 
Investigators described two kinds of challenges to incorporating patient feedback.  
The first, reported by about a quarter of investigators (n=5), occurred when feedback 
could not be implemented because of lack of time/resources or feasibility.  For example, 
patients from one study wanted the study available to non-English speakers, but 
researchers lacked resources to translate materials into other languages.  
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The second challenge, also reported by about a quarter of investigators (n=5), 
occurred when feedback was scientifically inappropriate.  As one researcher explained, 
“They don’t have a scientific understanding of research design, so they may want you to 
do stuff that… might actually compromise, especially, the internal validity” (119R).  This 
occurred when patients recommended substantive changes to study designs or validated 
instruments.   
About a third of investigators (n=7) reported difficulty sharing control of the 
research with patients.  While challenges to incorporating patient feedback could not be 
resolved, about a third of investigators (n=6) found it helpful to explain why feedback 
was not used.  
 
Successful Strategies 
 Informants were asked what worked well for engagement; responses included 
using existing resources, communicating goals, providing patient education, and treating 
patients respectfully.  
Using Existing Resources 
 About a third of researchers (n=6) took advantage of established advisory 
councils to find patients to engage.  A benefit of this was patients’ familiarity with 
clinical practice/research.  A patient described it as “wonderful for us because it has been 




Communicating Clear Goals  
 About a third of investigators (n=7) and nearly a fifth of patients (n=6) described 
the importance of knowing and communicating goals.  As one researcher said: “You just 
have to be so clear why you're doing this, to yourself and to the people that are 
participating” (113R).  About a fourth of patients (n=8) reported appreciating receiving 
agendas before meetings to inform them about plans or receiving summaries after 
meetings to recap what was accomplished.  
Providing Patient Education  
Although patient education was challenging, it was also regarded as crucial. 
About a quarter of investigators (n=5) described helpful techniques including developing 
plain language information sheets, sharing articles, and presenting on key topics.  One 
investigator created a glossary, which the patient for whom it was created found essential: 
“I need to understand those medical terms because I don't have a medical degree” 
(102Pt1).  Another investigator designed a training in which a lecture for clinicians was 
adapted for patients.  This method’s success, in prior work and in the project, reinforced 
the investigator’s belief that anyone can become proficient in advanced topics when 
information in provided appropriately.  A patient from that study viewed the training as 
enabling patients’ participation: it put “everybody on a more equal plane… so that we all 





Treating Patients Respectfully 
Over half of researchers (n=10) and nearly two-thirds of patients (n=21) described 
at least one of two ways in which it was helpful for interactions to be conducted with 
respect.  One way occurred when researchers acted politely toward patients; the other 
occurred when researchers respected patient input.  
First, about a fifth of researchers (n=4) and a fourth of patients (n=9) described 
ways in which researchers acted politely, making patients feel more able to participate.  
This included researchers taking care of paperwork for patient compensation, 
accommodating schedules, holding meetings at convenient locations, and building 
rapport.  As one patient expressed: “They feed us and they make sure we’re all 
comfortable and they engage us on a personal level” (103Pt2).   
Second, over half of both researchers (n=10) and patients (n=17) described the 
importance of researchers respecting patient input.  This included researchers soliciting 
and valuing patient opinions, promoting equality, and sharing how feedback was used.  
Patients reported feeling respected when researchers valued their perspectives: “[PI] has 
done a really good job of checking in all the time and saying, ‘What’s working? What’s 
not working?,’ and addressing what’s not working right away” (114Pt1).  Researchers 
expressed the same view: “Being respectful of their expertise is enormous” (104R).  
Nearly half of researchers (n=9) reported promoting equality.  About a fifth of 
investigators (n=4) used first names instead of professional titles.  One researcher had 
stakeholders develop guiding principles to “enforce the fact that everybody’s voice was 
equal” (102R).  One researcher described the importance of elevating patients to 
leadership roles including as co-investigators: “Doing things behaviorally that 
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demonstrate that you are behind some level of equality in power here, in this situation, is 
very, very important” (101R).  A few patients (n=5) reported feeling respected by being 
involved in decision-making.  
 Nearly a third of researchers (n=6) described the importance of reporting back 
how patient feedback was or was not used: “If you consider something and decide not to 
respond to it: ‘We didn't do that earlier and here’s the reason why.’  So… really just do 




 This study sought to understand what worked well for engaging patients, what 
was challenging, and resolutions to challenges from a sample of PCORI projects. 
Successful techniques included communicating goals, engaging patients from 
existing councils, educating patients, and treating patients respectfully.  The fact that 
engaging patients from existing councils was successful suggests engaging patients with 
more experience is helpful, perhaps by allowing for meaningful discussions to take place 
sooner or by lessening demands on researchers to educate patients.  In fact, patient 
education, though a successful strategy, was challenging and required skill and planning.  
Some successful techniques reported here have been described in the literature, lending 
further credence to these findings.  For example, one group developed a framework that 
includes training, communicating patient roles, and treating patients respectfully (Hewlett 
et al., 2006).  Others developed principles to guide stakeholder engagement in CER and 
specified strategies like preparatory meetings with patients (Hoffman et al., 2010).   
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Investigators with varying experience faced logistical challenges including extra 
time and work, institutional barriers, and difficulties with meeting logistics.  Creative 
solutions resolved challenges to meetings, with a few researchers accommodating patient 
preferences for meeting modality.  Trade-offs of virtual versus in-person engagement 
have been discussed in the literature, as have hybrid approaches capitalizing on the 
benefits of both (Lavallee, Wicks, Alfonso Cristancho, & Mullins, 2014).  Some practical 
challenges reported here are in the literature including limited resources and time (Brett 
et al., 2014; Cargo & Mercer, 2008; Concannon et al., 2014; Minkler et al., 2003; Trivedi 
& Wykes, 2002) and IRB challenges (Cargo & Mercer, 2008; Concannon et al., 2014); 
however, consistent with our findings, resolutions remain limited.  
Participants reported substantive challenges regarding how to select, orient, and 
interact with patients.  Challenges to incorporating patient feedback have been described 
in the literature (Buchanan, Miller, & Wallerstein, 2007; Trivedi & Wykes, 2002).  While 
informants did not offer strategies to address this, explaining why feedback was not used 
was helpful.  Consistent with previous literature, researchers expressed concerns about 
representativeness (Concannon et al., 2014; Snape et al., 2014; Stewart & Liabo, 2012).  
Informants endorsed screening patients to improve the selection process.  
Implications for Policy 
While informants experienced substantive and logistical challenges, some also 
found resolutions to challenges or reported successful strategies in these areas.  This 
indicates that additional guidance and resources may be valuable.  A series of actions 
may help address challenges identified by our informants and promote successful 
strategies.  These actions for consideration pertain to policies, programs, training, 
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resources, and network development and, as such, are relevant to funders, institutions, 
and researchers. 
Given the success of engaging patients from existing councils, researchers could 
benefit from being matched with experienced patients.  PCORI’s Ambassador Program, a 
relatively new initiative, is one such program that serves to “connect patients and other 
stakeholders with common interests and help position them as potential partners” 
(PCORI, 2013).  While matching programs alone are unlikely to improve 
representativeness, coupled with patient outreach and training, they can streamline patient 
selection and facilitate engaging patients from diverse backgrounds.  Engaging 
experienced and inexperienced patients together can also help prepare a new cadre of 
patient research partners. 
Challenges from patients’ lack of familiarity with research methods and study 
topics suggest the need for targeted training in these areas.  Layperson training on 
research methods and ethics, like what exists for CBPR (Allen, Culhane-Pera, Call, & 
Pergament, 2010; Anderson, 2012), could be adapted.  Equally important is researcher 
training on engagement. Funders could sponsor trainings and produce more guidance on 
successful strategies, and experienced researchers could train inexperienced researchers.  
PCORI’s Patient and Family Engagement Rubric, which was published after studies in 
this sample were funded, is one example (PCORI, 2014b).  More resources of this nature 
can be developed and shared to promote collaborative learning.  
Researchers may act collectively to resolve challenges more efficiently.  
Researchers could identify how this might best occur; possibilities include researchers 
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participating in networks created by funders, being connected on an ad hoc basis by 
project officers, using web-based platforms, or forming mentorships. 
Finally, to address institutional barriers, model policies on compensation for 
patients engaged in research and on IRB classification of patient partners could serve as 
templates for research institutions, reducing cumbersome processes and inappropriate 
classification of engagement partners as research subjects. 
Limitations 
 There were several limitations to this study.  One is that it only included PCORI 
projects, which are unique given their support for engagement.  While this could limit 
generalizability, the fact that challenges were identified even among well-resourced 
projects and the consistency between our findings and the literature suggest findings are 
relevant more broadly.  Another limitation is that projects were funded early in PCORI’s 
lifespan and may differ from later projects.  These researchers may have had more 
experience with patient engagement than later PCORI researchers.  Alternatively, they 
may have had less familiarity with successful strategies since some resources now 
available were not when studies began.  Nonetheless, experiences from early initiatives 
will resonate with the many investigators and patients new to engagement.  A third 
limitation is that those who declined participation may have had different experiences 
that were not captured.  Declining investigators were more senior so they may have had 
more experience; however, investigators with and without experience reported challenges 
in this study.  Last, this study included a subset of projects; other methods could 
accommodate collecting information from a larger set of projects, although would miss 




 This study identified successful techniques for engagement and challenges 
impeding engagement.  Modifications to policies, the development of programs and 
researcher networks, and the provision of resources and training are steps that could 
mitigate challenges.  Future research should evaluate the effectiveness of such actions in 
strengthening engagement.  As opportunities for experienced and inexperienced 

























Table 2.1: Overview of Recruitment and Enrollment Numbers 
 Pilot Projects Cycle I Awards TOTAL 
PIs Patients PIs Patients PIs Patients 
Eligible 42 n/a 25 n/a 67 n/a 
Recruited 19 18 14 19 33 37 
Refused 10 2 4 2 14 4 
Interviewed 9 16 10 17 19 33 
 
This table reports the number that were eligible, recruited, refused participation, and 
participated for researchers and patients by funding cycle and in total. The total number 
of patients engaged in eligible projects was not available, indicated by “n/a”. 
 
Table 2.2: Characteristics of Study Participants 
 PIs (n=19) Patients (n=33) 
Age   
Under 30 years 1 3 
31-40 years 4 1 
41-50 years 5 4 
51+ years 9 25 
Race   
African American (non-Hispanic) 1 4 
Asian/Pacific Islander (non-Hispanic) 1 1 
White (non-Hispanic) 17 26 
Hispanic 0 2 
Gender   
Female 10 23 
Male 9 10 
Additional Patient Demographics   
Prior experience being engaged in research - 13 
College or graduate degree - 25 
Employed full or part time - 24 
Self-reported chronic disease/condition - 17 
Additional Researcher Demographics   
Prior experience engaging patients in research 10 - 
Served as PI on ≤ 6 grants (inclusive) 10 - 
Served as PI on ≥ 7 grants (inclusive) 9 - 
Served on academic faculty ≤ 10 years 8 - 
Served on academic faculty ≥10 years 11 - 
 
This table reports data obtained from a questionnaire administered to interview 
participants. All data are self-reported. Some questions were only asked of researchers 
and some were only asked of patients, indicated by “-” in cases where there are no data 
to report. 
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Table 2.3: Select Quotations from Interviews   
Logistical Challenges 
Extra Time and Work: “It’s much easier... just to drive it forward. When you have to 
backup a little bit and get input and be participatory, it’s time consuming, and I would 
suspect that many researchers would be challenged by this model.” [118Pt1] 
Institutional Processes: “Just the logistics…it is a challenge, like institutionally, how do 
you pay these folks, those kinds of things. And you know, the IRB issues, they’re just red 
tape, extra red tape.” [107R] 
Meetings: “There are things I think everyone faces – logistical challenges… Physically 
meeting is hard. Some folks are disabled now. Some people work and have lives. And it’s 
just hard… any meeting with more than 2 people, it’s really hard to orchestrate.” [117R] 
Substantive Challenges 
Selecting Patients: “It can be a detriment in the sense that if people need to talk more 
than listen, they may not be ready to be an active participant in a way that’s helpful… 
I’ve seen that a lot where somebody just said, ‘I know a neighbor who had this 
experience and she’d be a good person to come be on an advisory committee.’ Well, 
sometimes yes, sometimes no.  I think that people who have used their experience to 
understand the larger experience of other people involved in your care can be very 
helpful.” [114Pt2] 
Orienting Patients: “When you involve non-professional science people in a science 
team, you’re going to have a lot of time taken out of a meeting to discuss something 
that… we don’t understand.” [115Pt2] 
The Engagement Interaction Itself: “It feels very fragmented because we don’t meet 
very often. Sometimes it’s easy to lose the thread of what’s going on… so that makes it a 
little harder, I think, to stay focused.” [103Pt2] 
Incorporating Patient Feedback: “There was a suggestion that we have this survey 
available in other languages and so we examined that and it would’ve been good... But 
it’s hard, and there’s a limit to the money and all of that.” [103Pt1] 
Successful Strategies  
Using Existing Resources: “We got help from the head of the [patient resource center at 
PI’s institution] to identify some patients and family representatives who already were 
serving on these kinds of committees and were interested in participating.” [112R] 
Communicating Clear Goals: “Just making clear what the expectations are, of their role, 
and giving them feedback periodically and updates… so that they don’t feel like their 
review or feedback was for naught.” [111R] 
Providing Patient Education: “When you bring in stakeholders that are not physician 
slash researchers, whether they are a patient or not a patient, you have to get people to a 
certain level in order to be able to interact.  There has to be common understanding to get 
people to a certain level, so things like developing a glossary, right?  It's time consuming, 
but it's really essential to do in educating and making sure that people can actively 
contribute to conversations about research.” [102R] 
Treating Patients Respectfully: “I think that just the basic respect for each other’s 
expertise and understanding that our community members are experts in their 
community; and they bring that to the table, to us. And we are experts in research design 
and research, and those types of things, and we bring that to the table. We each bring 
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MANUSCRIPT 3: When and Why is Patient Engagement in Research 
Morally Important?  
ABSTRACT 
 
Patient engagement in research refers to researchers involving patients in research in 
ways other than as subjects of research.  While there is increasing support for patient 
engagement, with justifications often based on its presumed effects, none of the rationales 
provided for engaging patients in research have been explored from a moral perspective.  
In light of the increased interest in patient engagement, it becomes important to explore 
the moral arguments that may motivate researchers to engage patients in their research or 
that may motivate funders to support such engagement.  Drawing on the existing 
literature and on findings from empirical interviews with researchers and patients, this 
paper explicates arguments for the moral importance of patient engagement.  This paper 
considers patient engagement as morally important both as a strategy to achieve morally 
important ends and also as an activity that itself is intrinsically morally valuable.  
Engaging patients in research has instrumental value because it serves as a strategy to 
enhance the relevance of the research to patients, to hold researchers accountable for 
decisions made in the context of research, and to help researchers learn specific ways to 
treat study participants with respect—all of which, I argue, are morally important for 
research.  Further, patient engagement has non-instrumental value because certain patient 
engagement activities—namely, seeking patients out and listening to them—are 
constitutive of researchers’ duty to respect the patient population as people with 
unconditional moral worth.  In ascertaining the circumstances in which patient 
engagement is morally important, this analysis offers insights into the kinds of research in 
which there are compelling reasons for researchers to engage patients.  Researchers, 
funders, and institutional review boards may consider policies endorsing patient 
engagement in research meeting certain conditions in accordance with the moral 





Patient engagement in research refers to researchers involving patients in research 
in ways other than as subjects of research (Hanley et al., 2003).  Patient engagement 
includes a range of activities involving patients as research partners at any stage of the 
research process.  Researchers conducting a study comparing treatment options, for 
example, may consult with patients for selecting study outcomes or work with patients in 
designing the study and developing materials.  Researchers may engage patients at a 
single point in time or they may interact with patients multiple times throughout the 
research process.  Frameworks for patient engagement specify hierarchal levels of patient 
involvement in research decision-making (Boote, Telford, & Cooper, 2002; Charles & 
DeMaio, 1993; Hanley et al., 2003; Tritter & McCallum, 2006).  At the bottom of the 
hierarchy, researchers solicit patient opinions on aspects of research but may or may not 
follow them (consultation); whereas, higher levels of engagement constitute ongoing 
partnerships in which researchers and patients share decision-making (collaboration) or, 
at the highest level, research is initiated and directed by patients (user/consumer control) 
(Boote et al., 2002; Hanley et al., 2003).   
Patient engagement in research is increasingly gaining support.  There have been 
calls for more engagement of patients and other health care stakeholders in all aspects of 
the research process (Sox & Greenfield, 2009; Upton & DeGette, 2015).  The United 
States Congress authorized the Patient-Centered Outcomes Research Institute (PCORI) 
under the Patient Protection and Affordable Care Act of 2010 to fund comparative 
effectiveness research that is required to engage patients and other stakeholders in the 
research process (PCORI, 2014).  PCORI’s requirement suggests that patient engagement 
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has value specifically for comparative effectiveness research, research that compares the 
benefits and harms of alternative methods to treat clinical conditions or improve the 
delivery of care in the real world setting (Federal Coordinating Council for Comparative 
Effectiveness Research, 2009).  The United Kingdom’s National Institute for Health 
Research (NIHR) also requires active involvement of the public in a wide range of health 
research it funds (NIHR, 2014a), which suggests that patient engagement has value for 
other kinds of research in addition to comparative effectiveness research.  
Explicit justifications for patient engagement in research are not always provided; 
however, when they are, they often appeal to the presumed effects of engagement.  
Emerging evidence suggests patient engagement can have practical benefits for the 
research process including enhancing the relevance of the research to patients (Ellis & 
Kass, forthcoming; Brett et al., 2014; Caron-Flinterman, Broerse, & Bunders, 2005; 
Concannon et al., 2014; Domecq et al., 2014; Shippee et al., 2013), and both PCORI 
(Selby, Beal, & Frank, 2012) and NIHR (2014b) cite enhanced relevance of the research 
to patients as a main reason for engaging patients.  The belief that patient engagement can 
enhance researchers’ accountability for decisions made within the context of research has 
also been cited as a rationale for patient engagement (Tritter & McCallum, 2006; Bastian, 
1994; Bastian, 1998; Boote et al., 2002), and there have been reports that patient 
engagement can help researchers to learn specific ways to treat study participants with 
respect (Staley, 2009).   
In light of the current research milieu in which patient engagement is increasingly 
becoming an expectation for various kinds of research, we are faced with questions of 
whether, when, and why patient engagement in research is morally important.  This paper 
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aims to answer these questions by analyzing reasons that might motivate the moral 
importance of patient engagement.  The moral importance of patient engagement could 
stem entirely from its instrumental contributions to the presumed ends of engagement or 
it could stem, in part, too, from some intrinsically important duty that is fulfilled by virtue 
of engaging patients.  In this paper, I first explore how patient engagement can be said to 
contribute instrumentally to certain ends—namely, relevance, accountability, and 
respect—and the extent to which these ends are morally important for research.  After 
arguing that these ends of patient engagement are indeed morally important for research, 
I ascertain the particular circumstances in which patient engagement is morally important 
as a means for achieving such ends.  Regardless of the moral importance of the ends of 
patient engagement, there could be something intrinsically valuable within patient 
engagement itself that motivates its moral importance, so I also turn my attention to this 
separate question by explicating an argument for the intrinsic value of patient 
engagement.  Ultimately, I hope to show that patient engagement has both instrumental 
and non-instrumental value: I argue that patient engagement is morally important because 
it is a strategy for achieving multiple morally important ends and also because it is 
constitutive of the duty to respect patients as people.  At the conclusion, I briefly indicate 
the implications of this analysis for the practice of patient engagement in research; 
however, a comprehensive discussion of the bearings of this moral analysis on the 







 Several activities were undertaken to help determine the framing, content, and 
scope of this moral analysis: a review of the literature on patient engagement; a review of 
the literature on relevant topics in ethics, bioethics, and moral philosophy; an 
examination of data from qualitative interviews conducted with researchers and patients 
on rationales for and effects of patient engagement; and a critical reflection on the 
rationales for patient engagement that seemed most compelling from a moral perspective.    
 The review of the extant literature on patient engagement revealed the paucity of 
discussion on rationales for patient engagement, lending further support for pursuing 
conceptual scholarship in this area.  Two rationales, however, were mentioned in brief by 
multiple authors: engaging patients to enhance the relevance of the research to patients 
(Selby, Beal, & Frank, 2012; NIHR 2014b) and engaging patients to promote 
accountability of researchers and funders (Gradinger et al., 2013; Tritter & McCallum, 
2006; Bastian, 1994; Bastian, 1998; Boote et al., 2002).  The literature’s attention to these 
rationales suggested their importance, and the lack of arguments to support them 
indicated that they would be appropriate for more in-depth exploration. 
The review of the literature in ethics, bioethics, and moral philosophy aided the 
identification of relevant ethical concepts needed to construct arguments that were firmly 
grounded in ethical theory and that constructively advanced concepts in the field of 
bioethics.  The review also informed the framing of this paper.  In ethics, value is 
differentiated by instrumental value (e.g., value as a means for obtaining something else 
that is held as good) and non-instrumental value (e.g., something that is good for its own 
sake) (Schroeder, 2012).  This distinction was adopted to frame the arguments explicated 
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in this analysis.  Instrumental value refers to patient engagement having value because it 
is a strategy for achieving a morally important outcome, and non-instrumental value 
refers to patient engagement having value because it is morally important itself, 
regardless of its effects. 
An examination of data from qualitative interviews I conducted with researchers 
and with patients engaged in the researchers’ projects aided in the selection of rationales 
explicated in this analysis and also helped to both validate and challenge the thinking and 
assumptions presented in this paper.  In interviews, researchers and patients cited 
enhancing the relevance of the research to patients as both a main reason for and effect of 
engagement (Ellis & Kass, forthcoming).  Given the prominence of relevance—both in 
my prior empirical work and in the extant literature—this rationale was selected to 
explicate in this analysis.  While not as commonly mentioned, accountability was also 
discussed as an effect of patient engagement and was selected as a rationale to explore 
further because of its mention in both the literature and in interviews and because of its 
importance in moral philosophy.  Last, interview data also revealed that the concept of 
respect emerged repeatedly from both researchers and patients in discussing the value of 
patient engagement.  The importance of respect in the field of bioethics, critical reflection 
of this concept as ethically relevant for arguments for patient engagement, and inference 
to respect in discussions on the value of patient engagement all contributed to the 
decision to explore arguments invoking respect.  
The use of the empirical data to inform the moral arguments advanced in this 
work allowed for the moral arguments to be tested and challenged as they were being 
developed and also ensured that the analysis was consistent with findings from 
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interviews.  The empirical data also helped inform the scope of this work.  Interview 
participants discussed engagement in comparative effectiveness research; however, their 
responses suggested the value of patient engagement more broadly, so this analysis is not 
limited to comparative effectiveness research and instead considers the value of patient 
engagement in research more generally. 
The methodological approach involved an examination of the literature and 
interview findings combined with critical reflection to explicate arguments for the 
instrumental and non-instrumental value of patient engagement in research.  The 
arguments and concepts explored in this conceptual work are not the only arguments that 
one could use to consider the moral importance of patient engagement; however, they 
appear to be the most salient, which is why they were selected for this conceptual project 
aiming to explicate the moral importance of patient engagement in research. 
 
 
INSTRUMENTAL VALUE OF PATIENT ENGAGEMENT 
 
 This section explicates three arguments for the instrumental value of patient 
engagement in research.   Instrumental value refers to patient engagement having value 
because it is a strategy for achieving a morally important outcome.  In each argument 
explored in this section, patient engagement is held as valuable because it leads to 
outcomes that are morally important for research.  Specifically, I argue that patient 
engagement is a strategy to enhance the relevance of the research to patients, to hold 
researchers and funders accountable, and to help researchers learn ways to show respect 





It is commonly said that patient engagement is a way to understand patients’ 
needs and interests in order to produce research that is more relevant to patients.  In 
interviews with researchers who had engaged patients and also with some of the patients 
they engaged, there were references to increased relevance as both a reason to engage 
patients and as a main outcome of engagement.1  Both researchers and patients described 
two ways in which patient engagement enhanced the relevance of the research.  First, 
patient engagement was thought to help ensure that the research project as a whole was 
important to patients: 
By including the community, and especially in how we formed the question, we 
were able to come up with something that was what the community perceived as 
being an issue for them. – Researcher 105 
 
We must be more inclusive of the areas of health that matter most to patients and 
attend to the outcomes that are of relevance to them.  You can't possibly do that 
unless you are more engaging. – Researcher 102 
 
Research has gotten too far off on its own, in its own little silo.  Those little guys 
in locked doors, huddled over the petri dishes… and then they come up with 
something and it is presented to the real world, the patient world, and patients are 
going, “Yeah, so what?”  So we are trying to build relevancy. – Patient A 102 
 
Second, informants specifically described how patient review of study instruments helped 
to ensure that the questions asked in study instruments were relevant to patients:  
This tool has been… validated extensively. We say that all the time. But that 
person might say, “But you know what you’re missing?  You never asked this.”  
– Researcher 109 
 
Sometimes the [survey] questions about how you’ve been treated medically don’t 
really get at a patient’s concerns at all. In fact, they completely miss them. And 
so lots of times we’ve been able to say, “Well, that question doesn’t work; a 
1 Interview references and quotations throughout this paper are from qualitative interviews with 
19 researchers engaging patients in their research and with 33 patients engaged in the same 
researchers’ studies.  Researchers and patients were asked about their experiences with 
engagement including reasons for engaging patients and the effects of engagement on the 
research process.  Quotations are identified by the respondent type (“Researcher” or  “Patient A” 
or “Patient B”) and by a number randomly assigned to each participating study.   
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better question would be this one.” – Patient A 103 
 
If I hadn't been on the study and I hadn't brought up the point that a lot of the 
people… don't read well, what would the study [instrument] questions have been 
like?  And are you really capturing the right kind of information if you don't 
know your population? – Patient A 202 
 
These examples highlight how patient engagement can be a mechanism for patients to 
provide input on the interpretation of instrument items and the extent to which they are 
able to capture what patients recognize as important.  
  The fact that patient engagement can enhance the relevance of the research overall 
and of research instruments makes patient engagement seemingly desirable, for what 
researcher would not welcome the opportunity to make her research project more useful 
and meaningful to the intended end users of her research?  While there are practical 
benefits to enhancing the relevance of research in the ways described above, if patient 
engagement is to be morally important on grounds that it enhances the relevance of 
research, then relevance must be held as morally important for the conduct of research.  
The question explored in this argument is whether relevance is morally important for 
research. 
When patients give input that is said to enhance the relevance of the research 
question, they are expressing what they take to be important or valuable to them and 
other patients.  Thus, patients’ views of the relevance of a research study may 
approximate the social value of that study, at least in the eyes of patients.  This is 
consistent with prominent accounts of value in the research ethics literature, which reflect 
that assessments of relevance can contribute to or even define the social value of a 
research study.  Freedman (1987), for example, defines value as the importance or 
usefulness of the research hypothesis.  Other accounts of value include the relevance of 
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the research question to the patient population and the public’s perception of the 
condition as factors that can enhance value (Casarett, Karlawish, & Moreno, 2002; 
Grady, 2002).  
Three qualifications are pertinent to this discussion.  First, an assessment of a 
study’s relevance, as a social construction, is a function of the assessor, so multiple 
stakeholders’ views on the relevance of a research study are potentially important to 
determining the overall social value of that study.  What patients view as a relevant 
research question may differ from what researchers and policymakers consider relevant 
or even from what patients’ clinicians might have considered relevant; therefore, a 
complete assessment of relevance requires more than just patient input.  An assessment 
of relevance that takes multiple stakeholders’ views into account—namely, a global 
assessment of relevance—is ideally what should contribute to determinations of social 
value. 
Second, other factors in addition to stakeholders’ views of the relevance of the 
research contribute to determinations of the social value of the research.  For example, 
Casarett and colleagues (2002) include the generalizability of findings, the existence of 
mechanisms for translation of results, and the availability of the intervention (if found 
effective) as features that contribute to the social value of a research study, and Freedman 
(1987) includes the scientific validity of a study as a formal requirement of value.  
Third, social value is a matter of degree, rather than a binary distinction.  The 
question is often not whether or not a study has social value at all, but rather how much 
social value a study has.  Further, it is not clear what the threshold level of social value is 
or the precise extent to which stakeholders must find a study relevant in order for 
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relevance to be held as enhancing social value.  This suggests that a study that is relevant 
to some stakeholders but of little relevance to others can still be socially valuable; 
however, its social value would be increased if all stakeholders were to find the study 
relevant. 
Social value is widely regarded as ethically required for all clinical research 
(Emanuel, Wendler, & Grady, 2000).2  Insofar as patients’ perspectives on relevance 
contribute to a global assessment of relevance, which helps to determine the social value 
of a research project, patients’ view of relevance is morally important.  Because studies 
that are of little relevance to some stakeholder groups but highly relevant to other groups 
can still be considered socially valuable and because other factors may influence 
assessments of social value, there is no clear guide for determining precisely how much 
the patients’ view of the relevance of the research alone matters for the global assessment 
of relevance and thus contributes to determining the social value.  Despite these 
qualifications, it is still possible to delineate key characteristics of research that, when 
present, strongly suggest that patients’ view of relevance enhances the overall social 
value of that research.  This is to say that there are some kinds of research for which 
getting patients’ perspectives on the relevance of the research, while alone not 
determinative of the global assessment of relevance or even of social value, is important 
2 While some in the field of bioethics hold social value as morally important without explicitly 
referencing any underlying ethical values as justification for its moral importance, Emanuel and 
colleagues reference two ethical values: the responsible use of scare resources and the avoidance 
of exploitation.  Wertheimer (2014) has argued that these specific ethical values do not, in fact, 
provide a robust ethical justification for the social value requirement; however, there are perhaps 
other ethical justifications one could use to argue that social value is morally important or 
required, and so it remains widely accepted in the field of bioethics.  The social value requirement 
is also codified in several ethical guidelines and assessed by institutional review boards during 
review of research plans.   
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from a moral standpoint.  In such circumstances, patients’ point of view on the relevance 
of research carries special significance.  These circumstances include studies for which 
findings are likely to have immediate implications for patients’ health and wellbeing and 
studies in which patients’ values or preferences are at stake.  
As mentioned earlier, social value is a multifaceted concept, and as such it is 
generally understood to include both studies that contribute to scientific knowledge but 
have no immediate implications for health and wellbeing and also studies that do have 
more direct implications for prevention, treatment, or diagnosis.  The social value of 
studies with direct ramifications on patients’ health should be assessed by their relevance 
to patients because patients have a considerable stake in the outcome of the research, 
perhaps more so than other stakeholder groups.  Further upstream research such as early 
phase clinical research does not have direct implications for patients’ health, and so 
patients’ assessment of relevance is less important.  Later phase clinical research (e.g., 
comparative effectiveness research and pragmatic clinical trials) tend to have more direct 
implications for patients, so patients’ assessment of relevance is important for the social 
value of these kinds of studies.  Patients’ assessment of relevance is also important when 
the research involves patients’ values or preferences.  For example, patient decision aids 
take for granted that what is important to patients is reflected in the aids, so patients’ 
assessment of the relevance of the overall research question of studies developing or 
testing decision aids is important for determining the social value.  While these 
distinctions regarding the circumstances in which patients’ assessment of relevance 
enhances the social value of that research are admittedly a bit blurry, they serve as a 
heuristic that can help identify the kinds of research in which patient input is morally 
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important on grounds that it enhances the relevance of the research from the patients’ 
perspective.  
In considering the moral importance of the other sense of relevance—that is, 
relevance of study instrument items—the same kind of argument applies.  Relevance in 
this sense is morally important not only as a means to enhance social value, but also as a 
means to enhance the scientific validity or quality of the research, including the face 
validity and content validity of study instruments.  This is to say that by making 
instrument items more reflective of what patients view as important, patient input can 
help the study to more accurately capture what is important to patients, thereby increasing 
both social value and validity.  The scientific validity of a study has been described as a 
component of social value (Freedman, 1987), and is also held as a separate ethical 
requirement of all clinical research (Emanuel et al., 2000).  Patient input on study 
instruments, accordingly, is morally important so far as it improves the validity of study 
findings.  
Like social value, however, the question of scientific validity is often a matter of 
degree, without a clear threshold.  Studies without patient input could certainly still be 
scientifically valid, even if they could be made more scientifically valid by way of patient 
engagement.  For example, a patient with a chronic disease reported in an interview that 
while the study instrument included questions on many aspects of her disease that were 
important to patients like level of pain and functioning, there were no questions on sleep 
and fatigue, which patients felt were important indicators of how well their disease was 
managed.  If researchers had not included questions on sleep and fatigue in the study 
instrument, the results of the study with respect to pain and functioning would not have 
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been invalid, but they would not have told the whole story.  In other words, the research 
may produce incomplete conclusions by the omission of additional areas of relevance to 
patients.  A further complication is that it is usually not possible to know, prospectively, 
the extent to which patient input will impact the relevance of study instruments.  Study 
instruments developed without patient input may include all the domains that patients 
consider important.  
While it is not possible to know whether patient input will have marginal, 
moderate, or substantial impacts on the validity of study instruments until after patient 
input is sought, the fact that patient input can enhance validity suggests it is morally 
important, at least in some circumstances.  Studies in which information from patients is 
collected through interviews/focus groups and surveys are good candidates for obtaining 
patient input as a means to potentially enhance the relevance of study instruments 
because such studies rely on information patients provide themselves.  This includes 
patient-reported outcomes, self-assessments, and patient preferences or opinions collected 
as data.   
This argument shows that relevance is important to the social value and also the 
scientific validity of research, both of which are widely accepted as ethical requirements 
of all clinical research.  Therefore, patient engagement, as a mechanism to enhance 
relevance, is also morally important, at least in circumstances in which patients’ 
perspectives on relevance are important for social value and/or scientific validity.  
Specifically, research that has direct implications for patients’ health and research in 
which patients’ values and preferences are involved may improve their relevance and, by 
extension, their social value, by seeking patient input.  This is not to say that patients are 
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the only ones who can assess the relevance of the research or that patients’ view of 
relevance supersedes what other stakeholders view as relevant.  While patients’ 
assessment of the overall relevance of a study is just one component of the study’s social 
value and their view of relevance may differ from that of other stakeholders, to exclude 
patients from discussions about the relevance of research would be to decide what is 
socially valuable research without input from a key stakeholder whose view of relevance 
necessarily factors into the global assessment of a study’s relevance and subsequently, its 
social value.  
For research that collects patient-reported data, engaging patients may enhance 
the relevance of study instruments by prompting minor or substantial improvements to 
the scientific validity and overall value of the study.  This is not to suggest that studies 
without patient input are invalid or that patient input is only important to ensure that 
study outcomes are relevant.  Rather, it is to suggest that in addition to enhancing the 
relevance and social value of the research as a whole, getting patient input on study 
instruments holds the possibility of enhancing the face validity and content validity of 
study instruments, which may improve the overall scientific validity of the study.  
 
Accountability 
Some authors have argued that patient engagement in research serves as a means 
to enhance accountability.  A recent narrative review identified accountability and the 
related concept of transparency as underpinning values of public involvement in research 
(Gradinger et al., 2013), and accountability is cited as one of the main reasons for patient 
involvement in research in the United Kingdom (Bastian, 1994; Bastian, 1998; Boote et 
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al., 2002; Tritter & McCallum, 2006).  In colloquial use, “accountability” refers to the 
expectation that individuals are answerable or responsible for decisions they make, and 
“transparency” refers to making information visible or accessible.  Both transparency and 
accountability were mentioned as benefits of patient engagement in interviews with 
researchers and patients: 
The patients are there to discuss and impact the goals that are set in the grant, the 
promises that are made, the expectations that are created in it. – Patient B 203 
 
Last week there was that article about whether some of the data had been 
falsified… And I do think having to present what you're doing periodically to 
stakeholders [including patients] who are smart people may in some ways keep 
some of that from happening. – Researcher 204 
 
The scientist that is behind all of it has to be willing to incorporate the 
information that they’re getting from those stakeholders… I think it’s very 
simple... You just say- you actually do what you say you’re going to do.                    
– Researcher 209 
 
These statements reflect how both researchers and patients viewed patient involvement in 
the research as a way to compel researchers to be open and honest and to remain 
committed to doing what they promise to do in the course of the research.   
Before exploring whether accountability is a morally important end of patient 
engagement, it is necessary to clarify the more technical, non-colloquial meaning of 
“accountability” in the context of research.  A large body of literature in political 
philosophy explores accountability as a key dimension of formal representation in 
democratic processes (Dovi, 2014).  Accountability in this political sense is not germane 
to patient engagement in research, for this notion of accountability refers to formal ways 
in which citizens hold political institutions and officials to account, such as the electoral 
process.  The research enterprise is not a political institution and involves no formal 
democratic processes; thus, accountability in a political sense is not the kind of 
accountability that patient engagement is thought to enhance. 
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Accountability in a social sense is more suitable for considering patient 
engagement as a way to enhance the accountability of researchers or funders.  Whereas 
political accountability refers to formal mechanisms that exist in the political 
environment, social accountability refers to “alternative ways for social actors (citizens, 
civil associations and the media) to direct demands” (Jelmin, 2012, p. 7).  This includes a 
wide range of activities such as public demonstrations, discourse, and participation in 
decision-making (The World Bank, 2006).  On this view, patient engagement can be 
understood as an informal way in which patients hold researchers or funders to account.  
This analysis will focus on social accountability because this conception most 
closely approximates what is meant in discussions about patient engagement as a means 
to hold researchers accountable.  Accountability in this sense requires three specific 
commitments on the part of researchers.  First, accountability requires researchers to 
practice transparency regarding the decisions they make.  Patients, at least, are informed 
about the decisions being made or, at most, play a key role in making such decisions.  
Second, accountability requires researchers to explain the decisions they make in the 
context of their research.  This means that the act of engaging patients provides an 
opportunity for researchers to justify their reasoning to patients, and may, in some cases, 
prompt changes to their reasoning or decisions in response to patients’ input.  Last, 
accountability requires researchers to make good on their promises—to do what they said 
they would do.  
Is accountability, thus understood, morally important for clinical research?  This 
is to ask: is it morally important for researchers to be transparent, to explain their 
reasoning, and to be held to their word?  There are two compelling reasons for endorsing 
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accountability as morally important.  First, accountability promotes the utility of the 
research enterprise and fairness in the distribution of research benefits.  Second, 
researchers may have moral obligations to patients and to the general public pertaining to 
the way they conduct research and use public resources.  Each of these reasons is further 
explicated below.  
The research enterprise functions more effectively when researchers are open, 
answerable, and committed to their decisions.  When researchers are accountable, 
patients may be more likely to have confidence in the research system, accept research 
findings, and support future research through funding or participation, all of which are 
essential for sustaining the research enterprise.  In fact, openness and “proactive and 
expansive approaches to accountability” that extend beyond regulatory requirements have 
been identified as key strategies for promoting public trust in biomedical research 
(Yarborough, Fryer-Edwards, Geller, & Sharp, 2009, p. 474).  Further, there is some 
evidence of increased mistrust in the research system among racial and ethnic minority 
populations compared to the white population (Braunstein, Sherber, Schulman, Ding, & 
Powe, 2008; Kennedy, Mathis, & Woods, 2007; Ulrich et al., 2013).  Enhanced public 
trust in biomedical research may help to address the underrepresentation of minority 
populations in research, which could help to generate more generalizable research 
findings and promote fairness in the distribution of research benefits.  Researchers also 
demonstrate respect to patient populations when they take steps to establish and maintain 
trustworthiness.  Given that accountability fosters public trust essential for the utility and 
fairness of the research enterprise, mechanisms for accountability are generally morally 
important.  Such mechanisms are especially important in circumstances where the patient 
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population lacks trust, perhaps as a result of past wrongdoing, such as in the case of 
research with some minority populations.  
Second, there are circumstances in which researchers have moral obligations to 
account to study participants and to the general public during the conduct of their 
research.  These circumstances include when researchers make promises to study 
participants and thus become obligated to keep their promises and also when researchers 
use public resources and thus have obligations to the general public to conduct their 
research as intended and to use resources responsibly.  
While conducting research, researchers inevitably make promises to study 
participants; they are morally obligated to keep such promises.  Researchers set study 
participants’ expectations regarding how the research will be conducted and regarding 
what will happen to study participants over the course of the research.  Perhaps more 
importantly, researchers also make promises regarding what will happen when the 
research is over including how research results will be shared with study participants and 
other stakeholders and how results will be used.  Such expectations are often set by 
information provided during the recruitment and informed consent processes, and 
patients may even decide to participate in research because of what researchers promise 
during such discussions.  These promises can range from minor (such as promising to 
provide reimbursement for parking) to more serious (such as stating that the research 
results will be used to improve patient care).  When researchers articulate expectations, 
whether minor or significant in nature, they create moral obligations to uphold them.   
The generation of such moral obligations is not unique to the relationship between 
researchers and study participants; rather, the moral obligation to keep a promise is a 
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feature of any relationship in which one person explicitly makes a promise to another.  In 
certain professional roles, however, keeping one’s word may arguably be even more 
important because it helps preserve trust (e.g., religious, legal, and medical 
professionals).  Researchers may fall into this category of professional roles because 
study participants’ trust in them is preserved when they uphold their commitments over 
the course of the research.  Whether or not one accepts researchers as being in a 
professional role that heightens expectations to keep promises, promise keeping is a 
general moral obligation of all promise makers, and so researchers are morally obligated 
to keep their promises by adhering to research plans they convey to people participating 
in their research.  
The final circumstance in which researchers and also funders can be said to have 
moral obligations to account is when public resources support researchers’ work.  When 
funders award researchers public funds to conduct their proposed research, researchers 
are morally obligated to use the funds to conduct the research in accordance with what 
they proposed.  Whenever public funds are used, the public bears the opportunity cost of 
not pursuing alternative uses of limited public resources.  Researchers and funders must 
be accountable to the general public as a means to ensure that public resources are being 
spent responsibly and as intended.  This obligation falls on government funding 
organizations and other organizations that are resourced through public dollars because 
they have a role in deciding how public dollars are spent.  The moral obligation to 
account may be discharged in myriad ways from public deliberation at the level of the 
funding agency to patient engagement in individual research projects.  PCORI and NIHR, 
as publicly supported funding organizations, can be said to be honoring moral obligations 
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to account for how public resources are spent through their requirement for public 
involvement in the research process. 
As an accountability mechanism, patient engagement may not only help 
researchers to keep their promises, it may also provide a venue for researchers to make 
promises.  When researchers engage patients during the research process, they provide an 
opportunity for patients to express their concerns, give feedback, and make ancillary 
requests or suggestions.  Researchers who are receptive to patients’ input may make 
commitments in response to patients’ feedback.  For example, patient advisors may 
recommend to researchers that they share research results with influential advocacy 
organizations and medical associations in order to promote better uptake of research 
findings into practice, and if researchers agree to do so, they are obligated to follow 
through on their commitment.  This is to say that aside from patient engagement serving 
as a strategy for researchers to meet existing moral obligations, it may generate new 
moral obligations of researchers.  Patient engagement may also prompt researchers to 
commit to doing beneficial things that they otherwise would not have thought to do.   
In sum, accountability is morally important for research insofar as it fosters public 
trust essential for sustaining the research enterprise and also promotes fairness in the 
distribution of research benefits.  Researchers have moral obligations to uphold 
commitments made to study participants and to conduct research supported by public 
funds in accordance with what they proposed to do.  In such cases, patient engagement 
can serve as a mechanism to hold researchers accountable, and it may create the 
opportunity for researchers to make and keep additional promises to patients.  The moral 
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requirement for researchers to be held accountable may be satisfied through a range of 
mechanisms, one of which is patient engagement.   
 
Respect for Research Participants 
There is evidence suggesting that patient engagement can result in research that is 
conducted in a more respectful manner.  Examples reported in interviews illustrate some 
of the ways in which patients engaged in research informed researchers about specific 
steps they could take to ensure that they were treating their study participants with 
respect.  Interview participants reported how patient feedback helped researchers 
recognize unintentional signals of disrespect embedded in their behavior: 
There are those that keep their relationship with their typewriter and just forget 
the patient is even there… I came back to the group and I told them that.  
– Patient A 207 
 
I don’t think we, as researchers… understand how our actions demonstrate to 
people that we don't value their opinions… I've learned a lot about the behaviors 
and the actions that researchers do to show that to patient groups and children 
inadvertently. – Researcher 101 
 
In addition to teaching researchers about behaviors to avoid so that study participants do 
not feel disregarded, patient research partners also recommended changes to study 
protocols to accommodate study participants’ needs or preferences.  For example, patient 
advisors for one study insisted that researchers provide transportation for study 
participants and that remuneration be given in person in cash rather than a check sent 
through the mail in order to reduce inconvenience for study participants.  In some cases, 
substantial changes to study designs were made in consideration of study participants’ 
comfort:  
There was a discussion about… people not being as forthcoming in a group with 
people that they don’t know as opposed to being one-on-one with an investigator 
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and kind of being able to share more and feeling more comfortable in a one-on-
one situation, so we… decided that maybe that was the direction to go.  
– Patient B 204 
 
Through engaging patients, researchers were informed of many ways to demonstrate 
respect and were able to incorporate respectful practices into their research plans and 
interactions with participants, suggesting that patient engagement can serve as a tool for 
enhancing respectful treatment of study participants. 
Respect for research participants is widely accepted as morally required 
(Beauchamp & Childress, 2009; National Commission for the Protection of Human 
Subjects of Biomedical and Behavioral Research, 1978).  The questions that need to be 
addressed for the purpose of this analysis are first, whether the canonical 
conceptualization of respect can be said to entail obligations on the part of researchers to 
behave in the ways described above, and second, if such behaviors conform with 
researchers’ obligations of respect, whether patient engagement is morally important for 
researchers to meet such obligations.  
The bioethics principle of respect is traditionally understood as respect for 
autonomy.  Beauchamp and Childress (2009) articulate the principle of respect as 
acknowledging peoples’ “right to hold views, to make choices, and to take actions based 
on their personal values and beliefs” (p. 103).  Obligations on the part of researchers that 
are entailed by the principle of respect for autonomy include obtaining informed consent 
and allowing study participants to withdraw (Beauchamp & Childress, 2009; Emanuel et 
al., 2000).  These actions demonstrate respect for autonomy by recognizing and enabling 
study participants to express their views and act in accordance with them.  
One of the examples described above clearly relates to respect for research 
participants in this autonomy-directed sense.  The researcher who learned that researchers 
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inadvertently “demonstrate to people that we don't value their opinions” was implying the 
moral importance of recognizing study participants’ beliefs and their right to have them.  
The other kinds of respectful behaviors described above, however, do not seem to relate 
to respect for autonomy.  Rather, they speak to actions that are respectful to persons in 
the sense that they demonstrate attention to study participants’ needs, feelings, 
preferences, or level of comfort.  These behaviors seemingly fall outside the traditional 
purview of duties entailed by the principle of respect for autonomy as articulated by 
Beauchamp and Childress, yet they appear consistent with our every day usage of the 
term respect (Dickert, 2009).  Avoiding offense, for example, is considered important for 
ethical behavior in every day life and is done out of respect for others.  This suggests that 
these examples of respect may be ethically important, but a different conception of 
respect, one that more broadly includes what we think of when we speak of respect, is 
needed to make this claim. 
The fact that respect for people’s beliefs is required under the principle of 
autonomy while respect for people’s comfort and convenience, for example, is not 
indicates a distinction between respect for autonomy, as defined by Beauchamp and 
Childress, and respect for persons, the latter being a more expansive conception of 
respect containing the former.  In tracing the historical usage of the concept of respect in 
the field of bioethics, Lysaught (2004) identifies a shift from an initially broad conception 
of respect for persons to the much narrower conception of respect for autonomy.3 
3 Lysaught describes how in the early 1970s, Paul Ramsey put forth an expansive conception of 
respect for persons that included acknowledging a person’s beliefs and attending to his or her 
needs.  By 1979, however, when Beauchamp and Childress’ first edition of Principles of 
Biomedical Ethics was published, the principle of respect was defined in the context of autonomy. 
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While respect for autonomy remains the predominant account of respect in the 
field of bioethics, some scholars have argued that it is too narrow and have proposed 
broader conceptions of respect (Beach, Duggan, Cassel, & Geller, 2007; Dickert, 2009; 
Lebacqz, 2005).  Dickert (2009), for one, defines respect as “a combination of 
appreciating what is valuable or important about a person, recognizing the constraints or 
demands that such a valuation places on one’s own conduct, and acting in a way that 
expresses that recognition” (p. 315).  Respect for persons thus involves acknowledging 
what is important to people and demonstrating that acknowledgement through one’s 
actions.  Having knowledge of what is important to people is a requisite for showing 
respect to them.  This broader account of respect demands consideration of autonomy, 
but it also demands consideration of feelings, emotions, needs, and other subjective 
experiences that people may value.  
While respect for persons is sufficiently broad to include considerations beyond 
autonomy, it is still difficult to deduce what specific actions it requires.  Buss (1999) 
argues that regular manners such as avoiding “being discourteous, impolite, rude, 
inconsiderate, offensive, [and] insulting” fall under the scope of what it means to act 
respectfully, from a moral standpoint (p. 795-6).  In the medical care setting, Beach and 
colleagues (2007) suggest that a health professional may demonstrate respect by 
“extending common courtesies, expressing concern for others and their wellbeing, taking 
their feelings and experiences seriously” (p. 694).  In the research setting, Dickert (2009) 
similarly holds that respect for research participants entails “the obligation to attend to 
issues of comportment” such as using terms that participants can understand when 
speaking to them, giving them your full attention when speaking, and not talking past 
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them (p. 325).  The specific actions held as required under the principle of respect for 
persons are comparable to the examples that patients and researchers cited when 
explaining the effects of patient engagement on research participants.  Such actions, 
therefore, can be said to conform to researchers’ obligation to respect research 
participants. 
Given that researchers’ obligation to demonstrate respect to research participants 
can be said to entail behaviors like the ones reported as effects of patient engagement, 
patient engagement can be said to be morally important insofar as it may help researchers 
to learn about specific ways to show respect or avoid disrespect to research participants.  
There are some circumstances in which patient engagement may be particularly useful in 
helping researchers learn about how to show respect for research participants.  These 
include circumstances in which researchers may be unfamiliar with the study population 
or may have reason to be particularly concerned about showing respect to them.  In such 
cases, researchers can seek patient input to identify ways that increase the likelihood that 
their obligations of respect to research participants are able to be met.  
Researchers conducting research in communities with which they are unfamiliar 
may be unaware of what respect in those communities looks like because they lack 
sufficient knowledge about the study population’s needs, experiences, and values.  Given 
that patient engagement may help researchers to learn about what is important to the 
study population and how to show respect to them, patient engagement can serve as a 
morally important strategy to help researchers meet obligations of respect to people from 
these communities.  For example, a researcher working with study participants from 
another culture may learn about behaviors that are perceived as respectful in that culture 
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and can then adopt such behaviors to show respect to study participants.  In this way, 
patient input may increase researchers’ cultural competency to work with the study 
population (Minkler, 2005).  In discussing how community engagement contributes to the 
ethical conduct of global health research, King, Kolopack, Merritt, and Lavery (2014) 
make a similar point, noting that community input serves as a way for researchers to learn 
about research practices that may be offensive and about ways to minimize offense.  
Patient engagement can help researchers learn about respectful behaviors to adopt as well 
as disrespectful behaviors to avoid. 
Patient engagement is also a useful strategy when researchers have reason to be 
particularly concerned about respectful treatment of study participants.  Research 
involving communities that have been treated disrespectfully in prior interactions with 
the healthcare or research system—including populations whose values, needs, or 
experiences have not been given due consideration in the past—warrant researchers being 
especially attuned to showing respect.  These populations have reason to be suspicious of 
researchers and the healthcare system more generally, and because of their history of 
mistreatment, they may be predisposed to feeling disrespected.  Research suggests that 
minority populations have more distrust in the research system than whites (Braunstein et 
al., 2008; Kennedy et al., 2007; Ulrich et al., 2013), which may be due, at least in part, to 
historic mistreatment.  In fact, a recent qualitative study involving focus groups with 
African Americans found that lack of trust in the health care system among African 
Americans is rooted in the legacy of the Tuskegee Syphilis Study, sustained through 
generations, and exacerbated by disrespectful treatment in the present (Scharff et al., 
2010).  For populations that have experienced wrongdoing in the past, researchers need to 
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recognize the historical context that has bred suspicion and mistrust and subsequently do 
more to demonstrate respect and build trust with such populations.  Engaging these 
populations is a way to reduce mistrust and show respect. 
This is consistent with the position of the US Presidential Commission for the 
Study of Bioethical Issues, which, after reviewing syphilis studies that the United States 
Public Health Service conducted in Guatemala in the 1940s, recommended that 
researchers demonstrate respect for study participants and their communities and 
recognize cultural practices through engaging the population in the research process 
(Tanne, 2011).  Similarly, engagement has also been recommended to help address 
concerns with regard to genetic research with certain minority populations including 
American Indians, African Americans, and Latinos (Quinn, 2004; University of 
Washington Center for Genomics and Healthcare Equity, 2012).  Even if researchers 
themselves are members of these populations, their seeking patient input can not only 
help them to become more sensitized to concerns that members of the population have 
but can also show them as trustworthy to skeptics in their communities.  
Demonstrating respect is always morally important in research and requires 
researchers to behave in ways that show respect and to avoid behaviors that are 
disrespectful.  Populations with which researchers lack familiarity or that have 
experienced wrongdoing from past research may be at greater risk of not feeing 
completely respected or of feeling disrespected in research, either because researchers are 
unaware of what respect means in that population or because the population is recovering 
from prior mistreatment.  In these cases, researchers should have heightened attention to 
ensuring that their obligations of respect are met.  Patient engagement, as a means to help 
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researchers learn about ways to show respect to study participants and build trust, may 
increase the likelihood that researchers fulfill their moral obligations of respect to study 
participants.  
 
NON-INSTRUMENTAL VALUE OF PATIENT ENGAGEMENT  
 
Up to this point, this moral analysis has explicated arguments that hold patient 
engagement as morally important on grounds that its ends are morally important.  I will 
now shift my focus to explicating the argument that patient engagement is morally 
important independent of these ends.  Recall that non-instrumental value refers to patient 
engagement having value because it is morally important itself, regardless of its effects.  
The question taken up here is whether there is something non-instrumentally valuable, 
some intrinsic property of patient engagement itself that is morally important for research 
and thus provides justification for holding patient engagement to be morally important.  
Specifically, I argue that certain patient engagement activities are constitutive of the duty 
to respect the moral worth of patients as people. 
 Patient engagement consists of researchers including patients in the research 
process, listening to them, and involving them to varying degrees in research decision-
making.  Listening to patients is considered a distinctive feature of patient engagement. 
When patients and researchers described the value of patient engagement, they often 
referred to the idea of listening to patients as intrinsically valuable: 
Regardless of the outcome of the study, I think they feel respected and feel like 
we care about what they have to say. Even if the study is a total failure otherwise. 
– Researcher 106 
 
It’s this image of researchers kind of—no offense taken, I hope—in an ivory 
tower or in a lab, not really listening to the needs of the people who they think 
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they’re creating models to help, and I think when you have an opportunity to chat 
with people... I think it’s incredibly valuable to our community as a whole.  
– Patient A 209 
 
To know that somebody is listening out there and they're trying to change things.  
I think that’s very, very encouraging. – Patient A 109 
 
As these quotations suggest, researchers’ very act of listening to patients, whether or not 
it has any demonstrable effects on the research study, is perceived as valuable and is 
linked to patients’ being respected.  If listening to patients is constitutive of the duty of 
respect, then patient engagement can be considered intrinsically morally valuable.  As 
addressed earlier in this paper, it is widely accepted in the field of bioethics that 
researchers have a duty to respect research participants (Beauchamp & Childress, 2009; 
National Commission for the Protection of Human Subjects of Biomedical and 
Behavioral Research, 1978).  For the purpose of this analysis, it is necessary to explore 
how listening to the patient population relates to respect. 
 Researchers show respect to patients by seeking them out and listening to them. 
Researchers do not need to agree with what patients tell them or change the research 
project in response to patients’ views in order for researchers to respect patients in this 
way.  My earlier discussion of the concept of respect showed that engaging patients can 
help researchers to learn about specific ways to show respect over the course of the 
research project.  The claim I am making now, however, is that engaging patients itself 
shows respect to patients because the act of listening to patients is one way for 
researchers to recognize their value.  That is, it is not just the result of listening to patients 
that may show respect to patients, it is also the fact that researchers are seeking patients 
out and displaying a desire to hear them that demonstrates respect to patients.  The notion 
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that researchers respect patients by seeking their opinions and listening to them is deeply 
connected to what it means to respect patients as people.  
Described as the foundation on which contemporary discussions of respect are 
often based, Kant’s ethical theory provides an account of what it means to respect 
someone as a person (Dillon, 2014).  Kant (1785/1993) held that all people have 
distinctive moral worth and should be treated in a way that recognizes such worth—
namely, by treating people “never simply as a means but always at the same time as an 
end” (sec. 429).  The duty to respect the moral worth of an individual is a general ethical 
obligation that all people have to others and also to themselves (self-respect).  Beach and 
colleagues (2007) advance a Kantian conception of respect in the context of clinical care, 
holding respect as the “recognition of the unconditional value of patients as persons” (p. 
692).  Because this duty entails respecting patients as persons, it is not dependent on any 
particular characteristic of patients.  This Kantian conception of respect requires that we 
each recognize that every person has moral value simply by virtue of his or her 
personhood.4 
Given that respect requires that all people acknowledge the moral value of other 
people, researchers are required to acknowledge the moral value of patients as people too.  
The act of seeking out patients and listening to them respects patients precisely because it 
is a way for researchers to recognize the unconditional moral value that patients have as 
persons.  Because the act of listening to patients recognizes patients’ moral value, patient 
engagement has intrinsic moral value. 
4 This analysis treats the duty to recognize the unconditional value of people as a starting point.  
Recreating Kant’s argument for the moral worth of all humans is beyond the scope of this paper 
as is discussion of whether some humans do not have moral status (e.g., cognitively impaired 
individuals, fetuses) and thus are not entitled to respect as moral persons. 
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This argument holds that listening to an identified subset of patients is constitutive 
of respect to the larger and perhaps indeterminate patient population that includes that 
subset.  While patient research partners cannot be said to represent, in a formal sense, the 
larger patient population from which they come, the fact that some patients are being 
sought out and heard indicates that researchers recognize that all patients from that 
population have moral worth.  By engaging even a few patients in the research process, 
the researcher is demonstrating to the larger patient population that she values them 
enough to want to hear what patients from that group have to say.  This claim is at least 
intuitively plausible.  Patients who are not engaged in research may still appreciate the 
fact that researchers are listening to patients like them and gathering some patients’ 
perspectives, and patients who are engaged in research may recognize that not all patient 
views are likely to be captured by engaging even several patients from their population.  
Researchers and their patient research partners alike must be mindful that the patients 
engaged in research are not necessarily representative of the larger patient population of 
which they are a part; however, lack of representativeness does not undermine patient 
engagement as constitutive of the demonstration of respect to the general patient 
population.  Researchers concerned about representativeness among patients they are 
engaging can also take steps to have ample inclusion of patients with a range of 
predetermined characteristics (e.g., health status, geographic region, socioeconomic 
indicators) to help ensure that a diversity of perspectives are included (Crocker, 2008).   
 The act of listening to patients makes patient engagement intrinsically morally 
valuable as it recognizes the unconditional moral worth that patients have as people 
deserving of respect.  Because listening to patients is morally important, researchers 
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conducting research with populations that have been ignored or silenced in the past may 
consider engaging patients as a way to listen to them and show respect to them.  From a 
practical standpoint, listening to patients who have not been shown respect in the past or 
who feel that they have not been heard is a reasonable way to show that one does, in fact, 
care about what patients have to say.  In fact, empirical research suggests that feeling 
listened to is a salient feature of feeling respected (Frei & Shaver, 2002; Parse, 2006).  
When patients feel that researchers are listening to them, they feel valued and cared 
about.  From a moral perspective, patient engagement offers a way for researchers to 
make explicit that they recognize patients as deserving of respect. 
Patient populations that have not been shown respect or heard likely overlap with 
some of the other populations for which patient engagement is already morally 
important—namely, populations that have been mistreated in the past and minority 
populations that lack trust in the research system.  Additional populations that fit into this 
category may include socially marginalized or stigmatized groups and rare disease groups 
whose small numbers may impede their ability to receive due attention.  Researchers can 
engage patients from populations such as these as a way to listen to patients and 
demonstrate the respect that is due to all patients as people.  There are some well-known 
cases that show the power of patient engagement in giving voices to previously unheard 
or silenced groups that subsequently received the respect they deserved.  The early years 
of the HIV/AIDS crisis in the United States, for example, brought unprecedented 
activism from the socially stigmatized gay community that ultimately resulted in their 
engagement in HIV/AIDS policy and research and their being treated as people deserving 
of respect (Epstein, 1995).  
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In summary, respecting the moral worth of all people is a moral obligation that 
that can be discharged in different ways.  In clinical research, one such strategy for 
recognizing the unique moral value of patients as people is to seek them out and listen to 




This analysis described the role of patient engagement in enhancing the relevance 
of research, the accountability of researchers and funders, and the respectful treatment of 
research participants.  Then it argued that each of these effects of patient engagement is 
morally important for research, thus making patient engagement a morally important 
strategy for achieving each of these ends.  
Relevance is important to the social value and the scientific validity of research, 
both of which are moral requirements of research.  Patient engagement, as a strategy to 
enhance relevance, is thus morally important in some kinds of research.  In particular, 
patient engagement is morally important as a way to enhance relevance when the 
research has immediate health implications, involves patients’ values or preferences, or 
collects patient-reported data.  
There are some circumstances in which researchers have moral obligations to 
account for their actions.  Specifically, researchers must be held accountable for the 
promises they make to study participants and for how they spend public funds in the 
conduct of their research.  In these circumstances, patient engagement can serve as a 
mechanism for researchers or funders to meet moral obligations of accountability and as 
a venue for additional promises to be made.  While patient engagement is not morally 
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required in these circumstances, some form of accountability is, and patient engagement 
is one such strategy available for researchers or funders.  Because accountability can also 
enhance public trust, promote fairness, show respect to patients, and help sustain the 
research enterprise, patient engagement, as a mechanism for accountability, is morally 
important even when no moral obligations of accountability are present. 
Researchers are morally required to treat study participants with respect.  Patient 
engagement may increase the likelihood that researchers are meeting their moral 
obligations to treat research participants respectfully, obligations that are heightened 
when researchers lack familiarity with the study population or are working with 
historically disrespected populations who have reason to be suspicious of research.  This 
is not say that patient engagement in these circumstances is the only way to meet 
obligations of respect or that patient engagement is morally required, but it is to say that 
researchers must meet obligations of respect, one way or another, and patient engagement 
is one such way to help researchers meet their obligations, especially in these 
circumstances. 
In exploring whether patient engagement has non-instrumental value, this analysis 
found that patient engagement is constitutive of researchers’ moral obligation to 
recognize the patient population as persons with moral worth and thus has non-
instrumental value.  When researchers listen to patients, they are showing that they 
recognize the unique moral value of patients as people.  Researchers may discharge their 
moral obligation to respect the moral worth of patients by engaging patients, and this 
strategy may be especially important for populations who have not been respected or 
heard in the past.  This is not to imply that patient engagement is the only way to 
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recognize the moral value of patients as people.  Researchers may build strong personal 
relationships with patients and demonstrate respect for them as people through their 
personal interactions, or researchers with reputations for disseminating findings back to 
study participants can be said to be treating them as ends rather than merely as means for 
conducting their research, thus demonstrating respect for patients as people. Thus, while 
not necessary for fulfilling researchers’ obligations of respect, patient engagement in an 
additional way for researchers to respect the patient population as people with moral 
worth. 
This analysis revealed that patient engagement is helpful for enhancing relevance, 
accountability, and respectful treatment of research participants.  I argue that each of 
these ends is morally important for research, as is the act of seeking patients out and 
listening to them, an intrinsic feature of patient engagement.  Patient engagement, 
therefore, is morally important both as a strategy for achieving certain morally important 
ends and as a behavior that is constitutive of the duty to respect patients as people.  
Patient engagement could only be held as morally required if it were the only way to 
achieve these morally important results.  Because there may be other ways to enhance 
relevance, hold researchers and funders accountable, treat research participants 
respectfully, and acknowledge the unique moral value of patients, it cannot be said that 
patient engagement is morally required.  However, given that this analysis revealed the 
potential utility of patient engagement in satisfying multiple morally important results, 
patient engagement is a highly efficient strategy and a worthwhile endeavor, from a 
moral perspective. 
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In addition to explicating the moral importance of patient engagement, this 
analysis distilled the circumstances in which there are strong moral reasons for engaging 
patients and provided examples of the kinds of research in which these circumstances 
may exist.  Accordingly, this analysis has implications for the practice of patient 
engagement.  The strength of the moral reasons for engaging patients in research is 
dependent on a number of particular facts about any given research project that 
subsequently determine the extent to which the results of patient engagement are morally 
relevant.  These include considerations regarding the extent to which findings will have 
immediate implications for the health of patients, the kind of data collected from the 
research, whether public resources are being used, whether researchers have made 
promises to study participants, the level of trust the patient population has in the research 
system, researchers’ familiarity with the study population, and the extent to which the 
patient population has had an opportunity to be heard or has been respected in the past 
(Table 3.1).  Depending on these considerations, there may be strong or weak claims for 
the moral importance of engaging patients in research as a means for achieving morally 
important ends and respecting patients as people.  Further, whether alternative strategies 
are in place to achieve these morally important goals will also affect the strength of the 
argument for engaging patients in a particular research project.  By elucidating the moral 
underpinnings of patient engagement in research, this analysis suggests the kinds of 
research in which patient engagement is morally important.  Given the conceptual 
developments provided in this paper, researchers, funders, and institutional review boards 
may consider policies endorsing patient engagement in research meeting certain 




Table 3.1: Overview of the Moral Reasons for PE (Patient Engagement) in Research  
 
Reason for PE  Moral importance of 
reason for PE 
Circumstances in 
which PE is a morally 
important strategy for 
acting in accordance 
with said reason 
Examples of research in 
which circumstances 
may exist  
Relevance of 
research study 
Patients’ view of 
relevance contributes to 
social value, and social 
value is morally 
required for all clinical 
research. 
PE is morally important 
for studies in which 
patients’ view of 
relevance is likely to 
enhance the social 
value of that research. 
Studies with immediate 
implications for health 
 
Studies in which patients’ 





Relevance of items may 
enhance scientific 
validity and contribute 
to value, and both are 
morally required for all 
clinical research. 
PE is morally important 
for research collecting 
data from the patients’ 
perspective. 
  
Studies using surveys or 




reported outcomes  
Accountability  Accountability 
promotes utility and 
fairness of the research 
enterprise, making it 
morally important for 
clinical research.  In 
certain circumstances, 
researchers are morally 
obligated to be held 
accountable. 
PE is morally important 
when public trust and 
sustainability of the 
research is of particular 
concern.  PE can serve 
as a mechanism to 
fulfill the moral 
obligation of 
accountability when it 
exists. 
Studies with populations 
that lack trust (that have 
been mistreated) 
 
Studies in which 
researchers make 
promises to study 
participants  
 




Respect for research 
participants is morally 
required for all clinical 
research. 
PE is morally important 
insofar as it is one 
strategy for helping 
researchers learn 
specific ways to respect 
study participants.  
Studies with populations 
that have been mistreated 
 
Studies in which the 
researcher is unfamiliar 
with the patient 
population  
Intrinsic value  PE itself is intrinsically 
morally valuable 
because it recognizes 
the unconditional value 
patients have as people.  
PE is morally important 
as one strategy to listen 
to patients, thereby 
respecting the moral 
value of patients.  
Studies with populations 
who have not had the 
opportunity to be heard or 
who have been silenced in 
the past  
 
This table provides an overview of the moral importance of each reason for patient engagement 
and the circumstances in which engaging patients is morally important for acting in accordance 
with each reason.  The far right column serves as a practical guide providing examples of the 
kinds of research in which the circumstances that make patient engagement morally important are 
likely to be present.    
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APPENDIX 2: Extended Methods for Empirical Study  
 
This qualitative study had two aims: (1) to characterize the experiences and 
perceptions of researchers regarding patient engagement in PCORI-funded research 
projects and (2) to characterize the experiences and perceptions of patients regarding 
patient engagement in PCORI-funded research projects.  To achieve the aims of this 
project, qualitative interviews were conducted with 19 principal investigators (from 19 
different projects) and 33 patients (from 18 of the same 19 projects).  This study was 
reviewed and approved by the Johns Hopkins Bloomberg School of Public Health 
Institutional Review Board (JHSPH IRB) (Appendix 1). 
 
DEVELOPMENT OF MATERIALS  
Materials used for this empirical study included recruitment materials (Appendix 
3), consent forms (Appendix 4), interview guides (Appendix 5), and questionnaires 
(Appendix 6) for both researchers and patients.  The study materials were developed by 
the student investigator, reviewed by the student’s dissertation advisor, and approved by 
the JHSPH IRB.  
In order to test the interview guides, one in-person cognitive interview was 
conducted with a researcher from Johns Hopkins Hospital who had experience engaging 
patients and one cognitive phone interview was conducted with a patient serving on a 
research advisory board for a clinical research study at Johns Hopkins Hospital.  The 
student investigator developed cognitive probes to assess how questions were interpreted 
and understood following the approach outlined by Beatty and Willis (2007).  Cognitive 
interviews were audio-recorded but were not transcribed, and the student investigator 
 106 
took extensive notes during the cognitive interviews to inform changes to interview 
questions, which consisted of re-wording and re-framing questions to make them more 
understandable.  
The interview guides and short questionnaires were also reviewed by the Johns 
Hopkins Community Research Advisory Council (C-RAC) Research Review Committee, 
a group of volunteer Baltimore residents supported by the Community Engagement 
Program of the Johns Hopkins Institute for Clinical and Translational Research (ICTR) to 
evaluate and provide input on research projects (ICTR, n.d.).  The student investigator 
presented the research aims and methods, discussed the research project, shared study 
materials, and fielded questions from Committee members.  The Committee then 
provided written feedback to the student investigator after the presentation.  Several 
changes were made to the interview guides and short questionnaires in response to 
feedback from the Committee.  The student investigator gave a follow-up presentation to 
the Committee regarding how its feedback had been incorporated into the project.  The 
Committee’s feedback and a detailed list of the changes made in response to the feedback 
are located in Appendix 8. 
 
STUDY SITE AND SAMPLE 
Background Information about PCORI 
Authorized by the Patient Protection and Affordable Care Act (2010), the Patient-
Centered Outcomes Research Institute (PCORI) is an independent, nonprofit organization 
that funds comparative clinical effectiveness research (CER)  (PCORI, 2014b), which is 
research that compares the benefits and harms of alternative methods to treat clinical 
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conditions or improve the delivery of care in the real world setting (Federal Coordinating 
Council for Comparative Effectiveness Research, 2009).  A defining characteristic of 
PCORI’s research portfolio is that it aims to answer patient-centered questions in order to 
help patients and other healthcare stakeholders make informed, evidence-based decisions 
(PCORI, 2014a).  
As part of PCORI’s effort to fund patient-centered research, PCORI is committed 
to the inclusion of patients and other healthcare stakeholders throughout the research 
process starting with PCORI’s review of funding applications, which involves patient and 
other stakeholder reviewers along with scientific reviewers.  Funding applications 
submitted to PCORI are required to include a plan for how patients and other 
stakeholders will be engaged in the research, and patient and stakeholder engagement is 
one of the criteria against which funding applications submitted to PCORI are evaluated 
(PCORI, 2015). 
PCORI is set to spend over $3 billion on research in this decade (Washington & 
Lipstein, 2011).  Given PCORI’s commitment to funding research that engages patients, 
PCORI was selected as the site for this empirical study investigating patient engagement 
in research.  Projects from the first two PCORI funding awards, the Pilot Projects Grant 
Program and the Cycle I Awards, were selected for this study because these projects were 






Establishing a Relationship with PCORI  
The student investigator first became interested in the role of patients in health 
research and policy in January 2013.  At that point, the student investigator developed a 
research proposal under the direction of her advisor.  In May 2013, the research proposal 
was reviewed and approved by an interdisciplinary committee in conformity with the 
Johns Hopkins Bloomberg School of Public Health doctoral degree program 
requirements.  
After receiving the school’s approval to conduct her dissertation research, the 
student investigator contacted PCORI staff and arranged an informal meeting to learn 
more about patient engagement in PCORI research and to discuss having PCORI 
investigators and patients serve as the target sample for her research.  During the meeting, 
PCORI staff expressed interest in the research project.  They also informed the student 
investigator that PCORI was seeking to hire a student intern who could contribute to 
internal PCORI activities related to patient engagement.  In July 2013, the student 
investigator was formally offered and accepted a part-time internship position with 
PCORI, reporting to Lori Frank, who was the Program Director of Engagement Research 
at PCORI at the time.  Both PCORI and the student investigator understood the 
importance of keeping the student investigator’s work as an intern for PCORI separate 
from her role as an independent student investigator conducting research as part of her 
dissertation.  In her role as an intern, the student investigator assisted with synthesizing 
findings from the literature on patient engagement in research and contributed to data 
analysis for several evaluation projects including a project evaluating PCORI’s merit 
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review process.  She also helped contribute to the design and implementation of a 
longitudinal survey to measure patient engagement in PCORI’s entire research portfolio.   
In December 2013, the student investigator began conducting interviews with 
PCORI-funded investigators and their patient partners as part of her dissertation research.  
During the recruitment and informed consent processes, potential interview participants 
were notified that the project was being conducted as part of the student’s PhD 
dissertation research and also that the student was an intern at PCORI.  Recruitment 
emails also stated that PCORI was supportive of the student investigator conducting an 
“independent evaluation of PCORI-funded patient engagement.”  In the consent forms, 
interview participants were informed that PCORI would not have access to any 
information about which studies or individuals were recruited or interviewed.  Names of 
subjects were not recorded on study materials or transcripts and any potentially 
identifying information was redacted from the transcripts.  Further, PCORI did not have 
access to any data collected for this research project, and the student investigator retained 
full intellectual ownership of the data she collected as part of her dissertation research.  
The student investigator completed data collection for her dissertation research in May 
2014 and subsequently focused her attention on data analysis and on the development of 
her empirical and conceptual manuscripts.  
In June 2014, after 11 months serving as an intern at PCORI, the student 
investigator was formally offered and accepted a position as a part-time Program 
Associate for the Research Integration and Evaluation program at PCORI.  In this role, 
the student investigator continued to contribute to PCORI work related to patient 
engagement in research under the supervision of Lori Frank.  As with the internship 
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position, the student investigator’s work related to her dissertation research was kept 
separate from her work as a PCORI employee.  In February 2015, the student investigator 
left her position at PCORI so she could focus full time on completing her dissertation.   
The student investigator’s time working at PCORI gave her insights that helped 
her to cultivate a deeper understanding of the field of patient engagement, and she is 
grateful to have had such an opportunity; however, she also acknowledges that working 
at PCORI may have affected her results.  Interview participants may have viewed the 
student investigator as part of PCORI—the researchers’ funding organization—and so 
they may have been more inclined to give positive responses.  The student investigator, 
however, took several steps to mitigate the potential for social desirability bias by 
explaining that the interview transcripts were confidential, de-identified, and would not 
be shared with PCORI.  
 
Sampling from PCORI Pilot Projects  
The PCORI Pilot Projects Grants Program, PCORI’s inaugural funding award, 
was developed to lay the groundwork to support PCORI’s future portfolio of CER 
(PCORI, 2011a).  Unlike subsequent PCORI funding awards, the Pilot Projects were not 
required to be comparative studies; rather, they address a broad range of questions about 
developing instruments and methods for patient-centered outcomes research, establishing 
research priorities, engaging patients in research, and translating research findings into 
clinical practice.  The Pilot Projects were not required to engage patients as a stipulation 
of funding because the focus on these projects was on methods to inform CER rather than 
CER itself; however, patient and stakeholder engagement was one of the criteria against 
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which funding applications were reviewed and prioritized, and the majority of the 
projects included some patient engagement.  A total of 856 funding applications were 
submitted to the PCORI Pilot Projects Grant Program (PCORI, 2011b) and in June of 
2012, PCORI awarded $30 million in total funding to a slate of 50 two-year projects 
representing 23 states and the District of Columbia (PCORI, 2012a).  
Purposeful sampling was used to develop a sample of PCORI Pilot Projects for 
inclusion into this study.  The goal of the purposeful sampling was to include typical 
engagement approaches while also capturing variation with respect to several other 
aspects relevant to engagement.  The funding applications of all 50 Pilot Projects were 
reviewed to identify studies with patient engagement and to facilitate the selection 
process.  Studies with funding applications describing plans to engage patients were 
considered eligible.  Patient engagement was defined as a process or activity in which 
researchers involved patients, patient representatives, community members, and/or 
caregivers in the research process in a way other than as subjects of the research, which is 
consistent with definitions of patient engagement in the extant literature (Hanley et al., 
2003). 
The majority of funding applications from the Pilot Projects—42 out of 50 
(84%)—described plans for patient engagement and thus were considered eligible.  The 
projects that were excluded consisted of an analytic methods study with no patient 
engagement plan, a study that exclusively engaged non-patient stakeholders such as 
hospital administrators, two studies that described engaging patients as research subjects 
but not in ways other than as subjects of research and thus not meeting the definition of 
patient engagement, and four studies that assessed one or more method(s) of engagement 
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but that did not engage patients beyond the method(s) under investigation.  Studies 
assessing methods of patient engagement in which patients were also engaged beyond the 
patient engagement methods under investigation were considered eligible.  
Eligible Pilot Projects—that is, projects with patient engagement—were 
categorized by the different kinds of approaches to engagement described in the funding 
applications.  The main approaches described in funding applications and by which 
projects were categorized included advisory groups, focus groups/interviews, surveys, 
patient co-investigators, patient research team members, pilot testing, and novel methods.  
Because the goal of sampling was to capture typical approaches to patient engagement, a 
spreadsheet listing eligible projects by their engagement approach(es) was created to 
facilitate the selection of studies from each engagement approach.  Further, a secondary 
goal of sampling was to capture diversity with respect to other characteristics relevant to 
patient engagement including the population engaged (e.g., healthy patients, sick patients, 
patients from advocacy organizations, lay patients, minority patients, elderly patients), 
whether researchers has a previous relationship with the patients they were engaging, 
whether projects were also engaging non-patient stakeholders (e.g., clinicians, 
policymakers, purchasers, payers), and the study topic (e.g., behavioral health, chronic 
disease, rare disease).  This information was also extracted from the funding applications 
and entered into the spreadsheet to ensure that the study sample comprised a diverse and 
balanced selection of projects and captured the breadth of engagement approaches.  
The selection, recruitment, and enrollment process took place in an iterative 
fashion.  Initially, 10 studies that included all the engagement approaches and that 
captured variety across the other relevant characteristics described above were selected 
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for inclusion in this study.  Principal investigators were recruited by email.  If there was 
no response after two emails, principal investigators were then contacted by phone.  
During recruitment, potential participants were contacted up to four times (two emails 
followed by two phone calls).  If principal investigators only had one way of being 
contacted, they were contacted up to four times by the mechanism available (phone or 
email).  Each time that a principal investigator declined participation, the extraction 
spreadsheet for the eligible projects was reviewed and a suitable alternative project using 
the same approach or that was otherwise similar with respect to the sampling criteria was 
identified so as to maintain balance in the study sample.  For example, a principal 
investigator of a project using focus groups with patients to solicit patient feedback on the 
content and design of a novel intervention declined participation because the patient 
focus groups had not yet been conducted at the time the investigator was contacted, so the 
investigator of an alternative project also involving focus groups with patients to solicit 
patient preferences on the content of a novel intervention was then recruited and enrolled 
in this study.  Ultimately, 19 principal investigators of PCORI Pilot Projects were 
contacted; nine of the 19 investigators were enrolled in the study, and 10 of the 19 
investigators declined participation.  Of the 10 declining investigators, one principal 
investigator did not respond after four attempts and the others cited the following 
reasons: no time (n=3), IRB concerns (n=1), not yet engaging patients (n=1), not willing 
to have patients interviewed (n=2), and no longer able to contact patients whom they had 
engaged (n=2).  The nine investigators who agreed to be interviewed directed Pilot 
Projects that used various typical engagement approaches and that were diverse across 
the range of characteristics cited above. 
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For every study that was included in the sample, a phone or in-person interview 
was conducted with the principal investigator and with one to two patients whom the 
principal investigator was engaging in his/her research.  After principal investigators had 
agreed to participate in the study, they were asked to help identify two information-rich 
patients whom they had engaged as part of their PCORI project and who were different 
from each other in some meaningful way.  Patients whom the principal investigator saw 
as being involved and interested in the patient engagement activities were considered 
information-rich.  When two patients were interviewed, the way in which they were 
meaningfully different depended on the total number of patients engaged in the project 
and the make-up of the group of engaged patients but could include differences with 
respect to the following characteristics: affiliation with advocacy organizations, health 
status and experience with condition/disease being studied, previous experience being 
engaged in research, pre-existing relationship with the principal investigator, professional 
experience in the medical field, age, or gender.  
Principal investigators were asked to assist with patient recruitment by first 
contacting patients to gauge their willingness to be contacted by the student investigator 
about participating in an interview.  One principal investigator opted to notify all patients 
whom he was engaging about the possibility of being interviewed and then had the 
student investigator follow up with patients who expressed interest; however, the rest of 
the principal investigators recommended two patients and contacted only those two 
patients about participating in this study.  For two of the nine projects, only one patient 
was contacted about being interviewed and thus was the only patient interview conducted 
for that project.  In one of these cases, only one patient was actively involved in the 
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project; and in the other, the principal investigator only felt comfortable recommending 
one of the two patients engaged in the project due to the burden of participation 
combined with the poor health status of the other patient engaged in the project.  A total 
of 18 Pilot Project patients were recruited; 16 enrolled and two declined participation 
because of lack of interest.  
 
Sampling from PCORI Cycle I Awards 
The Cycle I Awards, PCORI’s first set of CER projects, include projects on 
PCORI’s first four areas of national priorities for research: Assessment of Prevention, 
Diagnosis, and Treatment Options; Improving Healthcare Systems; Communication and 
Dissemination Research; and Addressing Disparities.  Funding applications submitted to 
the Cycle I Awards were required to have a plan for engaging patients and other 
stakeholders, and engagement was one of the review criteria against which applications 
were evaluated.  Nearly 500 applications were submitted to the PCORI Cycle I Award 
Program, and in December of 2012, PCORI awarded $40.7 million in total funding to a 
slate of 25 three-year CER projects representing 17 states (PCORI, 2012b). 
The purposeful sampling procedures for the PCORI Cycle I Awards took place 
after the majority of Pilot Project interviews were completed and followed the same 
procedures used for sampling the PCORI Pilot Projects.  The goal of the purposeful 
sampling was again to include typical engagement approaches while also capturing 
variation with respect to several other attributes of the projects.  The funding applications 
of all 25 Cycle I Awards were reviewed to identify studies with patient engagement and 
to facilitate the selection process.  Studies with funding applications describing plans to 
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engage patients were eligible for inclusion, with patient engagement defined as a process 
or activity in which researchers involved patients, patient representatives, community 
members, and/or caregivers in the research process in a way other than as subjects of the 
research. 
Upon review of the funding applications, all 25 Cycle I Awards were found to 
have plans for engaging patients and thus no studies from the Cycle I Awards were 
deemed ineligible.  The Cycle I Awards were categorized by the different kinds of 
approaches to engagement described in the funding applications: advisory groups, focus 
groups/interviews, surveys, patient co-investigators, patient research team members, pilot 
testing, and novel methods.  Because the goal of sampling was to capture typical 
approaches to patient engagement, a spreadsheet listing eligible studies by their 
engagement approach(es) was created to facilitate the selection of studies from each 
engagement approach.  Further, a secondary goal of sampling was to capture variation 
with respect to other characteristics relevant to patient engagement including the 
population engaged (e.g., healthy patients, sick patients, patients from advocacy 
organizations, lay patients, minority patients, elderly patients), whether researchers has a 
previous relationship with the patients they were engaging, whether projects were also 
engaging non-patient stakeholders (e.g., clinicians, policymakers, purchasers, payers) and 
the study topic (e.g., behavioral health, chronic disease, rare disease).  This information 
was also extracted from the funding applications and entered into the spreadsheet to 
ensure that the study sample comprised a diverse and balanced selection of projects and 
captured the breadth of engagement approaches.  
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The selection, recruitment, and enrollment process took place in an iterative 
fashion.  Initially, 10 studies that included all the engagement approaches and that 
captured variation across the other characteristics described above were selected for 
inclusion in this study.  During recruitment, potential participants were contacted up to 
four times (two emails followed by two phone calls or up to four times by a single 
mechanism for participants that only had one way of being contacted).  Every time that a 
principal investigator declined participation, the extraction spreadsheet for the eligible 
studies was reviewed and a suitable alternative study using the same approach or that was 
otherwise similar with respect to other characteristics was identified so as to maintain 
balance in the study sample.  For example, an investigator of a study involving a patient 
advisory panel with chronically ill patients from a national patient organization did not 
respond to recruitment emails or phone calls, so an investigator of an alternative study 
engaging two patient partners with a chronic condition, also from a national patient 
organization, was recruited and enrolled in this study.  Ultimately, 14 principal 
investigators of Cycle I Awards were recruited; 10 of the 14 investigators were enrolled 
in the study, and the remaining four investigators declined participation.  Of the four 
declining investigators, one did not respond after four attempts and the others that 
declined cited lack of time (n=1) and not willing to have patients interviewed (n=2) as 
reasons for declining.  The ten investigators who agreed to participate directed Cycle I 
Awards that used various typical approaches to engagement and that were diverse across 
the range of characteristics cited above.  
For every study that was included in the sample, a phone or in-person interview 
was conducted with the principal investigator and an attempt was made to interview one 
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to two patients whom the principal investigator was engaging in his/her research.  After 
principal investigators had agreed to participate in the study, they were asked to help 
identify one to two information-rich patients whom they had engaged as part of their 
PCORI project and who were different from each other in some meaningful way.  
Patients whom the principal investigator saw as being involved and interested in the 
patient engagement activities were considered information-rich.  When two patients were 
interviewed, the way in which they were meaningfully different depended on the total 
number of patients engaged in the project and the make-up of the group but could include 
differences with respect to the following characteristics: affiliation with advocacy 
organizations, health status and experience with condition/disease being studied, previous 
experience being engaged in research, pre-existing relationships with the principal 
investigator, professional experience in the medical field, age, or gender.  
Principal investigators were asked to assist with patient recruitment by first 
contacting patients to gauge their willingness to be contacted by the student investigator 
about participating in an interview. Two principal investigators opted to notify all 
patients whom they were engaging about the possibility of being interviewed and then 
had the student investigator follow up with patients who expressed interest; however, the 
rest of the principal investigators recommended two patients and contacted only those 
two patients about participating in this study.  One principal investigator who participated 
in an interview was subsequently unable to recommend patients for interview, citing 
difficulty contacting patients, and was eventually lost to follow up.  Nineteen Cycle I 
Award patients were recruited, and 17 of the 19 enrolled.  Of the two that declined 
participation, one cited lack of time and there was no response from the other. 
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INTERVIEW STRUCTURE  
Each interview was conducted by the student investigator.  Interviews were 
conducted in person (n= 25) or by phone (n=27).  Prior to the start of each interview, oral 
informed consent was obtained.  All interviews were audio-recorded and transcribed.  
The overall interview structure was the same for all interviews, which were conducted 
following an interview guide (Appendix 5); however, there was some variation in 
questions that were asked depending on the flow of conversation, and interview 
participants were free to elaborate on topics within the interview guide that were of 
greatest interest to them.  At the start of the interview, principal investigators were asked 
to describe the research project and the way that patients were being engaged in the 
project, and patients were asked to describe the research project and the way that they had 
been involved in the project to date.  After this introductory, grand tour question, follow-
up probes were asked to gather additional background information and to explore key 
domains related to patient engagement.  Both the patient and researcher interview guides 
contained four domains pertaining to patient engagement and specific questions within 
each domain were tailored to respondent type (patient or researcher): 
1. Background information: This domain included general information about the 
research project and engagement approach including the research topic and 
methods, how researcher-patient relationships were established, and the nature 
of the engagement activities.  
2. Purpose of patient engagement: This domain explored why researchers 
decided to engage patients, why patients decided to participate, what patients 
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took to be the purpose of engagement, what the expectations and specific 
goals of engagement were, and the extent to which goals had been achieved.  
3. Experience of patient engagement: This domain consisted of probing 
questions on how researchers and patients felt the patient engagement 
activities went, including which procedures worked and did not work, what 
the challenges to and facilitators for engagement were, how patients 
influenced the projects, and what the effects of engagement on the research 
were. 
4. Beliefs about patient engagement more generally: This domain included 
questions exploring beliefs about the purpose and usefulness of patient 
engagement in research in general, including at what stage in research is it 
appropriate to engage patients, for what kinds of research it is appropriate to 
engage patients, and how patient engagement may effect the research 
enterprise. 
Participants were also asked to complete a short questionnaire (Appendix 6).  The 
questionnaire was emailed to interview participants in advance of the interview.  Some 
interview participants completed and returned the questionnaire to the student 
investigator via email prior to the interview; however, most participants completed the 
questionnaire after the interview.  For phone interviews, participants were read the 
response options and the student investigator documented the participants’ responses.  
There were two versions of the questionnaire—a researcher questionnaire containing 
seven questions and a patient questionnaire containing 10 questions.  Both questionnaires 
contained demographic questions asking the respondent’s race/ethnicity, age, and gender 
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as well as a question about whether the participant had ever participated in research as a 
research subject.  The researcher questionnaire asked whether the researcher had 
previously engaged patients in prior research (if so, how many times), how many years 
the researcher had been an academic faculty member, and on how many grants the 
researcher had served as a primary investigator.  The patient questionnaire asked patients 
if they had previously been engaged in a research project prior to this research (if so, how 
many times), whether the patient had a chronic condition, what stakeholder community 
the patient identifies with, the patient’s highest level of education attained, and the 
patient’s employment status.  
 
DATA MANAGEMENT AND ANALYSIS 
 After each interview, the student investigator reviewed hand-written notes, 
entered the data from the questionnaire into the computer, and typed new analytic memos 
or added to existing analytic memos to note important topics or impressions.  Interview 
audio-recordings were either transcribed by the student investigator or sent to a 
transcription service for transcription.  Identifying information was redacted from all 
interview transcripts.  Each interview transcript was checked against the full audio 
recording in order to identify and correct errors.  The content of each interview transcript 
was also reviewed in order to identify areas to improve for future interviews and to 
identify emergent themes.  
The approach to data analysis most closely followed a qualitative descriptive 
approach, which aims to generate a comprehensive description of the event under 
investigation (Sandelowski, 2000).  Qualitative analysis of the interview data was an 
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iterative process with interviews conducted until informational redundancy was reached.  
The interview questions were used as a starting point for developing a deductive analytic 
coding scheme, with additional inductive codes added based on salient topics identified 
during the review of transcripts.  All codes were then organized into thematic families 
and assigned descriptions.  The draft coding scheme was applied to a subset of 
transcripts, and the codes and code families were further refined before applying the 
finalized coding scheme to all transcripts.  Code families were reviewed and coded 
segments of text were compared to identify patterns and main themes.  The coding 
scheme can be found in Appendix 6. 
To test the reliability of the coding scheme, a second coder was trained on the 
coding scheme and independently applied codes to a total of six transcripts.  The double-
coded transcripts were compared and percent agreement was calculated.  There was 80% 
agreement between coders, with the majority of discrepancies being where the primary 
coder applied a code and the second did not apply any code.  There were some instances 
where the coders applied different codes from the same code family to the same section 
of text, but there were no instances in which the coders applied codes from different code 
families to the same section of text.  
Data from the questionnaires were entered into a computer software program and 
analyzed to understand the demographics of the study sample and assess relationships 
with the qualitative findings.  The qualitative software program ATLAS.TI (1999) was 
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APPENDIX 3: Initial Recruitment Emails 
A: Initial Recruitment Email for Principal Investigators 
 
JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH 
INITIAL EMAIL TO RECRUIT PRINCIPAL INVESTIGATORS 
 
Study Title: Exploring Patient Engagement in PCORI-Funded Health Research  
Principal Investigator: Nancy Kass, ScD 
IRB Number: 5238 
PI version number/date: Version 2 (8/5/2013) 
 
To: Research Participants [Principal Investigators] 
From: Lee-Lee Ellis, MA, doctoral candidate 
CC: Nancy Kass, ScD, professor and PhD advisor 
Email title: Request to Participate in Research 
 
Dear [Name of Principal Investigator], 
 
I am a doctoral student at Johns Hopkins Bloomberg School of Public Health, and I am 
writing to seek your willingness to be part of a qualitative interview study designed to 
evaluate patient engagement in PCORI-funded research projects.  I am also currently 
serving as an intern at PCORI who is supportive of my conducting an independent 
evaluation of PCORI-funded patient engagement. 
 
I am writing to you, as you are a recipient of a PCORI funding award, in the hope you 
would be willing to participate in a 45-60 minute interview.  The interview will ask you 
to describe your experiences doing patient engagement in your PCORI-funded project. 
 
We also hope to interview patients who have participated in these same patient 
engagement activities. The study will involve one 45-60 minute interview with principal 
investigators of PCORI-funded studies as well as interviews with two patients from each 
participating study.  
 
I would greatly appreciate your considering being part of an interview.  Please let me 
know your willingness by responding to this email or by contacting me by phone at 
[number].  I will then further explain the study and of course answer any questions.   
 







Study Title:  Exploring Patient Engagement in PCORI-Funded Health Research  
Principal Investigator:  Dr. Nancy Kass  
IRB Study No.:  IRB00005238 
If you have any questions about your rights as a research participant, you may call the 
Johns Hopkins School of Public Health Institutional Review Board (IRB) at 410-955-
3193, or 1-888-262-3242. 
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B: Initial Recruitment Email for Patients 
 
JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH 
INITIAL EMAIL TO RECRUIT PATIENTS/CONSUMERS 
 
Study Title: Exploring Patient Engagement in PCORI-Funded Health Research  
Principal Investigator: Nancy Kass, ScD 
IRB Number: 5238 
PI version number/date: Version 2 (8/5/2013) 
 
To: Research Participants [Patients/Consumers]  
From: Lee-Lee Ellis, MA, PhD candidate 
CC: Nancy Kass, ScD, professor and PhD advisor 
CC: [Name of Principal Investigator] 
Email title: Request to Participate in Research 
 
Dear [Name of Patient/Consumer], 
 
I am a graduate student at Johns Hopkins Bloomberg School of Public Health.  I have 
been approved to do a project to do interviews with researchers and patients who took 
part in “patient engagement” activities.   
 
I am writing to you because I believe that you helped researchers, or were part of an 
“engagement” activity in the last year or so.  We are always trying to learn more about 
what works and what doesn’t when researchers involve patients and get their input.   
 
I am trying to interview many patients who took part in activities like this to see what 
they think worked well and what didn’t.  [Name of Principal Investigator] indicated that 
you are willing to be contacted about being interviewed for my project. 
 
I am hoping to interview you once.  The interview will last about 45 to 60 minutes.  I can 
interview you in person or by phone.  Please let me know if it is OK to interview you, or 
if you have questions.  You can respond to this email, or you can call me at [number].  I 
will then explain the study and of course answer any questions.   
 






Study Title:  Exploring Patient Engagement in PCORI-Funded Health Research  
Principal Investigator:  Dr. Nancy Kass (IRB Study No.:  IRB00005238) 
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If you have any questions about your rights as a research participant, you may call the 
Johns Hopkins School of Public Health Institutional Review Board (IRB) at 410-955-




























APPENDIX 4: Participant Consent Forms 
A: Consent Form for Principal Investigators 
 
JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH 
ORAL CONSENT FORM: 
INTERVIEWS WITH RESEARCHERS 
 
Study Title: Exploring Patient Engagement in PCORI-Funded Health Research  
Principal Investigator: Nancy Kass, ScD 
IRB Number: 5238 
PI version number/date: Version 2 (8/5/2013) 
 
WHAT YOU SHOULD KNOW ABOUT BEING IN THIS STUDY 
• You are being asked to join a research study. 
• This consent form explains the research study and your part in the study.   
• Please read it carefully and take as much time as you need.  
• You are a volunteer.  You can choose not to take part, and if you join, you may 
quit at any time. There will be no penalty if you decide to quit the study.   
• During the study, I will tell you if I learn any new information that might affect 
whether you wish to continue to be in the study. 
 
PURPOSE 
You are invited to take part in a research study.  The purpose of this study is to describe 
the experiences and views of researchers who have conducted patient engagement as part 
of their research funded by the Patient-Centered Outcomes Research Institute (PCORI).  
We will also be interviewing patients who took part in these patient engagement 
activities.   
 
WHY YOU ARE BEING ASKED TO PARTICIPATE 
You are being asked to participate in this study because you are a principal investigator 
whose PCORI-funded study involves patient engagement. 
 
PROCEDURES 
I am asking you, as the principal investigator of a PCORI-funded study that involves 
patient engagement, if you are willing to be interviewed about your experiences and 
perceptions of the patient engagement you conducted. I hope to interview the principal 
investigators from up to 20 different PCORI-funded studies.  From each PCORI-funded 
study, I also hope to interview two patients about their experiences and perceptions of 
patient engagement. 
 
In the interview, you will be asked questions about the patient engagement you conducted 
as part of your PCORI-funded study.  I will ask you why you conducted patient 
engagement, your experience conducting patient engagement, and your views on how the 
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patient engagement went and what it achieved.  I will also ask you a little about your 
views of patient engagement in general. You can skip any questions that you do not feel 
comfortable answering.  With your permission, I will record the interview with a digital 
recorder.  I expect that the interview will take 45 to 60 minutes of your time.  
 
Because this research study seeks to explore patient engagement, I also plan to interview 
patients who have participated in the patient engagement activities of each participating 
PCORI-funded study.  I have asked your willingness, or the willingness of someone on 
your staff, in recruiting two patients who have participated in your patient engagement 
activities.  I have asked you to choose two patients who seemed particularly interested or 
involved in the patient engagement activities you conducted and who are different from 
each other in some meaningful way.  I then asked that you or a member of your research 
staff contact these patients to see if they are willing to be contacted by me for this study.  
I have contacted or soon will contact patients who have agreed to be contacted about 
being interviewed as part of this study.  If a selected patient is not interested in 
participating, I may ask you or the staff member to repeat the selection process until two 
information-rich patients are enrolled in this study.   
 
RISKS/DISCOMFORTS  
The risks of participating in this study are minimal.  There are no physical risks to being 
in this study.  I will be asking questions about your experiences and perceptions about the 
patient engagement you conducted.  Some of these questions could make you feel 
uncomfortable.  You do not have to answer any questions you would prefer not to 
answer.  There is also a risk that someone may find out that you are in this study.  I will 
do everything I can to prevent that.  Your contact information will be stored separately 
from any notes, recordings, or transcripts resulting from this interview.  I will not include 
any identifying information—such as your name, the name of your study, or your 
geographic location—in any notes or transcripts from the interview.  PCORI will not 
have access to any information about which studies/individuals have been recruited for 
this study nor about who agreed to participate.  You will not be named in any reports that 
are written on the basis of this research.  Your contact information as well as the digital 
recording and transcript of the interview will be stored on a password-protected 
computer.  Only the members of the research team will have access to this information, 
and they will not be allowed to share it with anyone else.   
 
BENEFITS 
There is no direct benefit to you from participating in this study.  However, I hope the 




Your participation in this study is completely voluntary.  You do not have to agree to be 





WHO DO I CALL IF I HAVE QUESTIONS OR PROBLEMS? 
Call the principal investigator, Nancy Kass, at [number] if you have questions or 
complaints about being in this study.  Call or contact the Johns Hopkins Bloomberg 
School of Public Health IRB Office if you have questions about your rights as a study 
participant.  Contact the IRB if you feel you have not been treated fairly or if you have 
other concerns.  The IRB contact information is:   
 
 Address: Johns Hopkins Bloomberg School of Public Health 
   615 N. Wolfe Street, Suite E1100 
   Baltimore, MD   21205 
 Telephone: 410-955-3193 
   Toll Free: 1-888-262-3242 
            Fax: 410-502-0584 
        E-mail: irboffice@jhsph.edu 
 
PERMISSION TO PROCEED 
























B: Consent Form for Patients 
 
JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH 
ORAL CONSENT FORM: 
INTERVIEWS WITH PATIENTS/CONSUMERS 
 
Study Title: Exploring Patient Engagement in PCORI-Funded Health Research  
Principal Investigator: Nancy Kass, ScD 
IRB Number: 5238 
PI version number/date: Version 2 (8/5/2013) 
 
WHAT YOU SHOULD KNOW ABOUT BEING IN THIS STUDY 
• You are being asked to join a research study. 
• This consent form explains the research study and your part in the study.   
• Please read it carefully and take as much time as you need.  
• You are a volunteer.  You can choose not to take part, and if you join, you may 
quit at any time. There will be no penalty if you decide to quit the study.   
• During the study, I will tell you if I learn any new information that might affect 
whether you wish to continue to be in the study. 
 
PURPOSE 
You are invited to take part in a research study.  The purpose of this study is to describe 
the experiences and views of patients who have been involved in patient engagement 
activities as part of a research study.  We will also be interviewing researchers who have 
conducted these patient engagement activities.  
 
WHY YOU ARE BEING ASKED TO PARTICIPATE 
You are being asked to be part of this study because you are a patient who has taken part 
in patient engagement activities conducted as part of a research study.  These activities 
may have been focus groups, advisory board meetings, telephone conferences, meetings 
with researchers, or other kinds of consultation or collaboration between researchers and 
patients.  We are also interviewing for this project the main researcher who held the 
activities in which you took part.  That researcher recommended that we talk to you; I 
believe that the researcher also told us that you agreed to have me contact you about 
being in this study.  
 
PROCEDURES 
I am asking you, as a patient who has taken part in patient engagement, if you are willing 
to be interviewed about your experiences and views of patient engagement.  I hope to 
interview up to 40 patients. 
 
In the interview, I will ask you questions about the patient engagement in which you took 
part.  I will ask you why you took part in the patient engagement, your experience during 
patient engagement, and your views on how the patient engagement went and what it 
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accomplished.  I will also ask you a little about your views of patient engagement in 
general.  You can skip any questions that you do not feel comfortable answering.  
 
With your permission, I will record the interview with a digital recorder.  I expect that the 
interview will take 45 to 60 minutes of your time.   
 
RISKS/DISCOMFORTS  
The risks of being in this study are minimal.  There are no physical risks to being in this 
study.  I will be asking questions about your experiences and perceptions about the 
patient engagement in which you took part.  Some of these questions could make you feel 
uncomfortable.  You do not have to answer any questions that you do not want to answer.  
There is also a risk that someone may find out that you are in this study.  I will do 
everything I can to prevent that.  Your contact information will be stored separately from 
any notes, recordings, or transcripts from this interview.  I will not include any 
identifying information—such as your name, the name of the study in which you were 
involved, or your location—in any notes or transcripts from the interview.  You will not 
be named in any reports that are written on the basis of this research.  Your contact 
information, the digital recording, and the transcript of the interview will be stored on a 
password-protected computer.  Only the members of the research team will have access 
to this information, and they will not be allowed to share it with anyone else.   
 
BENEFITS 
There is no direct benefit to you from being in this study.  However, I hope the findings 
will be of interest to those doing patient engagement in research. 
 
VOLUNTARY PARTICIPATION 
Your participation in this study is completely voluntary.  You do not have to agree to be 
in this study. You may change your mind at any time.   
 
WHO DO I CALL IF I HAVE QUESTIONS OR PROBLEMS? 
Call the principal investigator, Nancy Kass, at [number] if you have questions or 
complaints about being in this study. Call or contact the Johns Hopkins Bloomberg 
School of Public Health IRB Office if you have questions about your rights as a study 
participant. Contact the IRB if you feel you have not been treated fairly or if you have 
other concerns. The IRB contact information is:   
 
 Address: Johns Hopkins Bloomberg School of Public Health 
   615 N. Wolfe Street, Suite E1100 
   Baltimore, MD   21205 
 Telephone: 410-955-3193 
   Toll Free: 1-888-262-3242 
            Fax: 410-502-0584 
        E-mail: irboffice@jhsph.edu 
 
PERMISSION TO PROCEED 
Is it okay to proceed with the interview?   
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APPENDIX 5: In-Depth Interview Guides 
A: In-Depth Interview Guide for Principal Investigators 
 
JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH 
IN-DEPTH INTERVIEW GUIDE:  
PRINCIPAL INVESTIGATORS 
 
Study Title: Exploring Patient Engagement in PCORI-Funded Health Research  
Principal Investigator: Nancy Kass, ScD 
IRB Number: 5238 
PI version number/date: Version 4  (12/16/2013) 
 
Thank you for being willing to talk with me today. This interview is part of a project 
examining patient engagement activities conducted by recipients of PCORI funding 
awards in order to learn more about patient engagement. The study is part of my 
doctoral dissertation conducted for my PhD in health policy and bioethics at Johns 
Hopkins Bloomberg School of Public Health. 
 
 
BACKGROUND INFORMATION & EXPERIENCE ENGAGING PATIENTS 
 
1. Please tell me about your study and then where patient engagement fits in. 
If not covered, ask the following probes: 
 What types of activities have been done or are planned?  
 How many engagement activities were conducted or are planned in 
total?  
 How many patients have participated?  
 Does the patient engagement for this study build on existing 
relationships you have with any patients or patient groups?  If so, 
tell me more about that. 
 Are you engaging any non-patient stakeholders? If so, are they 
participating in the same or separate activities as the patient 
stakeholders? 
 
2. How has the patient engagement component of your study been going? 
If not covered, ask the following probes: 
 What has worked well for your patient engagement? 
 What has not worked well? 
 What has facilitated your patient engagement?  
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 What has hindered it? What has been challenging? 
 
3. In a moment, I am going to ask you about what you have gotten out of involving 
patients in the study, but first I’d like you to tell me how involving patients has 
affected the research project.  
If not covered, ask the following probes: 
 In what ways, if any, has the patient engagement had a positive 
effect? 
 What have been the positive effects/impacts of involving people? 
 It’s also important to consider the other side: what have been the 
negative effects/impacts? 
 
4. As a researcher, what have you gotten out of the patient engagement component 
of your project? 
 
5. Did you do anything (or do you plan to do anything) to evaluate the patient 
engagement component of your project? If so, please tell me more about that. 
 
EXPECTATIONS AND GOALS  
 
1. Why did you decide to engage patients as part of your project? 
 
2. What was the purpose of engaging patients as part of your research?  What were 
the specific goals for the patient engagement?  
 
3. Up to this point in your research, do you feel that the purpose and goals of 
engagement are being achieved? Why or why not? 
 
4. What, if anything, went differently than you planned?  Was this OK with you or 
not? 
 
5. Looking forward, if you had the opportunity to design a new engagement plan, 
knowing what you know now, what changes, if any, would you make to your 




1. More generally, what does the term “patient engagement” mean to you? 
 
2. What do you believe is the purpose of patient engagement in health research? 
Why do you think patient engagement is sometimes done in research studies? 
 
3. For what types of studies do you think it is appropriate to engage patients? 
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 Why those types and not others? 
 Are there certain topic areas or fields or study populations for 
which patient engagement seems more appropriate? Why or why 
not? 
 At what points in the research process is it most appropriate to 
engage patients? 
 At what points in the research process, if any, is it inappropriate to 
engage patients? 
 
4. What do you think patient engagement in health research can accomplish?  For 
researchers?  For engaged patients?  For study participants?  For the larger 
community?  For the research enterprise?  
 
5. In your view, do you think patient engagement in health research is a worthwhile 
























B: In-Depth Interview Guide for Patients 
 
 JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH 
IN-DEPTH INTERVIEW GUIDE: 
PATIENTS/CONSUMERS 
 
Study Title: Exploring Patient Engagement in PCORI-Funded Health Research  
Principal Investigator: Nancy Kass, ScD 
IRB Number: 5238 
PI version number/date: Version 3 (10/11/2013) 
 
Thank you for being willing to meet with me today. This interview is part of a research 
project.  We want to find out more about involving people in health research.  The study 
is part of my research for my PhD at Johns Hopkins Bloomberg School of Public Health. 
 
 
BACKGROUND INFORMATION AND EXPERIENCE BEING INVOLVED 
 
1. Please tell me about the ways people have been involved in [PI]’s study. 
If not covered, ask the following probes: 
 How have you been involved?  
 Why did you decide to get involved?  
 How did you end up getting involved?  
 Did you know [PI] or anyone from the research team before being 
involved? 
 
2. Thinking back to times when you were involved in activities for the study, can 
you tell me what those activities/meetings were like? 
If not covered, ask the following probes: 
 What do you like best about being involved? 
 What has been the worst about being involved? 
 What are some things that [PI] does that make it work well? 
 What are some things that [PI] does that make it not work well? 
 What has been challenging? 
 
3. In a moment, I am going to ask you about what you have gotten out of being 
involved in the study, but first I’d like you to tell me how you think your 
involvement has affected the research project. 
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If not covered, ask the following probes: 
 What have been the good effects/impacts of involving people? 
 It’s also important to consider the other side: what have been the 
bad effects/impacts? 
 
4. What, if anything, have YOU gotten out of being involved? 
 
EXPECTATIONS AND GOALS  
 
1. What were you expecting about being involved in the study going into it?  Have 
your expectations been met?  
                      
2. What do you think were the specific goals [PI] had for involving people?  Up to 
this point in the project, do you feel that that the goals are being achieved?  Why 




1. Why do you think researchers involve people/patients in their research studies?  
 
2. What do you think involving people/patients in health research can accomplish? 
 
3. For what types of studies should researchers involve people?  
 
If not covered, ask the following probes: 
 Why those types of studies and not others? 
 Are there certain research topics for which involving people seems 
more important?  
 
4. Research involves many stages: coming up with what the study is going to look 
at, writing a grant proposal, designing the study methods, doing the research, 
analyzing the results, telling people about the results, and putting the results into 
practice.  At what stages during research is it best to involve people?  Are there 
times when it does not make sense to involve people? 
 
5. In your view, do you think involving people is research is a good thing to do?  






APPENDIX 6: Participant Questionnaires 
A: Questionnaire for Principal Investigators 
 
JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH 
DEMOGRAPHIC QUESTIONNAIRE FOR PRINCIPAL INVESTIGATORS 
 
Study Title: Exploring Patient Engagement in PCORI‐ Funded Health Research 
Principal Investigator: Nancy Kass, ScD 
IRB Number: 5238 
PI version number/date: Version 2 (11/21/13) 
 
1. Have you ever had a research project that included community or patient 
engagement before your PCORI study?  
☐ Yes    
☐  No (If No, please skip question 1a) 
 
1a.   If yes, how many previous projects have you had that included 
community or patient engagement (not including this study)? 
☐ 1    
☐ 2   
☐ 3   
☐ 4 or more 
 
2. Have you ever participated yourself as a research subject? 
☐ Yes    
☐  No 
 
3. How many years have you been an academic faculty member?   
☐ Less than 1 year   
☐ 1-5 years   
☐ 6-10 years   
☐ 11 to 20 years 
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☐ More than 20 years  
 
4. On how many grants (including this PCORI project) have you served as a 
primary investigator?  
☐ 1-3    
☐ 4-6    
☐ 7-9    
☐ 10 or more 
 
5. With which of the following racial or ethnic groups do you most identify? 
(check all that apply) 
☐ African American  
☐ American Indian/Native American 
☐ Asian/Pacific Islander   
☐ Caucasian  
☐ Hispanic or Latino   
☐ Other 
 
6. What is your age?        
☐ 21-30 years    
☐ 31-40 years 
☐ 41-50 years    
☐ 51-60 years    
☐ 61 years or older 
 
7. What is your gender?  





B: Questionnaire for Patients 
 
JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH 
DEMOGRAPHIC QUESTIONNAIRE FOR PATIENTS 
 
Study Title: Exploring Patient Engagement in PCORI‐ Funded Health Research 
Principal Investigator: Nancy Kass, ScD 
IRB Number: 5238  
PI version number/date: Version 3 (12/04/13) 
 
1. Have you ever been involved in a research project in a way other than as a 
participant of the research? 
☐ Yes   
☐ No   
 
2. If you have previously been involved, how many times have you done so (not 
including this one)? 
☐ 1    
☐ 2   
☐ 3   
☐ 4 or more 
 
3. Have you ever participated in a research study? 
☐ Yes    
☐ No 
 
4. Do you have a chronic disease or condition? 
☐ Yes    
☐ No 
 




☐ Patient advocate/representative     
☐ Caregiver 
☐ Family member/parent of patient  
☐ Community member 
☐ Other (please specify:____________________________________) 
 
6. What is your gender?  
☐ Male   
☐ Female 
 
7. Which of the following racial or ethnic groups do you most identify with? 
(check all that apply) 
☐ African American/Black  
☐ American Indian/Native American  
☐ Asian/Pacific Islander 
☐ Caucasian  
☐ Hispanic or Latino    
☐ Other 
 
8. What is the highest degree or level of school you have completed?  
☐ Some high school, no diploma   
☐ High school graduate    
☐ Trade/technical/vocational training 
☐ Some college credit, no degree 
☐ College graduate (Associate or Bachelor’s)                  
☐ Graduate degree (Master’s or Doctorate) 
 
9. Which of the following best describes your employment status? 
☐ Employed full-time   
☐ Employed part-time    
☐ Not employed and seeking employment 
☐ Not employed and not seeking employment  
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10.   What is your age?  
☐ 20 years or younger      
☐ 21-30 years    
☐ 31-40 years 
☐ 41-50 years    
☐ 51-60 years    




















APPENDIX 7: Coding Scheme for Qualitative Analysis 
 
Table A.1: Code Names and Definitions 
 
CODE NAME DEFINITION 
1.0 GOALS OF PE  
The Goals of Patient Engagement code family includes codes relating to 
the goals and expectations of patient engagement, whether goals of 
patient engagement have been achieved, and whether patient engagement 
is being evaluated in any way. 
1.1 GOALS OF PE 
Apply when participants describe the specific goals or tasks of engaging 
patients in this research project.  This is in response to a question about 
the specific goals of engagement and is often double coded with a code 
from the "Specific Rationale/Effect of PE" code family. 
1.2 
EXPECTATIONS 
Apply when participants describe their expectations for engagement, 
what they expected to happen or get out of engagement. This is in 




Apply when participants describe whether or not or the extent to which 
the goals have been achieved. This is in response to a direct question 
after the participant has described the goals.  
1.4 ASSESSMENT 
OF PE 
Apply when researchers describe plans to evaluate or measure 
engagement in their own projects. This could include plans to conduct 
interviews, administer surveys, or get other types of feedback from the 
patients who have been involved.  Also apply when researchers indicate 
that they do not have plans to assess engagement. This usually comes up 
in a response to a direct question about plans to assess engagement. 
2.0 PE 
EXPERIENCE  
The Patient Engagement Experience code family includes codes that 
describe aspects of the patient engagement process including the 
approach to patient engagement, the role of patients on the research 
project, challenges to patient engagement, facilitators for patient 
engagement, and ways in which patient engagement has personally 
impacted participants.  
2.1 PRIOR 
EXPERIENCE 
RESEARCHERS ONLY. Apply to comments about previous work 
engaging patients that provide an understanding for the researchers’ 
views or for engaging patients in their PCORI project. 
2.2 ENGAGEMENT 
APPROACH 
Apply to descriptions about the engagement approach including what the 
approach is and what it does. Approaches may include advisory boards, 
patient co-investigators, patient members of the research team, focus 
groups/interviews, surveys, group forums, pilot testing, or novel 
methods. Example comment: "We have a family advisory board that 
meets once a month". This code is not to be applied every time the 
engagement approach is mentioned; rather it is just a way to categorize 
descriptions of engagement approaches in each project. This is different 
from the research approach, which should not be coded. 
2.3 PATIENT ROLE 
Apply to descriptions about patients’ role on the research team or in the 
engagement approach. For example, "I am the patient-co investigator" or 
"The patient partner leads the family advisory board meetings." This 
code is not to be applied every time the patient role is mentioned; rather 
it is just a way to categorize descriptions of patient roles in each project. 
2.4 CHALLENGES/ This is a broad code to be applied to comments about challenging 
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CODE NAME DEFINITION 
DOWNSIDES aspects or barriers to engaging patients in the research project. This 
could include poor communication, time, scheduling, recruitment of 
patient partners, issues with compensation, IRB issues. Downsides have 
to do with reasons researchers may not want to engage patients and 
negative effects from patient engagement. For example, saying that 
"research with patient engagement is a lot more work" or "additional 
time demand". This is usually in response to questions about what did 
not work so well, what are the lessons learned, and what are the 
downsides. 
2.5 FACILITATORS 
This is a broad code to be applied to comments on what worked well for 
engaging patients, what has been helpful, and what lessons have been 
learned. For example, this can include comments on the helpfulness of 
communication, shared leadership, the learning network, patient training, 
the use of a glossary, payment, and allowing extra time to meet with 
patients. This code should also be applied to comments about strategies 
for overcoming barriers and may be double coded with 
challenges/downsides. Something may be a barrier and an asset—for 
example, allowing more time is helpful to patients but slows the research 
process. 
2.6 PERSONAL 
IMPACT FROM PE 
Apply when researchers describe how engaging patients (either in this 
study or previously) has impacted the way they approach research, 
medical care, or another aspect of their career or personal live.  Apply 
when patients describe that through participating in patient engagement, 




The Patient-Principle Investigator Relationship code family includes 
codes on how relationships were established, why patients decided to 
become involved, and the extent to which researchers or patients were 
trained for engagement. It also includes codes about tokenism in patient 
engagement, shared decision-making between researchers and patients, 
patients feeling like equals, patients having a sense of ownership over 
the project, the use of technical language when researchers talk to 
patients, and patients feeling included in the process.  
3.1 HOW 
ESTABLISHED 
Apply when researchers or patients describe how their relationship was 
established. This could include a description of previous interactions 
between the researchers and patients engaged in the project, preexisting 
personal relationships, or recruitment activities used to connect patient 
research partners and researchers. 
3.2 WHY PATIENTS 
DECIDED 
PATIENTS ONLY. Apply when patients describe why they decided to 
get involved in the project. This is usually in response to a direct 
question about why they decided to get involved. 
3.3 TRAINING FOR 
PE 
Apply to comments about conditioning, training, orienting, or educating 
patients or researchers with regard to patient engagement. Also apply to 
comments about training on research or science as needed for 
engagement. 
3.4 TOKENISM 
Apply when there are positive or negative comments about patients 
being engaged in a superficial or disingenuous manner.  Apply when 
there are references to "checking a box" or "tokenism". Apply to 
comments that explicitly describe the engagement as not tokenism as 
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CODE NAME DEFINITION 




Apply to comments about researchers and patients making decisions 
together or how decisions are not made without first consulting or 
involving patients. Do not apply to text describing a study topic about 
shared decision-making or the importance of shared decision-making in 
clinical care; this code should only be applied to decision-making in the 
context of patient engagement in research. 
3.6 EQUALITY 
Apply to positive or negative comments about equality such as patients 
feeling equal/unequal, the presence of power differentials, or patients 
being treated with equal respect. This also includes descriptions of 
techniques to address inequality or promote equality during engagement 
activities such as using first names only to avoid hierarchy or other 
techniques to equalize roles. 
3.7 OWNERSHIP 
Apply to comments about patients having a sense of ownership over the 
project or an aspect of the project, researchers having to share 




Apply to comments about researchers using language/concepts that are 
inappropriate to patients. This includes comments about changing the 
language, creating a glossary of jargon terms, speaking each others' 
language, patients being unable to understand the scientific concepts 




Apply to comments about patients feeling included as part of the 
research group; apply to comments about patients feeling like they have 
a voice that is heard. This includes comments on how researchers make 
an effort to involve the patients to get their feedback, and patients feeling 
that their feedback is valued, heard and incorporated into the project. 
4.0 PATIENT 
CHARACTERISTIC 
The Patient Characteristic code family includes codes on patients as 
advocates or typical patients, patients as having experience/expertise, 
and patients as representative of a larger patient population. 
4.1 ADVOCATE 
PATIENT 
Apply to comments about patients being professional/professional-
leaning advocates. Patients may describe themselves as advocates or as 
having a background in research and advocacy, or researchers may 
describe a patient as an advocate or having been involved in an 
advocacy/patient organization. This code may be double coded with the 
typical/lay patient code, which is the contrast to the trained advocate 
patient. This code is not meant to capture patients who view themselves 
as advocates for themselves or another in a casual way (for example, “I 
advocated for my dad when he was in the hospital”), this is really meant 




Apply this code to positive or negative comments about engaging the 
layperson, typical patient, regular person, normal Joe, and so on. This 
code may come up in a discussion about the value of or contrast between 




Apply to comments about patients bringing their experience as a patient 
or as a working professional to engagement activities. This includes 
comments about patients sharing their experience of disease or as a 
patient, which may be different than how clinicians understand the 
disease or patients’ experiences. This also includes comments about 
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patients' professional experience being an asset to engagement (for 
example, “She is a marketing expert and so she helped us think about 
dissemination”). Lastly, this includes comments that refer to patients 
being experts because of their experience. 
4.4 REPRESENTA- 
TIVENESS 
Apply to explicit, positive or negative comments about selecting patients 
who are representative of a certain group/condition. Also apply to 
comments about issues of representativeness in the engagement sample. 
If someone is referred to as a "patient representative", do not code unless 
broader message is about concept of representativeness. 
5.0 RESEARCH 
STAGE  
The Research Stage code family includes codes that describe various 




Apply to comments about patient engagement in developing the research 
topic or setting the research agenda. 
5.2 RESEARCH 
QUESTIONS 
Apply to comments about patient engagement in developing the research 
hypothesis or questions. 
5.3 PROPOSAL Apply to comments about patient engagement in developing the research proposal (PCORI application). 
5.4 RESEARCH 
TEAM 
Apply to comments about patient engagement in establishing the 
research team. This could include patients using their network to find 




Apply to comments about patient engagement in designing the study or 
choosing the study methods. 
5.6 STUDY 
MATERIALS 
Apply to comments about patient engagement in developing study 
materials. This includes interview questions, surveys, recruitment 
materials, and the like.   
5.7 STUDY 
INTERVENTION 
Apply to comments about patient engagement in designing or choosing 
the study intervention or aspects of the intervention. 
5.8 STUDY 
OUTCOMES 
Apply to comments about patient engagement in choosing or prioritizing 
study outcomes. 
5.9 RECRUITMENT Apply to comments about patient engagement in any aspect of study recruitment. 
5.10 STUDY 
LOGISTICS 
Apply to comments about patient engagement in miscellaneous aspects 
of study planning. This includes the IRB, consent procedures, and other 
logistical aspects of the study. 
5.11 DATA 




Apply to comments about patient engagement in analyzing or 
interpreting data from the study. 
5.13 
DISSEMINATION 





Apply when there is an explicit comment about patients being engaged at 
every stage or throughout the entire research process. 
6.0 NATURE OF 
INFLUENCE  
The Nature of Influence code family should be applied with the Research 
Stage code family, to the extent possible, to characterize what patient 
 148 
CODE NAME DEFINITION 





Apply to comments about patients giving advice, feedback, opinions, or 
their perspectives on an aspect of the study during engagement activities.  
6.2 CHANGED 
Apply when the researchers or patients describe an aspect of the project 
changing as a result of patient input or when there are comments about 
aspects of the project being refined, tweaked, or modified as a result of 
patient involvement. 
6.3 TESTED 
Apply to comments about patients pilot testing the study intervention, 
study instruments, or other study materials. This could include patient 
advisors being given study materials (an iPad, a survey, or the 
intervention itself) to test how it works and how it can be improved 
before/while it is used for the study. 
6.4 VALIDATED 
Apply to comments about patients reinforcing/confirming the 
researchers’ thinking or an aspect of the project. This could include 





Apply when patients criticize, challenge, or ask questions with regard to 
an aspect of the research. This also includes comments about researchers 
wanting patients to be critical of the research approach in order to 
improve it, comments about patients seeing their role as asking 
penetrating questions to researchers. 
6.6 OTHER 
INFLUENCE 





The Specific Rationales/Effect code family includes codes on various 
reasons cited for engagement and/or effects of patient engagement, as 
they relate to the SPECIFIC PCORI PROJECT.  
7.1 INCORPORATE 
PT PERSPECTIVE 
Apply to PCORI PROJECT-SPECIFIC comments about engaging 
patients to get patient perspective, input, and/or experience. This 




Apply to PCORI PROJECT-SPECIFIC comments about engaging 
patients as a way to enhance the legitimacy or credibility of the research.  
7.3 KEEP PT-
CENTERED 
Apply to PCORI PROJECT-SPECIFIC comments about engaging 
patients in order to ensure that the research is patient-centered, focused 
on the patient, or as a reminder of how patients are affected. 
7.4 ENHANCE 
RELEVANCE 
Apply to PCORI PROJECT-SPECIFIC comments about engaging 
patients to increase the relevance of the research to the patient 
population. This includes comments about engaging patients to make 
research more meaningful or useful to patients or more reflective of what 
patients think is important, their needs, or reality. 
7.5 ENHANCE 
FEASIBILITY 
Apply to PCORI PROJECT-SPECIFIC comments about engaging 
patients to enhance the appropriateness or acceptability of an aspect of 




Apply to PCORI PROJECT-SPECIFIC comments about engaging 
patients in order to enhance external validity/generalizability or to reach 
a wider or more diverse group of patients. 
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Apply to PCORI PROJECT-SPECIFIC comments about engaging 
patients in order to improve the quality of the research, the validity of the 
research findings, or to advance research more generally. This may 
include nonspecific comments about patient engagement making the 
research project better. 
7.8 IMPROVE CARE 
Apply to PCORI PROJECT-SPECIFIC comments about engaging 
patients as a way to improve patient care (for either the engaged patients 
or the patient community more broadly). This is usually an aspirational 




Apply to PCORI PROJECT-SPECIFIC comments about engaging 
patients in order to improve communication between 
researchers/clinicians and patients or to improve the dissemination and 
implementation of results. 
7.10 SHOW 
RESPECT TO PTS 
Apply to PCORI PROJECT-SPECIFIC comments about engaging 
patients in order to demonstrate respect to patients. This may include 
comments about patients deserving to be involved. 
7.11 PCORI 
REQUIREMENT 
Apply to PCORI PROJECT-SPECIFIC comments about researchers 
engaging patients because PCORI (or funders more generally) are 
interested in it or require it. 
7.12 OTHER Apply to PCORI PROJECT-SPECIFIC comments about rationales for or effects of PE that are not captured by other codes in this family. 
7.13 INFERENCE 
VALENCE CODE. Apply this code when the comment implies a 
rationale for or effect of engagement but does not explicitly reference the 
particular rationale. For example, if the logical conclusion of the 
influence of engaged patients is that it will make the results more 
relevant, code as "7.4 Enhanced Relevance" and then add this valence 




The General Rationales/Effects code family includes codes on various 
reasons cited for engagement and/or effects of patient engagement, as 
they relate to research in GENERAL (not specific to the PCORI project). 
8.1 INCORPORATE 
PT PERSPECTIVE 
Apply to GENERAL (not PCORI project-specific) comments about 
engaging patients to get patient perspective, input, and/or experience.  
8.2 ENHANCE 
LEGITIMACY 
Apply to GENERAL (not PCORI project-specific) comments about 
engaging patients as a way to enhance the legitimacy and/or credibility 
of the research.  
8.3 KEEP PT-
CENTERED 
Apply to GENERAL (not PCORI project-specific) comments about 
engaging patients in order to ensure that the research is patient-centered, 
focused on patients, or as a reminder of how patients are affected. 
8.4 ENHANCE 
RELEVANCE 
Apply to GENERAL (not PCORI project-specific) comments about 
engaging patients to increase the relevance of the research. This includes 
comments about engaging patients to make research more meaningful or 
useful to patients or more reflective of what patients think is important, 
their needs, or reality. 
8.5 ENHANCE 
FEASIBILITY 
Apply to GENERAL (not PCORI project-specific) comments about 
engaging patients to enhance the appropriateness or acceptability of an 
aspect of the study or to ensure that the research process is 
feasible/practical. 
8.6 ENHANCE Apply to GENERAL (not PCORI project-specific) comments about 
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CODE NAME DEFINITION 
GENERALIZ-
ABILITY 
engaging patients in order to enhance external validity/generalizability or 




Apply to GENERAL (not PCORI project-specific) comments about 
engaging patients in order to improve the quality of the research, the 
validity of the research findings, or to advance research more generally. 
This may include nonspecific comments about patient engagement 
making research better. 
8.8 IMPROVE CARE 
Apply to GENERAL (not PCORI project-specific) comments about 
engaging patients as a way to improve patient care (for either the 
engaged patients or the patient community more broadly). This is usually 




Apply to GENERAL (not PCORI project-specific) comments about 
engaging patients in order to improve communication between 
researchers/clinicians and patients or to improve the dissemination and 
implementation of results. 
8.10 SHOW 
RESPECT TO PTS 
Apply to GENERAL (not PCORI project-specific) comments about 
engaging patients in order to demonstrate respect to patients. This may 
include comments about patients deserving to be involved. 
8.11 PCORI 
REQUIREMENT 
Apply to GENERAL (not PCORI project-specific) comments about 
researchers engaging patients because PCORI (or funders more 
generally) are interested in it or require it. 
8.12 OTHER 
Apply to GENERAL (not PCORI project-specific) comments about 
rationales for or effects of PE that are not captured by other codes in this 
family. 
8.13 INFERENCE 
VALENCE CODE. Apply this code when the comment implies a 
rationale for or effect of engagement but does not explicitly reference the 
particular rationale. For example, if the logical conclusion of the 
influence of engaged patients is that it will make the results more 
relevant, code as "8.4 Enhanced Relevance" and then add this valence 
code to indicate that this is an inference the coder is making. 
9.0 GENERAL 
BELIEFS  
The General Beliefs code family includes codes about the participants 
beliefs about engagement in general, not necessarily specific to 
engagement in the PCORI project. 
9.1 STAGES FOR PE 
Apply to comments about stages of research (for example, proposal 
development, dissemination) when patients ought to be engaged. This 
arises often in response to a direct question but may appear elsewhere in 
transcript.  Sections of text coded here may also be double coded with 
"PE Early in Process" or "Stages Not for PE" as they are often discussed 
in the same thought. Do not apply codes from the "Research Stage" 
family to general beliefs about stages of research for patient engagement. 
9.2 STAGES NOT 
FOR PE 
Apply to comments about stages of research when patients ought NOT to 
be engaged. This arises often in response to a direct question but may 
appear elsewhere in transcript. Do not apply codes from the "Research 
Stage" family to general beliefs about stages of research for patient 
engagement. 
9.3 PE AT EVERY 
STAGE 
Apply to comments about the philosophical view that patients should be 
engaged in all stages of the research process. Note that this does not 
mean that patients must have the same level of engagement across the 
study, just that they should be involved throughout. Do not apply codes 
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CODE NAME DEFINITION 
from the "Research Stage" family to general beliefs about stages of 
research for patient engagement. 
9.4 PE EARLY IN 
PROCESS 
Apply to comments about the philosophical view that patients need to be 
engaged in the beginning of the research process. 
9.5 KIND OF 
RESEARCH FOR PE 
Apply to comments about the kind of research (disease topic area or 
methodology) in which it is appropriate to engage patients. 
9.6 CAN’T DO 
RESEARCH 
WITHOUT PE 
Apply to comments about the philosophical view that research (or a 
certain kind of research like outcomes research) cannot be done 
successfully without engaging patients. 
9.7 EVIDENCE OF 
PE NEEDED 
Apply to comments about the lack of evidence on the effects of patient 
engagement and the need to show that patient engagement is worthwhile. 
9.8 CULTURE 
AGAINST PE 
Apply to comments about the negative culture around patient 
engagement: a long history of not engaging patients or a view among 
researchers that patients cannot meaningfully contribute to research. 
10.0 METAPHORS The Metaphors code family includes metaphors that were commonly mentioned. 
10.1 IVORY 
TOWER 
Apply to the analogy of researchers doing work in an ivory tower, 
isolated from the rest of the world. Often this very analogy is used, but 
the comment does not have to invoke "ivory tower" just the idea (for 
example, researchers working behind locked doors, engagement getting 
researchers off the beaten path). 
10.2 VOICE AT 
TABLE 
Apply when there is a reference to patients having a voice at the table. 
Do not apply to comments that mention the patient voice but not in the 
context of being at the table. For example, a patient may say that they 
feel like their voice matters to the researchers, this should NOT be coded 




Apply to comments that compare engaging patients in research to 
consumers/users being involved in product development (for example, it 










APPENDIX 8: Community Research Advisory Council (C-RAC) 
Review 
A: Feedback from C-RAC Research Review Committee  
 
Community Research Advisory Council (C-RAC) 
 
October 28, 2013 Research Review Meeting 
 
Table A.2: C-RAC Feedback on Patient Questionnaire 
Question 1:  What is your gender should be grouped with questions about race, ethnicity, 
education, and age.  The question should not be the first item on the survey.   
Question 2:  Which of the following stakeholder groups do you most identify?  Delete the 
word “stakeholder” from the question; Delete the word “patient” as a response option 
Question 3 and Question 4:  Consider deleting the word “patient” from these items  
Questions 3, 4, 5:  Should be added to the in depth interview; they aren’t demographics 
Question 6:  Delete this question.  It does not fit with the other questions, seems out of 
place.  May raise concern among the Institutional Review Board or in an audit.   
Question 7:  Add a separate question; to determine if a respondent identifies as 
Hispanic/Latino since this is an ethnicity; delete the term Non-Hispanic  
Question 7:  Consider adding additional options for Asian/Pacific Islander  
Question 9:  Change the 1st response to 18-20 years; since all participants will be at least 




Table A.3: C-RAC Feedback on Patient Interview Guide 
Introduction -Add a definition of patient engagement    
Consider deleting or rephrasing question 1c, it appears out of place 
All questions appear to be redundant and require rephrasing  
Page 2 and Page 1 appear to be different versions of the same questions; Do you want the  
C-RAC to recommend which version to use.  If so, we recommend that you use page 2.  
The questions on page 2 are easier to understand and will help you get more information.   
Consider reorganizing the survey so that: 
Section 1-  Beliefs about patient engagement in health research general 
Section 2- The purpose of patient engagement   






Table A.4: Executive Summary of Discussion During C-RAC Research Review 
Background Information and Study Overview 
Presented by Lee-Lee Ellis, MA, Principal Investigator 
PhD Candidate, Johns Hopkins Bloomberg School of Public Health  
Patient engagement in health research is a process in which researchers collaborate 
with/or obtain advice from the general public regarding the planning and implementation 
of research.  A few examples of patient engagement in health research include 
community-based participatory research, community advisory boards, and focus groups.  
The stakeholders that researchers collaborate with/or obtain advice from are referred to as 
“patients”.      
The Patient-Centered Research Outcomes Institute (PCORI) is an organization that funds 
health research.  Researchers seeking funding from PCORI are required to submit patient 
engagement plans; describing how they will collaborate with/or obtain advice from 
patients throughout the planning, implementation, and dissemination of their study.   
Researchers and funders recognize the value of patient engagement in research, yet few 
studies have been conducted to demonstrate the effectiveness of this approach or how it is 
viewed by patients and researchers. 
Purpose of Research:  The purpose of the study is to determine how patients and 
researchers view patient engagement in health research; how patient engagement impacts 
health research; and which types of studies benefit the most from patient engagement.   
Methods:  My study will include up to 20 PCORI funded projects. Three representatives 
from each study (1 researcher; 2 patients) will be interviewed.  I will obtain oral consent 
from participants before the interview is conducted.  The interview will include 
demographic questions and questions to determine patients/researchers perceptions of 
patient engagement in health research.  There is very little risk to people who participate 
and no direct benefit.  We hope that the data can be used to improve patient engagement 
in health research.    
Reason for Research Review 
I am asking the C-RAC to provide feedback on my patient Demographic Questionnaire 
and Interview Guide.  In 6-12 months, I’d also like to share my study findings with the C-
RAC. 
Interactive Discussion: Questions about Research Study 
Member 1:  Will the interviews occur before or after the patient engagement has started?   
Lee-Lee:  The interviews will occur after the patient engagement has started.   
Member 2:  Are you interviewing the people individually or as a group? 
Lee-Lee:  Each person will be interviewed individually.     
Member 3:  Are you doing all of these interviews yourself? 
Lee-Lee:  Yes. 
Member 5:  Are the interviews done in person or phone? 
Lee-Lee: Some interviews will be done in person and some by phone. 
Member 6:  Why are you recruiting two patients per project?   That’s a small number. 
Lee-Lee:  I have approval to interview 60 people; so I will interview three people from 
each study (1 researcher and 2 patients). Some projects may only have one or two 
patients involved.  
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Member 1:  How will you select the two patients, in a manner that is fair and equal? 
Lee-Lee:  I will select people who are different from each other in some way.  For 
example, if one patient is a part of a disease group; the other patient won’t be.   
Member 4:  Have you identified the studies you are reaching out to? 
Lee-Lee:  Yes, I have a list of all the studies I could possibly include.  
Member 4:  Will the studies be at Hopkins or other institutions? 
Lee-Lee:  A few studies may be from Hopkins, but mostly other institutions all across the 
U.S.  
Member 5:  How are you recruiting? 
Lee-Lee:  I will email the head researcher.  If they are interested in participating, I will 
explain that I want to interview them and two patients engaged in the research study.  I 
will ask the researcher to identify two patients who may be interested in the study.    
Member 7:  Are you recruiting from all PCORI funded studies? 
Lee-Lee:  No, I will be emailing researchers of a subset of PCORI funded projects.   
Member 7:  What type of patients are you recruiting?     
Lee-Lee:  I am really recruiting members of the general public who serve as advisors or 
part of research of team.   
Member 7:  Oh, these are stakeholders, like our C-RAC board.  Why not call them 
advisors?   
Lee-Lee:  Yes. I call them “patients” because PCORI calls them patients and I want to be 
consistent. 
Feedback on the Demographic Questionnaire (organized by question or theme) 
Question 1:  What is your gender? 
Member 8:  Don’t think the survey should start off with gender.  Since the survey is not 
focused on gender identity.    
Member 5:  Gender should be included with education, race, and ethnicity.   
Question 7:  To which racial or ethnic group(s) do you most identify? 
Member 9:  You should have a separate question asking people if they are of 
Hispanic/Latino descent since this is an ethnicity.      
Member 10: This should be a separate question because people of any race can be of 
Hispanic/Latino descent.  A lot of African-Americans are of Hispanic/Latino descent.       
Question 6:  Do you consider yourself someone who has a chronic disease? 
Member 5:  Why are you asking if a person has a chronic disease?  How is this related to 
the survey?  Do you want to find out what type of chronic disease a person has? 
Lee-Lee:  I am not trying to find out what type of chronic disease someone has; just if 
they have a chronic disease.  Patients with chronic disease may be more likely to think 
patient engagement is a good idea  compared to patients who do not have a chronic 
condition. I want to be able to see if their views are different. 
Lee-Lee:  I have to leave the meeting early.  Please continue to discuss.     
Member 3: The question is too long and could be written clearer.   
Member 1:  She could change the question to: Do you have a chronic disease?   
Member 5:  Some people may feel uncomfortable answering this question.   
Member 8: Asking people if they have a chronic health condition is invasive. I wonder if 
it is necessary to get this information to answer the research question.      
Member 11:  She may want to delete the question.  It seems beyond the scope of the 
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study.   
Member 5:  Let’s recommend that she remove the question.  
Questions 3 and 4:  Use of the term community or patient engagement activities. 
Member 8:  I’m not sure how familiar people will be with the words “patient”, 
“stakeholder”, and “community engagement”.  She will need to define them and include 
examples.  She may want to delete the word “patient” from these questions.   
Question 2:  Which of the following stakeholder groups do you most identify?   
Member 8:  She may want to delete the word “stakeholder” from the question.   
Member 11:  She may want to delete term “patient”.   
Member 3:  I agree the word is confusing. Everyday people do not think of the word 
“patient” as “research advisors”.  This could be confusing.      
Member 4:  Let’s suggest that the term is deleted.     
Question 9:  What is your age? 
Member 5:  Change the response 20 years or younger to 18-20 years.    
Feedback on the Interview Guide (organized by page) 
Page 1 
Member 9:  The introduction should include a description of what patient engagement is 
and how the term patient will be used throughout the study.     
Member 8:  The wording should be more conversational. 
Member 9:  For question 1, the probes don’t seem to go with the question.    
Member 4:  Question 1a or Question 1b should be the first question.     
Member 5:  She should delete or rephrase Question 1c.  It doesn’t fit with the survey. 
Member 4:  Questions 2a-2f; 3-7 appear to be redundant and are hard to understand.  She 
should rephrase and condense these questions.   
Page 2 
Member 3:  I like questions on 2nd page.  Those questions should be on page 1.  
Page 2- Start the survey with questions on beliefs related to patient engagement 
Member 8:  She may want to start the survey by asking questions about the general 
beliefs about patient engagement in research.         
Next Steps 
Schedule a follow up meeting with Ms. Ellis to discuss feedback. 
Member 11:  We may want to hold a follow up meeting. 
Member 5:  I will prepare the minutes and incorporate our feedback into the surveys.  I 











B: Response to Feedback from C-RAC Review 
 
Changes made based on C-RAC Research Review feedback 
 
Demographic Questionnaire: 
1. Reordered questions in the order C-RAC suggested (this meant starting with the 
question about the participant’s previous experience with patient engagement, 
rather then starting with the question about gender).  This was a helpful 
suggestion because it made the questionnaire flow better. 
2. I re-worded both questions about previous engagement so that I did not have to 
say “patient engagement”—this, again, was a very helpful suggestion as the 
participants may not be familiar with that jargon. 
3. I re-worded the question about which stakeholder group people belong to so that I 
would not have to use the word “stakeholder”.  This cut down on my use of 
unfamiliar jargon. 
4. I removed the question about living with a chronic disease or condition.  From our 
conversation, it became clear that this question was confusing.  Here is the new 
question I came up with instead: “Do you have a chronic disease or condition”?  
There was some debate about the reason for including this question, and I’d like 
to tell you why I want to include it and see what you guys think. 
5. I re-worded the question about racial/ethnic groups in order to place the power 
with the participant, as you suggested.  Instead of asking them which ethnic 
group(s) best describes them, I am asking them which ethnic group(s) they 
identify with—this was the C-RAC’s recommended language. 
6. The C-RAC noticed that I had left out a response for people under 20 years old.  I 
changed that to include ages below 20 as I may have participants between 18 and 
20 years of age.  
 
Interview Guide 
1. Big picture: What I heard repeatedly in our discussion and what came across in 
the written feedback was that the interview guide seemed redundant and 
confusing in places. I really appreciated this feedback, and have taken several 
steps to address these issues.   
2. Based on feedback from C-RAC and from a practice interview, I have deleted 
some questions that were either repetitive or unclear (see Table A.5).   
3. Based on feedback from C-RAC, a practice interview participant, and my advisor, 
I have rephrased questions that were confusing (see Table A.6) 
4. Based on feedback from C-RAC, I have tried to improve the flow of the interview 
guide by reorganizing the guide to have probes that I will only ask if the topic has 
not already been covered.  The new guide has streamlined questions with follow-
up probes to ask only when needed.   
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5. I have removed all references to “engagement” and “patient engagement” and 
replaced with “involving” (Table A.7). 
6. I have removed references to “patient” and replaced with “people”.  I am going to 
take cues from the participant about which words they use to describe the people 
involved (e.g., community members, people like them, patient representatives, 
caregivers, community partners, people) (Table A.7). 
7. Since the C-RAC recommended I reverse the order of the questions in the 
interview guide and start with general questions first, I tested this out in a practice 
interview.  I am not sure whether it is best to start with GENERAL questions 
about being involved or to start with the participant’s EXPEREIENCE.  I plan to 
decide after conducting a few more interviews, and I would like to get C-RAC’s 
input on this. 
 
Table A.5: Interview Questions That Have Been Deleted 
  Deleted Interview Questions Reason for Deleting 
What does the term “patient engagement” 
mean to you? 
Patient interview participants are not 
likely to be familiar with this term, so it 
will not be used during the interview. 
Do you think involving people in health 
research is a worthwhile activity? 
Similar question in a two-part question, 
deleted one of two (repetitive) 
Are there certain topic areas or fields in 
health or patient populations when it’s most 
important to involve people?  Why or why 
not? 
Intuitive answer that would not provide 
any new information about patient 
engagement; also the question is long and 
confusing 
What do you think was the purpose of 
involving people as part of the study? 
Nearly identical to another question 
(repetitive) 
How do you feel your involvement has been 
going? 
Confusing question that did not get at 
what I was trying to ask 
 What has worked well? Nearly identical to another question 
(repetitive) 
What has not worked well? Nearly identical to another question 
(repetitive) 
In your opinion, what was achieved by the 
patient engagement? Was this in line 
with what you thought would be achieved? 




















Table A.6: Interview Questions That Have Been Rephrased 
Original Interview Questions Rephrased Interview Question 
I’d like to hear about the patient 
engagement activities for [name of 
study]. Can you tell me about those? 
Please tell me about the ways people have been 
involved in [PI]’s study? 
 
What have you liked about it? What 
haven’t you liked about it? 
What do you like best about being involved? 
What has been the worst about being involved? 
Has anything helped make the patient 
engagement work well? If so, please 
tell me more about that.  Has anything 
made it not work so well? If so, please 
tell me more about that. 
What are some things that [PI] does that make 
it work well?  What are some things that [PI] 
does that make it not work well? 
What has been challenging? 
How do you think the patient 
engagement had a good effect on the 
research project? How do you think the 
patient engagement had a bad effect on 
the research project? 
I’d like you to tell me how you think your 
involvement has affected the research project? 
[Probe on good/bad if not covered] 
Table A.7: Jargon Terms That Have Been Removed from the Interview Guide 
Original term Replacement 
Patient People (will take cues from participant and can use other terms 
including patient, patient representative, community member, 
caregiver, patient partner) 
Patient engagement Involving people in research 
Patient populations n/a 
Research enterprise n/a 
Research process Research (with listing out the different stages from coming up 
with what the study is going to look at to telling people about 
the results and putting them into practice 
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APPENDIX 9: Lay Person Summary 
 
 
Learning About Patient Engagement in Research 
 
Background  
Health researchers are involving patients in research in a new way.  They are 
inviting patients to be advisors or partners, and not just to be “subjects” in their research.  
More and more, researchers are asking patients to give opinions on research.  For 
example, researchers may ask patients about what to study.  And patients can help 
researchers make decisions.  Patients can also look at study forms like the consent form 
or a survey to see if they make sense.  Patients may even help do research.  Asking for 
patients to help make studies better in this way is called patient engagement.   
People are excited about patient engagement.  Some groups that give money to do 
research want researchers to involve patients in ways like this.  They think it is a good 
thing to do.  Even though people are excited about patient engagement, there are still lots 
of things to learn about it.  We need to learn about the best ways to involve patients.  We 
need to know what the effects of patient engagement are.  Last, researchers need to know 




We did a research project to learn more about patient engagement.  This research 
project had two parts.   
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• First, we did interviews both with researchers and with patients involved 
in the researchers’ work.  The goal was to hear about what researchers and 
patients thought about how patient engagement was going.  We also 
wanted to learn about its effects.   
• Second, in part two of this project, we wrote about why patient 





We did 19 interviews with researchers and 33 interviews with patients.  After 
doing the interviews, we learned how patients were involved in research.  Some patients 
were on advisory groups, and some were part of the research team.  Some researchers 
met with patients a lot and some only met with them a few times.  Patients gave ideas and 
reviewed research materials.  Patients’ advice sometimes led to changes to the research 
and other times it did not.  It could make the research better, more useful, or easier to do.   
Sometimes patient engagement was hard.  It was hard for researchers to find 
patients and meet with them.  It was also more work and time for researchers.  Some 
patients felt that it was hard for them to share ideas when they did not know a lot about 
the research topic. 
Some things made patient engagement go well.  It was helpful when researchers 
had clear goals and told patients what those were.  Teaching patients about the research 
topic helped patients be able to give better feedback.  Researchers liked working with 
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patients who had been involved in research before.  Patients also said that it was helpful 
when researchers were kind and polite to them. 
After doing the interviews, we believe that there are things that can make patient 
engagement go better.  New policies can make it easier for researchers to involve 
patients.  Researchers need training on how to involve patients.  Patients need to learn 
more about research.  Researchers can share and learn from each other so that researchers 
who have done engagement before can help researchers who are new to it.  New 
programs can help researchers find patients who want to be involved.  These things can 
improve patient engagement. 
 
Part Two 
A lot of people think that it is important to engage patients, but it is hard to 
explain why.  After doing this work, we believe that there are four reasons why patient 
engagement is important.  First, patients can tell researchers about what is important to 
them.  This may change what the research looks at or how the research is done.  In that 
way, the research might end up being more useful to patients.  Second, patient 
engagement can help researchers keep their promises, since patients can keep asking 
researchers about things they said, early on, that they would do.  Making sure researchers 
keep their promises can help patients have trust in researchers in the future.  Third, 
patient engagement is a way for researchers to learn how to show respect to patients.  
Researchers always need to respect patients.  But sometimes they don’t know how, and if 
they talk to patients, the patients can give them advice about ways to be more respectful.  
Fourth, even if involving patients does not change the research, involving patients itself 
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shows that researchers care and want to hear what patients have to say.  Some patients 
have been ignored in the past.  Patient engagement is a way to show that researchers are 
not ignoring patients, are thinking of them, and want to hear what patients care about. 
These reasons make patient engagement important.  They can help researchers decide 





This research taught us about how, when, and why researchers involve patients.  It 
showed what is hard about it.  We came up with things to do to make patient engagement 
better.  This project showed what makes patient engagement a good thing to do.  The 
results may help guide researchers and groups that fund research.  We still have more to 









Ph.D. Johns Hopkins Bloomberg School of Public Health    Baltimore, MD 
Doctor of Philosophy in Health Policy & Bioethics, June 2015 
Dissertation Title: Characterizing Patient Engagement in Research Funded by the 
Patient-Centered Outcomes Research Institute and Exploring the Moral Importance of 
Patient Engagement in Research 
 
M.A. New York University Graduate School of Arts and Sciences    New York, NY 
 Master of Arts in Bioethics, May 2010 
 
B.A. Colgate University         Hamilton, NY 
 Bachelor of Arts in Philosophy, Cum laude, May 2008 
 Honors in Philosophy, Honors in Liberal Arts Core Curriculum  
 
RESEARCH EXPERIENCE 
Patient-Centered Outcomes Research Institute (PCORI)                              Washington, D.C.                              
Program Associate      June 2014 – February 2015 
Fellow                          July 2013 – June 2014  
• Conducted literature reviews on topics related to patient engagement in research 
• Designed and managed original survey research on stakeholder engagement in PCORI research 
• Analyzed qualitative data for several projects including data collected from PCORI applicants, 
reviewers, funded investigators, and patients and stakeholders engaged in PCORI projects 
• Contributed to manuscripts for peer-reviewed publication and prepared presentations to internal 
and external audiences to disseminate research findings 
• Worked with senior staff to coordinate and manage research activities with external consultants  
 
Johns Hopkins Berman Institute of Bioethics                                                      Baltimore, MD 
Research Assistant      August 2011 – Present 
• Developed research materials, conducted interviews, and performed preliminary data analysis 
for a project studying ways to improve how the concept of randomization is explained to 
potential research participants during the informed consent process 
 
Johns Hopkins Berman Institute of Bioethics                                                      Baltimore, MD 
Research Assistant      October 2013 – April 2014  
• Co-authored a conceptual manuscript exploring three practical reasons for researchers to 





Johns Hopkins Hospital                                                                                          Baltimore, MD 
Project Leader  January 2013 – September 2014 
Research Assistant         January 2012 – May 2012 
• Conducted qualitative interviews and analyzed data as part of an interdisciplinary research 
team studying the experiences of surgical intensive care unit patients, their families, and their 
providers 
• Oversaw three graduate students in subsequent rounds of data collection and analysis and 
directed the preparation of a manuscript for peer-reviewed publication 
  
Johns Hopkins Bloomberg School of Public Health     Baltimore, MD 
Research Assistant February 2011 – December 2011  
• Conducted a moral analysis of issues that arise in regard to international food aid   
• Developed a framework and rapid assessment tool used to enhance fairness in community 
selection for food aid in the Democratic Republic of the Congo 
 
Food and Drug Administration (FDA)             Silver Spring, MD 
Graduate Intern     June 2011 – August 2011 
• Developed an ethics-based justification for FDA’s position on the inclusion of children who 
are wards of the state in medical research 
• Contributed to FDA Draft Guidance for ethics review boards, drug trial sponsors, and 
researchers  
 
Colgate University                 Hamilton, NY 
Research Assistant      August 2007 – December 2007 
• Performed a literature review and analyzed data from focus groups with people from rural 
communities in northeast Africa 
• Produced an analytic report on community perceptions of how HIV/AIDS is spread in South 
Sudan 
 
Dana Farber Cancer Institute and Children’s Hospital Boston       Boston, MA 
Research Assistant   May 2006 – August 2006 
• Performed advanced laboratory techniques as part of biomedical research on rare genetic 
bone marrow failure disorders 
 
TEACHING EXPERIENCE AT GRADUATE LEVEL 
Guest Lecturer, Community-Based Participatory Research Seminar                   Spring 2015 
Teaching Assistant, Ethics of Public Health Practice in Developing Countries             Spring 2014 
Teaching Assistant, Research Ethics and Integration                     2012-2014 
Project Leader, Qualitative Research I: Theory & Methods               Spring 2013 
Project Leader, Qualitative Research II: Data Analysis                Spring 2013 
Teaching Assistant, Ethical Issues in Public Health               Spring 2013 
Teaching Assistant, Research Ethics Intensive          Summer 2012 




Center of Excellence in Regulatory Science & Innovation (CERSI) Scholar            July 2014 
Granted by the Johns Hopkins University and Food and Drug Administration  
 
June Culley Scholarship in Health Policy and Management           April 2014 
Granted by the Johns Hopkins Bloomberg School of Public Health 
 
Marcia Pines Prize in Bioethics and Public Health             June 2011           
Granted by the Berman Institute of Bioethics 
 
M. Holmes Hartshorne Memorial Award              May 2008 
Granted by Colgate University 
 
PUBLICATIONS/PRESENTATIONS 
Peer Reviewed Journal Articles 
Ellis L, Gergen J, Wohlgemuth L, Nolan MT, Aslakson R. Empowering the "cheerers": A 
qualitative study on the role of surgical intensive care unit nurses in enhancing family resilience. 
American Journal of Critical Care (forthcoming). 
 
Forsythe L, Ellis L, Edmundson L, Sabharwal R, Rein A, Konopka K, Frank L. Patient and 
Stakeholder Engagement in the PCORI Pilot Projects: Description and Lessons Learned. Journal 
of General Internal Medicine (forthcoming) 
 
Frank L, Forsythe L, Ellis L, Schrandt S, Sheridan S, Gerson J, Konopka K, Daugherty S. 
Conceptual and practical foundations of patient engagement in research at the Patient-Centered 
Outcomes Research Institute. Quality of Life Research. 2015 Jan 6 (Epub ahead of print). DOI: 
10.1007/s11136-014-0893-3. 
 
Holzer JK, Ellis L, Merritt MW. Why we need community engagement in medical research. 
Journal of Investigational Medicine. 2014;62(6):851-855. 
 
Submitted Articles 
Ellis L, Kass N. Characterizing patient engagement in PCORI-funded research to enhance 
understanding of its ethical and practical value: A qualitative study of principal investigators and 
patients (submitted) 
 




Ellis, L. Exploring ethical rationales for patient engagement in research. American Society for 
Bioethics and the Humanities. September 6-9, 2014. San Diego, CA. 
 
 166 
Ellis, L. Sabharwal R, Forsythe L, Edmundson L, Rein A, Frank L. Assessment of patient and 
stakeholder engagement in the PCORI Pilot Projects. AcademyHealth 2014 Annual Research 
Meeting. June 8-10, 2014. San Diego, CA. 
 
Ellis, L. Aslakson R. Traveling with patients and their families on the “long road”: A qualitative 
analysis of Surgical Intensive Care Unit nurse perceptions. Anesthesiology and Critical Care 
Medicine Research Conference. December 10, 2012. Baltimore, MD 
 
VOLUNTEER WORK 
Community Research Advisory Council (C-RAC)    Baltimore, MD 
Council Member     August 2013 – Present  
• Attend regular meetings to review and provide input on research projects as part of a council 
supported by the Johns Hopkins Institute for Clinical and Translational Research 
• Serve on the planning committees for biannual workshops on community-engaged research 
• Provide content expertise for ongoing evaluations of the research review process and outcomes 
 
Southern Madison County (SOMAC) Volunteer Ambulance Corps  Hamilton, NY 
Director of Membership December 2006 – May 2008 
EMT    September 2005 – May 2008 
• Volunteered 40+ hours a week as an on-call Emergency Medical Technician (EMT) for a 
rural, low-income county in central New York by providing patient care and transport in 
medical emergencies  
• Managed 40+ volunteers in the ambulance service, organized bimonthly clinical trainings, 
and scheduled crew shifts each week to ensure continuous ambulance service coverage 
PROFESSIONAL DEVELOPMENT 
Brocher Foundation Summer Academy in Population Health          Geneva, Switzerland 
Summer Student  June 2012 
• Selected as one of 40 graduate student scholars from around the world for a weeklong 
academy on ethics and policy issues regarding the distribution of human resources for health 
 
Proficient in Microsoft Office Suite, ATLAS.ti, NVivo 
 
Proficient in Spanish (conversational) 
 
 
 
 
 
 
 
 
 
 
 167 
